WO2019178471A1 - High-purity steviol glycosides - Google Patents
High-purity steviol glycosides Download PDFInfo
- Publication number
- WO2019178471A1 WO2019178471A1 PCT/US2019/022456 US2019022456W WO2019178471A1 WO 2019178471 A1 WO2019178471 A1 WO 2019178471A1 US 2019022456 W US2019022456 W US 2019022456W WO 2019178471 A1 WO2019178471 A1 WO 2019178471A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- rebaudioside
- udp
- glucosyltransferase
- amino
- acid sequence
- Prior art date
Links
- 239000004383 Steviol glycoside Substances 0.000 title claims abstract description 378
- 229930182488 steviol glycoside Natural products 0.000 title claims abstract description 378
- 150000008144 steviol glycosides Chemical class 0.000 title claims abstract description 378
- 235000019202 steviosides Nutrition 0.000 title claims description 487
- 235000019411 steviol glycoside Nutrition 0.000 title claims description 374
- 229930188195 rebaudioside Natural products 0.000 claims abstract description 1264
- 239000000203 mixture Substances 0.000 claims abstract description 294
- 238000000034 method Methods 0.000 claims abstract description 293
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 claims abstract description 117
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 claims abstract description 117
- 229940013618 stevioside Drugs 0.000 claims abstract description 117
- QSIDJGUAAUSPMG-CULFPKEHSA-N steviolmonoside Chemical compound O([C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(O)=O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O QSIDJGUAAUSPMG-CULFPKEHSA-N 0.000 claims abstract description 84
- OMHUCGDTACNQEX-OSHKXICASA-N Steviolbioside Natural products O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(O)=O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O OMHUCGDTACNQEX-OSHKXICASA-N 0.000 claims abstract description 81
- JLPRGBMUVNVSKP-AHUXISJXSA-M chembl2368336 Chemical compound [Na+].O([C@H]1[C@@H](O)[C@H](O)[C@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C([O-])=O)[C@@H]1O[C@@H](CO)[C@@H](O)[C@H](O)[C@@H]1O JLPRGBMUVNVSKP-AHUXISJXSA-M 0.000 claims abstract description 81
- GSGVXNMGMKBGQU-PHESRWQRSA-N rebaudioside M Chemical compound C[C@@]12CCC[C@](C)([C@H]1CC[C@@]13CC(=C)[C@@](C1)(CC[C@@H]23)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@H]1O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)C(=O)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@H]1O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O GSGVXNMGMKBGQU-PHESRWQRSA-N 0.000 claims abstract description 65
- RPYRMTHVSUWHSV-CUZJHZIBSA-N rebaudioside D Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O RPYRMTHVSUWHSV-CUZJHZIBSA-N 0.000 claims abstract description 41
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 claims abstract description 40
- 239000001512 FEMA 4601 Substances 0.000 claims abstract description 38
- HELXLJCILKEWJH-SEAGSNCFSA-N Rebaudioside A Natural products O=C(O[C@H]1[C@@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1)[C@@]1(C)[C@@H]2[C@](C)([C@H]3[C@@]4(CC(=C)[C@@](O[C@H]5[C@H](O[C@H]6[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O6)[C@@H](O[C@H]6[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O6)[C@H](O)[C@@H](CO)O5)(C4)CC3)CC2)CCC1 HELXLJCILKEWJH-SEAGSNCFSA-N 0.000 claims abstract description 38
- HELXLJCILKEWJH-UHFFFAOYSA-N entered according to Sigma 01432 Natural products C1CC2C3(C)CCCC(C)(C(=O)OC4C(C(O)C(O)C(CO)O4)O)C3CCC2(C2)CC(=C)C21OC(C1OC2C(C(O)C(O)C(CO)O2)O)OC(CO)C(O)C1OC1OC(CO)C(O)C(O)C1O HELXLJCILKEWJH-UHFFFAOYSA-N 0.000 claims abstract description 38
- 235000019203 rebaudioside A Nutrition 0.000 claims abstract description 38
- YWPVROCHNBYFTP-OSHKXICASA-N rubusoside Chemical compound O([C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O YWPVROCHNBYFTP-OSHKXICASA-N 0.000 claims abstract description 27
- YWPVROCHNBYFTP-UHFFFAOYSA-N Rubusoside Natural products C1CC2C3(C)CCCC(C)(C(=O)OC4C(C(O)C(O)C(CO)O4)O)C3CCC2(C2)CC(=C)C21OC1OC(CO)C(O)C(O)C1O YWPVROCHNBYFTP-UHFFFAOYSA-N 0.000 claims abstract description 26
- 244000005700 microbiome Species 0.000 claims abstract description 22
- RLLCWNUIHGPAJY-SFUUMPFESA-N rebaudioside E Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O RLLCWNUIHGPAJY-SFUUMPFESA-N 0.000 claims abstract description 21
- DRSKVOAJKLUMCL-MMUIXFKXSA-N u2n4xkx7hp Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(O)=O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O DRSKVOAJKLUMCL-MMUIXFKXSA-N 0.000 claims abstract description 21
- RLLCWNUIHGPAJY-RYBZXKSASA-N Rebaudioside E Natural products O=C(O[C@H]1[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O2)[C@@H](O)[C@@H](O)[C@H](CO)O1)[C@]1(C)[C@@H]2[C@@](C)([C@@H]3[C@@]4(CC(=C)[C@@](O[C@@H]5[C@@H](O[C@@H]6[C@@H](O)[C@H](O)[C@@H](O)[C@H](CO)O6)[C@H](O)[C@@H](O)[C@H](CO)O5)(C4)CC3)CC2)CCC1 RLLCWNUIHGPAJY-RYBZXKSASA-N 0.000 claims abstract description 20
- 235000013361 beverage Nutrition 0.000 claims abstract description 12
- 238000005187 foaming Methods 0.000 claims abstract description 3
- 235000015218 chewing gum Nutrition 0.000 claims abstract 2
- 239000003623 enhancer Substances 0.000 claims abstract 2
- 150000001413 amino acids Chemical group 0.000 claims description 507
- 101100101356 Stevia rebaudiana UGT91D2 gene Proteins 0.000 claims description 239
- 101100262416 Stevia rebaudiana UGT76G1 gene Proteins 0.000 claims description 190
- 238000004519 manufacturing process Methods 0.000 claims description 188
- 102000004190 Enzymes Human genes 0.000 claims description 85
- 108090000790 Enzymes Proteins 0.000 claims description 85
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 61
- 239000008103 glucose Substances 0.000 claims description 47
- QFVOYBUQQBFCRH-UHFFFAOYSA-N Steviol Natural products C1CC2(C3)CC(=C)C3(O)CCC2C2(C)C1C(C)(C(O)=O)CCC2 QFVOYBUQQBFCRH-UHFFFAOYSA-N 0.000 claims description 39
- 229940032084 steviol Drugs 0.000 claims description 39
- 101100048059 Stevia rebaudiana UGT85C2 gene Proteins 0.000 claims description 37
- 238000004064 recycling Methods 0.000 claims description 36
- QFVOYBUQQBFCRH-VQSWZGCSSA-N steviol Chemical compound C([C@@]1(O)C(=C)C[C@@]2(C1)CC1)C[C@H]2[C@@]2(C)[C@H]1[C@](C)(C(O)=O)CCC2 QFVOYBUQQBFCRH-VQSWZGCSSA-N 0.000 claims description 36
- 229920001542 oligosaccharide Polymers 0.000 claims description 29
- 101100427140 Stevia rebaudiana UGT74G1 gene Proteins 0.000 claims description 27
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 25
- 150000001720 carbohydrates Chemical class 0.000 claims description 23
- 235000014633 carbohydrates Nutrition 0.000 claims description 21
- 230000015572 biosynthetic process Effects 0.000 claims description 15
- -1 organic acid salts Chemical class 0.000 claims description 15
- 235000013305 food Nutrition 0.000 claims description 12
- 235000000346 sugar Nutrition 0.000 claims description 12
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 9
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 claims description 9
- 150000002482 oligosaccharides Chemical class 0.000 claims description 9
- 229920005862 polyol Polymers 0.000 claims description 9
- 150000003077 polyols Chemical class 0.000 claims description 9
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 claims description 8
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 claims description 8
- 239000011942 biocatalyst Substances 0.000 claims description 8
- 238000002360 preparation method Methods 0.000 claims description 8
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 claims description 7
- 230000037361 pathway Effects 0.000 claims description 7
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 claims description 6
- YFAUKWZNPVBCFF-XHIBXCGHSA-N 4-CDP-2-C-methyl-D-erythritol Chemical compound O[C@@H]1[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H](O)[C@@](O)(CO)C)O[C@H]1N1C(=O)N=C(N)C=C1 YFAUKWZNPVBCFF-XHIBXCGHSA-N 0.000 claims description 6
- 101710166309 4-diphosphocytidyl-2-C-methyl-D-erythritol kinase Proteins 0.000 claims description 6
- 241000228257 Aspergillus sp. Species 0.000 claims description 6
- 241000194110 Bacillus sp. (in: Bacteria) Species 0.000 claims description 6
- 241000588724 Escherichia coli Species 0.000 claims description 6
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 claims description 6
- PNNNRSAQSRJVSB-UHFFFAOYSA-N L-rhamnose Natural products CC(O)C(O)C(O)C(O)C=O PNNNRSAQSRJVSB-UHFFFAOYSA-N 0.000 claims description 6
- 241000235061 Pichia sp. Species 0.000 claims description 6
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 6
- 241000235088 Saccharomyces sp. Species 0.000 claims description 6
- 229930006000 Sucrose Natural products 0.000 claims description 6
- 108010060155 deoxyxylulose-5-phosphate synthase Proteins 0.000 claims description 6
- 239000001177 diphosphate Substances 0.000 claims description 6
- 239000000796 flavoring agent Substances 0.000 claims description 6
- 235000019634 flavors Nutrition 0.000 claims description 6
- 150000002894 organic compounds Chemical class 0.000 claims description 6
- 239000005720 sucrose Substances 0.000 claims description 6
- 150000005846 sugar alcohols Chemical class 0.000 claims description 6
- KJTLQQUUPVSXIM-ZCFIWIBFSA-M (R)-mevalonate Chemical compound OCC[C@](O)(C)CC([O-])=O KJTLQQUUPVSXIM-ZCFIWIBFSA-M 0.000 claims description 5
- KJTLQQUUPVSXIM-UHFFFAOYSA-N DL-mevalonic acid Natural products OCCC(O)(C)CC(O)=O KJTLQQUUPVSXIM-UHFFFAOYSA-N 0.000 claims description 5
- SHZGCJCMOBCMKK-JFNONXLTSA-N L-rhamnopyranose Chemical compound C[C@@H]1OC(O)[C@H](O)[C@H](O)[C@H]1O SHZGCJCMOBCMKK-JFNONXLTSA-N 0.000 claims description 5
- 229920002472 Starch Polymers 0.000 claims description 5
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 claims description 5
- 235000003599 food sweetener Nutrition 0.000 claims description 5
- QSRAJVGDWKFOGU-WBXIDTKBSA-N rebaudioside c Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]1(CC[C@H]2[C@@]3(C)[C@@H]([C@](CCC3)(C)C(=O)O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)CC3)C(=C)C[C@]23C1 QSRAJVGDWKFOGU-WBXIDTKBSA-N 0.000 claims description 5
- 235000019698 starch Nutrition 0.000 claims description 5
- 239000008107 starch Substances 0.000 claims description 5
- 239000003765 sweetening agent Substances 0.000 claims description 5
- 239000006188 syrup Substances 0.000 claims description 5
- 235000020357 syrup Nutrition 0.000 claims description 5
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 claims description 4
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 claims description 4
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 claims description 4
- 229930091371 Fructose Natural products 0.000 claims description 4
- 239000005715 Fructose Substances 0.000 claims description 4
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 claims description 4
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 4
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 claims description 4
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 claims description 4
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 claims description 4
- 229910052799 carbon Inorganic materials 0.000 claims description 4
- 125000004432 carbon atom Chemical group C* 0.000 claims description 4
- 150000001875 compounds Chemical class 0.000 claims description 4
- 229930182830 galactose Natural products 0.000 claims description 4
- FZWBNHMXJMCXLU-BLAUPYHCSA-N isomaltotriose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O)O1 FZWBNHMXJMCXLU-BLAUPYHCSA-N 0.000 claims description 4
- 150000008163 sugars Chemical class 0.000 claims description 4
- AJPADPZSRRUGHI-RFZPGFLSSA-N 1-deoxy-D-xylulose 5-phosphate Chemical compound CC(=O)[C@@H](O)[C@H](O)COP(O)(O)=O AJPADPZSRRUGHI-RFZPGFLSSA-N 0.000 claims description 3
- ONVABDHFQKWOSV-UHFFFAOYSA-N 16-Phyllocladene Natural products C1CC(C2)C(=C)CC32CCC2C(C)(C)CCCC2(C)C31 ONVABDHFQKWOSV-UHFFFAOYSA-N 0.000 claims description 3
- XMWHRVNVKDKBRG-UHNVWZDZSA-N 2-C-Methyl-D-erythritol 4-phosphate Natural products OC[C@@](O)(C)[C@H](O)COP(O)(O)=O XMWHRVNVKDKBRG-UHNVWZDZSA-N 0.000 claims description 3
- 101710184086 2-C-methyl-D-erythritol 2,4-cyclodiphosphate synthase Proteins 0.000 claims description 3
- 101710201168 2-C-methyl-D-erythritol 4-phosphate cytidylyltransferase Proteins 0.000 claims description 3
- 101710195531 2-C-methyl-D-erythritol 4-phosphate cytidylyltransferase, chloroplastic Proteins 0.000 claims description 3
- MSWZFWKMSRAUBD-IVMDWMLBSA-N 2-amino-2-deoxy-D-glucopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 claims description 3
- 108010006229 Acetyl-CoA C-acetyltransferase Proteins 0.000 claims description 3
- 102100037768 Acetyl-CoA acetyltransferase, mitochondrial Human genes 0.000 claims description 3
- 102000057412 Diphosphomevalonate decarboxylases Human genes 0.000 claims description 3
- 108010007508 Farnesyltranstransferase Proteins 0.000 claims description 3
- 102000007317 Farnesyltranstransferase Human genes 0.000 claims description 3
- 235000010469 Glycine max Nutrition 0.000 claims description 3
- 244000068988 Glycine max Species 0.000 claims description 3
- 108090000895 Hydroxymethylglutaryl CoA Reductases Proteins 0.000 claims description 3
- 102000004286 Hydroxymethylglutaryl CoA Reductases Human genes 0.000 claims description 3
- 102000003960 Ligases Human genes 0.000 claims description 3
- 108090000364 Ligases Proteins 0.000 claims description 3
- 229920002774 Maltodextrin Polymers 0.000 claims description 3
- 108700040132 Mevalonate kinases Proteins 0.000 claims description 3
- 108010045510 NADPH-Ferrihemoprotein Reductase Proteins 0.000 claims description 3
- 101000958834 Neosartorya fumigata (strain ATCC MYA-4609 / Af293 / CBS 101355 / FGSC A1100) Diphosphomevalonate decarboxylase mvd1 Proteins 0.000 claims description 3
- 108090000854 Oxidoreductases Proteins 0.000 claims description 3
- 102000004316 Oxidoreductases Human genes 0.000 claims description 3
- 101000958925 Panax ginseng Diphosphomevalonate decarboxylase 1 Proteins 0.000 claims description 3
- 102100024279 Phosphomevalonate kinase Human genes 0.000 claims description 3
- XMWHRVNVKDKBRG-CRCLSJGQSA-N [(2s,3r)-2,3,4-trihydroxy-3-methylbutyl] dihydrogen phosphate Chemical compound OC[C@](O)(C)[C@@H](O)COP(O)(O)=O XMWHRVNVKDKBRG-CRCLSJGQSA-N 0.000 claims description 3
- PYMYPHUHKUWMLA-LMVFSUKVSA-N aldehydo-D-ribose Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 claims description 3
- 235000001014 amino acid Nutrition 0.000 claims description 3
- NIKHGUQULKYIGE-OTCXFQBHSA-N ent-kaur-16-en-19-oic acid Chemical compound C([C@@H]1C[C@]2(CC1=C)CC1)C[C@H]2[C@@]2(C)[C@H]1[C@](C)(C(O)=O)CCC2 NIKHGUQULKYIGE-OTCXFQBHSA-N 0.000 claims description 3
- ONVABDHFQKWOSV-HPUSYDDDSA-N ent-kaur-16-ene Chemical compound C1C[C@H](C2)C(=C)C[C@@]32CC[C@@H]2C(C)(C)CCC[C@@]2(C)[C@@H]31 ONVABDHFQKWOSV-HPUSYDDDSA-N 0.000 claims description 3
- 108010067758 ent-kaurene oxidase Proteins 0.000 claims description 3
- 108010064741 ent-kaurene synthetase A Proteins 0.000 claims description 3
- 229960002442 glucosamine Drugs 0.000 claims description 3
- 150000002453 idose derivatives Chemical class 0.000 claims description 3
- NIKHGUQULKYIGE-UHFFFAOYSA-N kaurenoic acid Natural products C1CC2(CC3=C)CC3CCC2C2(C)C1C(C)(C(O)=O)CCC2 NIKHGUQULKYIGE-UHFFFAOYSA-N 0.000 claims description 3
- 102000002678 mevalonate kinase Human genes 0.000 claims description 3
- 108091000116 phosphomevalonate kinase Proteins 0.000 claims description 3
- LGQKSQQRKHFMLI-SJYYZXOBSA-N (2s,3r,4s,5r)-2-[(3r,4r,5r,6r)-4,5,6-trihydroxyoxan-3-yl]oxyoxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)CO[C@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)OC1 LGQKSQQRKHFMLI-SJYYZXOBSA-N 0.000 claims description 2
- SERLAGPUMNYUCK-BLEZHGCXSA-N (2xi)-6-O-alpha-D-glucopyranosyl-D-arabino-hexitol Chemical compound OCC(O)[C@@H](O)[C@H](O)[C@H](O)CO[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O SERLAGPUMNYUCK-BLEZHGCXSA-N 0.000 claims description 2
- SERLAGPUMNYUCK-DCUALPFSSA-N 1-O-alpha-D-glucopyranosyl-D-mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O SERLAGPUMNYUCK-DCUALPFSSA-N 0.000 claims description 2
- MSWZFWKMSRAUBD-GASJEMHNSA-N 2-amino-2-deoxy-D-galactopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@H](O)[C@@H]1O MSWZFWKMSRAUBD-GASJEMHNSA-N 0.000 claims description 2
- MSWZFWKMSRAUBD-CBPJZXOFSA-N 2-amino-2-deoxy-D-mannopyranose Chemical compound N[C@@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-CBPJZXOFSA-N 0.000 claims description 2
- ASJSAQIRZKANQN-CRCLSJGQSA-N 2-deoxy-D-ribose Chemical compound OC[C@@H](O)[C@@H](O)CC=O ASJSAQIRZKANQN-CRCLSJGQSA-N 0.000 claims description 2
- JCSJTDYCNQHPRJ-UHFFFAOYSA-N 20-hydroxyecdysone 2,3-acetonide Natural products OC1C(O)C(O)COC1OC1C(O)C(O)C(OC2C(C(O)C(O)OC2)O)OC1 JCSJTDYCNQHPRJ-UHFFFAOYSA-N 0.000 claims description 2
- DBTMGCOVALSLOR-UHFFFAOYSA-N 32-alpha-galactosyl-3-alpha-galactosyl-galactose Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(OC2C(C(CO)OC(O)C2O)O)OC(CO)C1O DBTMGCOVALSLOR-UHFFFAOYSA-N 0.000 claims description 2
- LGQKSQQRKHFMLI-UHFFFAOYSA-N 4-O-beta-D-xylopyranosyl-beta-D-xylopyranose Natural products OC1C(O)C(O)COC1OC1C(O)C(O)C(O)OC1 LGQKSQQRKHFMLI-UHFFFAOYSA-N 0.000 claims description 2
- PVXPPJIGRGXGCY-TZLCEDOOSA-N 6-O-alpha-D-glucopyranosyl-D-fructofuranose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)C(O)(CO)O1 PVXPPJIGRGXGCY-TZLCEDOOSA-N 0.000 claims description 2
- ODEHMIGXGLNAKK-OESPXIITSA-N 6-kestotriose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@@H]1[C@@H](O)[C@H](O)[C@](CO)(O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)O1 ODEHMIGXGLNAKK-OESPXIITSA-N 0.000 claims description 2
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 claims description 2
- 229920000945 Amylopectin Polymers 0.000 claims description 2
- 235000016068 Berberis vulgaris Nutrition 0.000 claims description 2
- 241000335053 Beta vulgaris Species 0.000 claims description 2
- 229920000858 Cyclodextrin Polymers 0.000 claims description 2
- GUBGYTABKSRVRQ-CUHNMECISA-N D-Cellobiose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-CUHNMECISA-N 0.000 claims description 2
- YTBSYETUWUMLBZ-UHFFFAOYSA-N D-Erythrose Natural products OCC(O)C(O)C=O YTBSYETUWUMLBZ-UHFFFAOYSA-N 0.000 claims description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims description 2
- WQZGKKKJIJFFOK-CBPJZXOFSA-N D-Gulose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@H](O)[C@H]1O WQZGKKKJIJFFOK-CBPJZXOFSA-N 0.000 claims description 2
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims description 2
- WQZGKKKJIJFFOK-WHZQZERISA-N D-aldose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-WHZQZERISA-N 0.000 claims description 2
- WQZGKKKJIJFFOK-IVMDWMLBSA-N D-allopyranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@H](O)[C@@H]1O WQZGKKKJIJFFOK-IVMDWMLBSA-N 0.000 claims description 2
- LKDRXBCSQODPBY-JDJSBBGDSA-N D-allulose Chemical compound OCC1(O)OC[C@@H](O)[C@@H](O)[C@H]1O LKDRXBCSQODPBY-JDJSBBGDSA-N 0.000 claims description 2
- YTBSYETUWUMLBZ-IUYQGCFVSA-N D-erythrose Chemical compound OC[C@@H](O)[C@@H](O)C=O YTBSYETUWUMLBZ-IUYQGCFVSA-N 0.000 claims description 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims description 2
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 claims description 2
- PHOQVHQSTUBQQK-SQOUGZDYSA-N D-glucono-1,5-lactone Chemical compound OC[C@H]1OC(=O)[C@H](O)[C@@H](O)[C@@H]1O PHOQVHQSTUBQQK-SQOUGZDYSA-N 0.000 claims description 2
- AEMOLEFTQBMNLQ-AQKNRBDQSA-N D-glucopyranuronic acid Chemical compound OC1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-AQKNRBDQSA-N 0.000 claims description 2
- RXVWSYJTUUKTEA-UHFFFAOYSA-N D-maltotriose Natural products OC1C(O)C(OC(C(O)CO)C(O)C(O)C=O)OC(CO)C1OC1C(O)C(O)C(O)C(CO)O1 RXVWSYJTUUKTEA-UHFFFAOYSA-N 0.000 claims description 2
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 claims description 2
- ZCLAHGAZPPEVDX-UHFFFAOYSA-N D-panose Natural products OC1C(O)C(O)C(OC(C(O)CO)C(O)C(O)C=O)OC1COC1C(O)C(O)C(O)C(CO)O1 ZCLAHGAZPPEVDX-UHFFFAOYSA-N 0.000 claims description 2
- SRBFZHDQGSBBOR-SOOFDHNKSA-N D-ribopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@@H]1O SRBFZHDQGSBBOR-SOOFDHNKSA-N 0.000 claims description 2
- ZAQJHHRNXZUBTE-NQXXGFSBSA-N D-ribulose Chemical compound OC[C@@H](O)[C@@H](O)C(=O)CO ZAQJHHRNXZUBTE-NQXXGFSBSA-N 0.000 claims description 2
- UNXHWFMMPAWVPI-QWWZWVQMSA-N D-threitol Chemical compound OC[C@@H](O)[C@H](O)CO UNXHWFMMPAWVPI-QWWZWVQMSA-N 0.000 claims description 2
- ZAQJHHRNXZUBTE-UHFFFAOYSA-N D-threo-2-Pentulose Natural products OCC(O)C(O)C(=O)CO ZAQJHHRNXZUBTE-UHFFFAOYSA-N 0.000 claims description 2
- YTBSYETUWUMLBZ-QWWZWVQMSA-N D-threose Chemical compound OC[C@@H](O)[C@H](O)C=O YTBSYETUWUMLBZ-QWWZWVQMSA-N 0.000 claims description 2
- SQNRKWHRVIAKLP-UHFFFAOYSA-N D-xylobiose Natural products O=CC(O)C(O)C(CO)OC1OCC(O)C(O)C1O SQNRKWHRVIAKLP-UHFFFAOYSA-N 0.000 claims description 2
- ZAQJHHRNXZUBTE-WUJLRWPWSA-N D-xylulose Chemical compound OC[C@@H](O)[C@H](O)C(=O)CO ZAQJHHRNXZUBTE-WUJLRWPWSA-N 0.000 claims description 2
- 229920002307 Dextran Polymers 0.000 claims description 2
- CANAPGLEBDTCAF-NTIPNFSCSA-N Dulcoside A Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@H]1[C@H](O[C@]23C(C[C@]4(C2)[C@H]([C@@]2(C)[C@@H]([C@](CCC2)(C)C(=O)O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)CC4)CC3)=C)O[C@H](CO)[C@@H](O)[C@@H]1O CANAPGLEBDTCAF-NTIPNFSCSA-N 0.000 claims description 2
- CANAPGLEBDTCAF-QHSHOEHESA-N Dulcoside A Natural products C[C@@H]1O[C@H](O[C@@H]2[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]2O[C@]34CC[C@H]5[C@]6(C)CCC[C@](C)([C@H]6CC[C@@]5(CC3=C)C4)C(=O)O[C@@H]7O[C@H](CO)[C@@H](O)[C@H](O)[C@H]7O)[C@H](O)[C@H](O)[C@H]1O CANAPGLEBDTCAF-QHSHOEHESA-N 0.000 claims description 2
- 239000004386 Erythritol Substances 0.000 claims description 2
- 206010056474 Erythrosis Diseases 0.000 claims description 2
- 239000001776 FEMA 4720 Substances 0.000 claims description 2
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 claims description 2
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 claims description 2
- 229920001202 Inulin Polymers 0.000 claims description 2
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 claims description 2
- AYRXSINWFIIFAE-SCLMCMATSA-N Isomaltose Natural products OC[C@H]1O[C@H](OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O)[C@@H](O)[C@@H](O)[C@@H]1O AYRXSINWFIIFAE-SCLMCMATSA-N 0.000 claims description 2
- LKDRXBCSQODPBY-AMVSKUEXSA-N L-(-)-Sorbose Chemical compound OCC1(O)OC[C@H](O)[C@@H](O)[C@@H]1O LKDRXBCSQODPBY-AMVSKUEXSA-N 0.000 claims description 2
- WQZGKKKJIJFFOK-VSOAQEOCSA-N L-altropyranose Chemical compound OC[C@@H]1OC(O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-VSOAQEOCSA-N 0.000 claims description 2
- SHZGCJCMOBCMKK-DHVFOXMCSA-N L-fucopyranose Chemical compound C[C@@H]1OC(O)[C@@H](O)[C@H](O)[C@@H]1O SHZGCJCMOBCMKK-DHVFOXMCSA-N 0.000 claims description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 2
- 229930195725 Mannitol Natural products 0.000 claims description 2
- FLDFNEBHEXLZRX-DLQNOBSRSA-N Nystose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(O[C@@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 FLDFNEBHEXLZRX-DLQNOBSRSA-N 0.000 claims description 2
- AYRXSINWFIIFAE-UHFFFAOYSA-N O6-alpha-D-Galactopyranosyl-D-galactose Natural products OCC1OC(OCC(O)C(O)C(O)C(O)C=O)C(O)C(O)C1O AYRXSINWFIIFAE-UHFFFAOYSA-N 0.000 claims description 2
- FSJSODMMIYGSTK-AGJIYOFVSA-N OC[C@H]1O[C@@H](OC[C@H]2O[C@@H](OC[C@H]3O[C@@H](OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O)[C@H](O)[C@@H](O)[C@@H]3O)[C@H](O)[C@@H](O)[C@@H]2O)[C@H](O)[C@@H](O)[C@@H]1O Chemical compound OC[C@H]1O[C@@H](OC[C@H]2O[C@@H](OC[C@H]3O[C@@H](OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O)[C@H](O)[C@@H](O)[C@@H]3O)[C@H](O)[C@@H](O)[C@@H]2O)[C@H](O)[C@@H](O)[C@@H]1O FSJSODMMIYGSTK-AGJIYOFVSA-N 0.000 claims description 2
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 claims description 2
- FTNIPWXXIGNQQF-UHFFFAOYSA-N UNPD130147 Natural products OC1C(O)C(O)C(CO)OC1OC1C(CO)OC(OC2C(OC(OC3C(OC(OC4C(OC(O)C(O)C4O)CO)C(O)C3O)CO)C(O)C2O)CO)C(O)C1O FTNIPWXXIGNQQF-UHFFFAOYSA-N 0.000 claims description 2
- LUEWUZLMQUOBSB-UHFFFAOYSA-N UNPD55895 Natural products OC1C(O)C(O)C(CO)OC1OC1C(CO)OC(OC2C(OC(OC3C(OC(O)C(O)C3O)CO)C(O)C2O)CO)C(O)C1O LUEWUZLMQUOBSB-UHFFFAOYSA-N 0.000 claims description 2
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims description 2
- GNTQICZXQYZQNE-HSUXUTPPSA-N abequose Chemical compound C[C@@H](O)[C@H](O)C[C@@H](O)C=O GNTQICZXQYZQNE-HSUXUTPPSA-N 0.000 claims description 2
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 claims description 2
- HDTRYLNUVZCQOY-BTLHAWITSA-N alpha,beta-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-BTLHAWITSA-N 0.000 claims description 2
- SRBFZHDQGSBBOR-STGXQOJASA-N alpha-D-lyxopyranose Chemical compound O[C@@H]1CO[C@H](O)[C@@H](O)[C@H]1O SRBFZHDQGSBBOR-STGXQOJASA-N 0.000 claims description 2
- BNABBHGYYMZMOA-AHIHXIOASA-N alpha-maltoheptaose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)O[C@H](O[C@@H]2[C@H](O[C@H](O[C@@H]3[C@H](O[C@H](O[C@@H]4[C@H](O[C@H](O[C@@H]5[C@H](O[C@H](O[C@@H]6[C@H](O[C@H](O)[C@H](O)[C@H]6O)CO)[C@H](O)[C@H]5O)CO)[C@H](O)[C@H]4O)CO)[C@H](O)[C@H]3O)CO)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O BNABBHGYYMZMOA-AHIHXIOASA-N 0.000 claims description 2
- OCIBBXPLUVYKCH-QXVNYKTNSA-N alpha-maltohexaose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)O[C@H](O[C@@H]2[C@H](O[C@H](O[C@@H]3[C@H](O[C@H](O[C@@H]4[C@H](O[C@H](O[C@@H]5[C@H](O[C@H](O)[C@H](O)[C@H]5O)CO)[C@H](O)[C@H]4O)CO)[C@H](O)[C@H]3O)CO)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O OCIBBXPLUVYKCH-QXVNYKTNSA-N 0.000 claims description 2
- 239000003963 antioxidant agent Substances 0.000 claims description 2
- 235000006708 antioxidants Nutrition 0.000 claims description 2
- FBJQEBRMDXPWNX-CFCQXFMMSA-N beta-D-Glcp-(1->6)-beta-D-Glcp-(1->6)-beta-D-Glcp Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](OC[C@@H]2[C@H]([C@H](O)[C@@H](O)[C@H](O)O2)O)O1 FBJQEBRMDXPWNX-CFCQXFMMSA-N 0.000 claims description 2
- JCSJTDYCNQHPRJ-FDVJSPBESA-N beta-D-Xylp-(1->4)-beta-D-Xylp-(1->4)-D-Xylp Chemical compound O[C@@H]1[C@@H](O)[C@H](O)CO[C@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O)C(O)OC2)O)OC1 JCSJTDYCNQHPRJ-FDVJSPBESA-N 0.000 claims description 2
- DLRVVLDZNNYCBX-ZZFZYMBESA-N beta-melibiose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](O)O1 DLRVVLDZNNYCBX-ZZFZYMBESA-N 0.000 claims description 2
- 229960001948 caffeine Drugs 0.000 claims description 2
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 claims description 2
- 235000009508 confectionery Nutrition 0.000 claims description 2
- 239000002537 cosmetic Substances 0.000 claims description 2
- 230000008878 coupling Effects 0.000 claims description 2
- 238000010168 coupling process Methods 0.000 claims description 2
- 238000005859 coupling reaction Methods 0.000 claims description 2
- 229940097362 cyclodextrins Drugs 0.000 claims description 2
- 235000005911 diet Nutrition 0.000 claims description 2
- 230000037213 diet Effects 0.000 claims description 2
- 235000013399 edible fruits Nutrition 0.000 claims description 2
- 239000003995 emulsifying agent Substances 0.000 claims description 2
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 claims description 2
- 235000019414 erythritol Nutrition 0.000 claims description 2
- 229940009714 erythritol Drugs 0.000 claims description 2
- UQPHVQVXLPRNCX-UHFFFAOYSA-N erythrulose Chemical compound OCC(O)C(=O)CO UQPHVQVXLPRNCX-UHFFFAOYSA-N 0.000 claims description 2
- FBPFZTCFMRRESA-GUCUJZIJSA-N galactitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-GUCUJZIJSA-N 0.000 claims description 2
- DBTMGCOVALSLOR-AXAHEAMVSA-N galactotriose Natural products OC[C@@H]1O[C@@H](O[C@@H]2[C@@H](O)[C@H](CO)O[C@@H](O[C@H]3[C@@H](O)[C@H](O)O[C@@H](CO)[C@@H]3O)[C@@H]2O)[C@H](O)[C@H](O)[C@H]1O DBTMGCOVALSLOR-AXAHEAMVSA-N 0.000 claims description 2
- DLRVVLDZNNYCBX-CQUJWQHSSA-N gentiobiose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)C(O)O1 DLRVVLDZNNYCBX-CQUJWQHSSA-N 0.000 claims description 2
- 239000000174 gluconic acid Substances 0.000 claims description 2
- 235000012208 gluconic acid Nutrition 0.000 claims description 2
- 229950006191 gluconic acid Drugs 0.000 claims description 2
- 235000012209 glucono delta-lactone Nutrition 0.000 claims description 2
- 229960003681 gluconolactone Drugs 0.000 claims description 2
- 229940097043 glucuronic acid Drugs 0.000 claims description 2
- 235000019534 high fructose corn syrup Nutrition 0.000 claims description 2
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 claims description 2
- 229960000367 inositol Drugs 0.000 claims description 2
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 claims description 2
- 229940029339 inulin Drugs 0.000 claims description 2
- 229960004903 invert sugar Drugs 0.000 claims description 2
- 239000000905 isomalt Substances 0.000 claims description 2
- 235000010439 isomalt Nutrition 0.000 claims description 2
- HPIGCVXMBGOWTF-UHFFFAOYSA-N isomaltol Natural products CC(=O)C=1OC=CC=1O HPIGCVXMBGOWTF-UHFFFAOYSA-N 0.000 claims description 2
- DLRVVLDZNNYCBX-RTPHMHGBSA-N isomaltose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)C(O)O1 DLRVVLDZNNYCBX-RTPHMHGBSA-N 0.000 claims description 2
- 239000000832 lactitol Substances 0.000 claims description 2
- 235000010448 lactitol Nutrition 0.000 claims description 2
- VQHSOMBJVWLPSR-JVCRWLNRSA-N lactitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-JVCRWLNRSA-N 0.000 claims description 2
- 229960003451 lactitol Drugs 0.000 claims description 2
- 239000008101 lactose Substances 0.000 claims description 2
- JCQLYHFGKNRPGE-FCVZTGTOSA-N lactulose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 JCQLYHFGKNRPGE-FCVZTGTOSA-N 0.000 claims description 2
- 229960000511 lactulose Drugs 0.000 claims description 2
- PFCRQPBOOFTZGQ-UHFFFAOYSA-N lactulose keto form Natural products OCC(=O)C(O)C(C(O)CO)OC1OC(CO)C(O)C(O)C1O PFCRQPBOOFTZGQ-UHFFFAOYSA-N 0.000 claims description 2
- 239000007788 liquid Substances 0.000 claims description 2
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 claims description 2
- 235000010449 maltitol Nutrition 0.000 claims description 2
- 239000000845 maltitol Substances 0.000 claims description 2
- 229940035436 maltitol Drugs 0.000 claims description 2
- DJMVHSOAUQHPSN-UHFFFAOYSA-N malto-hexaose Natural products OC1C(O)C(OC(C(O)CO)C(O)C(O)C=O)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(OC4C(C(O)C(O)C(CO)O4)O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 DJMVHSOAUQHPSN-UHFFFAOYSA-N 0.000 claims description 2
- FJCUPROCOFFUSR-UHFFFAOYSA-N malto-pentaose Natural products OC1C(O)C(OC(C(O)CO)C(O)C(O)C=O)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 FJCUPROCOFFUSR-UHFFFAOYSA-N 0.000 claims description 2
- UYQJCPNSAVWAFU-UHFFFAOYSA-N malto-tetraose Natural products OC1C(O)C(OC(C(O)CO)C(O)C(O)C=O)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(O)C(CO)O2)O)C(CO)O1 UYQJCPNSAVWAFU-UHFFFAOYSA-N 0.000 claims description 2
- FJCUPROCOFFUSR-GMMZZHHDSA-N maltopentaose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O[C@H]([C@H](O)CO)[C@H](O)[C@@H](O)C=O)O[C@H](CO)[C@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O[C@@H]2[C@@H]([C@@H](O)[C@H](O[C@@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)[C@@H](CO)O2)O)[C@@H](CO)O1 FJCUPROCOFFUSR-GMMZZHHDSA-N 0.000 claims description 2
- 239000000594 mannitol Substances 0.000 claims description 2
- 235000010355 mannitol Nutrition 0.000 claims description 2
- FYGDTMLNYKFZSV-UHFFFAOYSA-N mannotriose Natural products OC1C(O)C(O)C(CO)OC1OC1C(CO)OC(OC2C(OC(O)C(O)C2O)CO)C(O)C1O FYGDTMLNYKFZSV-UHFFFAOYSA-N 0.000 claims description 2
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims description 2
- 230000000051 modifying effect Effects 0.000 claims description 2
- 239000002417 nutraceutical Substances 0.000 claims description 2
- 235000021436 nutraceutical agent Nutrition 0.000 claims description 2
- FLDFNEBHEXLZRX-UHFFFAOYSA-N nystose Natural products OC1C(O)C(CO)OC1(CO)OCC1(OCC2(OC3C(C(O)C(O)C(CO)O3)O)C(C(O)C(CO)O2)O)C(O)C(O)C(CO)O1 FLDFNEBHEXLZRX-UHFFFAOYSA-N 0.000 claims description 2
- 150000007524 organic acids Chemical class 0.000 claims description 2
- 235000005985 organic acids Nutrition 0.000 claims description 2
- ZCLAHGAZPPEVDX-MQHGYYCBSA-N panose Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@@H](O[C@H]([C@H](O)CO)[C@H](O)[C@@H](O)C=O)O[C@@H]1CO[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 ZCLAHGAZPPEVDX-MQHGYYCBSA-N 0.000 claims description 2
- 239000008194 pharmaceutical composition Substances 0.000 claims description 2
- 229920000642 polymer Polymers 0.000 claims description 2
- 239000003755 preservative agent Substances 0.000 claims description 2
- 108090000623 proteins and genes Proteins 0.000 claims description 2
- HYLAUKAHEAUVFE-AVBZULRRSA-N rebaudioside f Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)CO1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HYLAUKAHEAUVFE-AVBZULRRSA-N 0.000 claims description 2
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 claims description 2
- 239000000600 sorbitol Substances 0.000 claims description 2
- 235000010356 sorbitol Nutrition 0.000 claims description 2
- 235000019505 tobacco product Nutrition 0.000 claims description 2
- RULSWEULPANCDV-PIXUTMIVSA-N turanose Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](C(=O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O RULSWEULPANCDV-PIXUTMIVSA-N 0.000 claims description 2
- 235000010447 xylitol Nutrition 0.000 claims description 2
- 239000000811 xylitol Substances 0.000 claims description 2
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims description 2
- 229960002675 xylitol Drugs 0.000 claims description 2
- ABKNGTPZXRUSOI-UHFFFAOYSA-N xylotriose Natural products OCC(OC1OCC(OC2OCC(O)C(O)C2O)C(O)C1O)C(O)C(O)C=O ABKNGTPZXRUSOI-UHFFFAOYSA-N 0.000 claims description 2
- FYGDTMLNYKFZSV-BYLHFPJWSA-N β-1,4-galactotrioside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@H](CO)O[C@@H](O[C@@H]2[C@@H](O[C@@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-BYLHFPJWSA-N 0.000 claims description 2
- 150000003839 salts Chemical class 0.000 claims 7
- 241000251468 Actinopterygii Species 0.000 claims 3
- 229930186291 Dulcoside Natural products 0.000 claims 3
- 239000003795 chemical substances by application Substances 0.000 claims 3
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims 2
- WZUVPPKBWHMQCE-UHFFFAOYSA-N Haematoxylin Chemical compound C12=CC(O)=C(O)C=C2CC2(O)C1C1=CC=C(O)C(O)=C1OC2 WZUVPPKBWHMQCE-UHFFFAOYSA-N 0.000 claims 2
- 150000001298 alcohols Chemical class 0.000 claims 2
- 235000015895 biscuits Nutrition 0.000 claims 2
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims 2
- 239000004615 ingredient Substances 0.000 claims 2
- 235000013372 meat Nutrition 0.000 claims 2
- 235000013580 sausages Nutrition 0.000 claims 2
- 235000014102 seafood Nutrition 0.000 claims 2
- 235000013555 soy sauce Nutrition 0.000 claims 2
- 235000013311 vegetables Nutrition 0.000 claims 2
- 235000021419 vinegar Nutrition 0.000 claims 2
- 239000000052 vinegar Substances 0.000 claims 2
- NPWRSXJQDKRXOR-SJORKVTESA-N (+)-taxifolin 3-O-acetate Chemical compound C1([C@@H]2[C@H](C(C3=C(O)C=C(O)C=C3O2)=O)OC(=O)C)=CC=C(O)C(O)=C1 NPWRSXJQDKRXOR-SJORKVTESA-N 0.000 claims 1
- RMLYXMMBIZLGAQ-UHFFFAOYSA-N (-)-monatin Natural products C1=CC=C2C(CC(O)(CC(N)C(O)=O)C(O)=O)=CNC2=C1 RMLYXMMBIZLGAQ-UHFFFAOYSA-N 0.000 claims 1
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 claims 1
- GHBNZZJYBXQAHG-KUVSNLSMSA-N (2r,3r,4s,5s,6r)-2-[[(2r,3s,4s,5r,6r)-6-[[(3s,8s,9r,10r,11r,13r,14s,17r)-17-[(2r,5r)-5-[(2s,3r,4s,5s,6r)-4,5-dihydroxy-3-[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-[[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy Chemical compound C([C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@H](CC[C@@H](C)[C@@H]1[C@]2(C[C@@H](O)[C@@]3(C)[C@H]4C(C([C@@H](O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]6[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O6)O)O5)O)CC4)(C)C)=CC[C@H]3[C@]2(C)CC1)C)C(C)(C)O)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O GHBNZZJYBXQAHG-KUVSNLSMSA-N 0.000 claims 1
- JPFGFRMPGVDDGE-GWRCVIBKSA-N (2r,3s,4s,5r)-2-(hydroxymethyl)-5-[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxane-2,3,4-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@H]1[C@@H](O)[C@H](O)[C@@](O)(CO)OC1 JPFGFRMPGVDDGE-GWRCVIBKSA-N 0.000 claims 1
- RMLYXMMBIZLGAQ-HZMBPMFUSA-N (2s,4s)-4-amino-2-hydroxy-2-(1h-indol-3-ylmethyl)pentanedioic acid Chemical compound C1=CC=C2C(C[C@](O)(C[C@H](N)C(O)=O)C(O)=O)=CNC2=C1 RMLYXMMBIZLGAQ-HZMBPMFUSA-N 0.000 claims 1
- QZOALWMSYRBZSA-PDSBIMDKSA-N (3r,5r,8r,9r,10r,13s,14r)-3-[(2r,3r,4s,5s,6r)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-10,13-dimethyl-17-[(1s)-1-[(2r,5s,6r)-5-methyl-6-[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@H]1C[C@H]2C(=O)C[C@@H]3[C@H]4CCC([C@]4(CC[C@H]3[C@@]2(C)CC1)C)[C@H](C)[C@@H]1O[C@H](O[C@H]2[C@@H]([C@H](O)[C@@H](O)[C@H](C)O2)O)[C@@H](C)CC1)[C@@H]1O[C@@H](C)[C@H](O)[C@@H](O)[C@H]1O QZOALWMSYRBZSA-PDSBIMDKSA-N 0.000 claims 1
- YTKBWWKAVMSYHE-OALUTQOASA-N (3s)-3-[3-(3-hydroxy-4-methoxyphenyl)propylamino]-4-[[(2s)-1-methoxy-1-oxo-3-phenylpropan-2-yl]amino]-4-oxobutanoic acid Chemical compound C([C@@H](C(=O)OC)NC(=O)[C@H](CC(O)=O)NCCCC=1C=C(O)C(OC)=CC=1)C1=CC=CC=C1 YTKBWWKAVMSYHE-OALUTQOASA-N 0.000 claims 1
- NUFKRGBSZPCGQB-FLBSXDLDSA-N (3s)-3-amino-4-oxo-4-[[(2r)-1-oxo-1-[(2,2,4,4-tetramethylthietan-3-yl)amino]propan-2-yl]amino]butanoic acid;pentahydrate Chemical compound O.O.O.O.O.OC(=O)C[C@H](N)C(=O)N[C@H](C)C(=O)NC1C(C)(C)SC1(C)C.OC(=O)C[C@H](N)C(=O)N[C@H](C)C(=O)NC1C(C)(C)SC1(C)C NUFKRGBSZPCGQB-FLBSXDLDSA-N 0.000 claims 1
- YDDUMTOHNYZQPO-UHFFFAOYSA-N 1,3-bis{[(2E)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy}-4,5-dihydroxycyclohexanecarboxylic acid Natural products OC1C(O)CC(C(O)=O)(OC(=O)C=CC=2C=C(O)C(O)=CC=2)CC1OC(=O)C=CC1=CC=C(O)C(O)=C1 YDDUMTOHNYZQPO-UHFFFAOYSA-N 0.000 claims 1
- YEDFEBOUHSBQBT-UHFFFAOYSA-N 2,3-dihydroflavon-3-ol Chemical compound O1C2=CC=CC=C2C(=O)C(O)C1C1=CC=CC=C1 YEDFEBOUHSBQBT-UHFFFAOYSA-N 0.000 claims 1
- 108030005203 2-C-methyl-D-erythritol 2,4-cyclodiphosphate synthases Proteins 0.000 claims 1
- MIDXCONKKJTLDX-UHFFFAOYSA-N 3,5-dimethylcyclopentane-1,2-dione Chemical compound CC1CC(C)C(=O)C1=O MIDXCONKKJTLDX-UHFFFAOYSA-N 0.000 claims 1
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 claims 1
- NNXQSUSEFPRCRS-YCKMUKMSSA-N 3-[(3S,3aR,4R,5aR,6S,7S,9aR,9bR)-3-[(E,2S)-2,6-dihydroxy-6-methylhept-4-en-2-yl]-6,9a,9b-trimethyl-7-prop-1-en-2-yl-4-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy-1,2,3,3a,4,5,5a,7,8,9-decahydrocyclopenta[a]naphthalen-6-yl]propanoic acid Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1[C@@H]2[C@@H]([C@@](C)(O)C\C=C\C(C)(C)O)CC[C@@]2(C)[C@]2(C)CC[C@@H](C(C)=C)[C@](C)(CCC(O)=O)[C@H]2C1 NNXQSUSEFPRCRS-YCKMUKMSSA-N 0.000 claims 1
- 229930191364 Abrusoside Natural products 0.000 claims 1
- WBZFUFAFFUEMEI-UHFFFAOYSA-M Acesulfame k Chemical compound [K+].CC1=CC(=O)[N-]S(=O)(=O)O1 WBZFUFAFFUEMEI-UHFFFAOYSA-M 0.000 claims 1
- 239000004394 Advantame Substances 0.000 claims 1
- 239000004377 Alitame Substances 0.000 claims 1
- 108010011485 Aspartame Proteins 0.000 claims 1
- ZROGCCBNZBKLEL-FHXNIQKESA-N Astilbin Natural products O([C@H]1[C@@H](c2cc(O)c(O)cc2)Oc2c(c(O)cc(O)c2)C1=O)[C@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](C)O1 ZROGCCBNZBKLEL-FHXNIQKESA-N 0.000 claims 1
- 241001474374 Blennius Species 0.000 claims 1
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 claims 1
- 240000006766 Cornus mas Species 0.000 claims 1
- 235000003363 Cornus mas Nutrition 0.000 claims 1
- UDIPTWFVPPPURJ-UHFFFAOYSA-M Cyclamate Chemical compound [Na+].[O-]S(=O)(=O)NC1CCCCC1 UDIPTWFVPPPURJ-UHFFFAOYSA-M 0.000 claims 1
- SITQVDJAXQSXSA-CEZRHVESSA-N Cynarin Natural products O[C@@H]1C[C@@](C[C@H](O)[C@H]1OC(=O)C=Cc2ccc(O)c(O)c2)(OC(=O)C=Cc3cccc(O)c3O)C(=O)O SITQVDJAXQSXSA-CEZRHVESSA-N 0.000 claims 1
- YDDUMTOHNYZQPO-RVXRWRFUSA-N Cynarine Chemical compound O([C@@H]1C[C@@](C[C@H]([C@@H]1O)O)(OC(=O)\C=C\C=1C=C(O)C(O)=CC=1)C(O)=O)C(=O)\C=C\C1=CC=C(O)C(O)=C1 YDDUMTOHNYZQPO-RVXRWRFUSA-N 0.000 claims 1
- BJHIKXHVCXFQLS-PUFIMZNGSA-N D-psicose Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)C(=O)CO BJHIKXHVCXFQLS-PUFIMZNGSA-N 0.000 claims 1
- LKDRXBCSQODPBY-OEXCPVAWSA-N D-tagatose Chemical compound OCC1(O)OC[C@@H](O)[C@H](O)[C@@H]1O LKDRXBCSQODPBY-OEXCPVAWSA-N 0.000 claims 1
- GGLIEWRLXDLBBF-UHFFFAOYSA-N Dulcin Chemical compound CCOC1=CC=C(NC(N)=O)C=C1 GGLIEWRLXDLBBF-UHFFFAOYSA-N 0.000 claims 1
- 239000001329 FEMA 3811 Substances 0.000 claims 1
- 239000001689 FEMA 4674 Substances 0.000 claims 1
- 239000004471 Glycine Substances 0.000 claims 1
- GLLUYNRFPAMGQR-UHFFFAOYSA-N Glycyphyllin Natural products OC1C(O)C(O)C(C)OC1OC1=CC(O)=CC(O)=C1C(=O)CCC1=CC=C(O)C=C1 GLLUYNRFPAMGQR-UHFFFAOYSA-N 0.000 claims 1
- HYQNKKAJVPMBDR-HIFRSBDPSA-N Hernandulcin Chemical compound CC(C)=CCC[C@](C)(O)[C@@H]1CCC(C)=CC1=O HYQNKKAJVPMBDR-HIFRSBDPSA-N 0.000 claims 1
- HYQNKKAJVPMBDR-UHFFFAOYSA-N Hernandulcin Natural products CC(C)=CCCC(C)(O)C1CCC(C)=CC1=O HYQNKKAJVPMBDR-UHFFFAOYSA-N 0.000 claims 1
- SHZGCJCMOBCMKK-PQMKYFCFSA-N L-Fucose Natural products C[C@H]1O[C@H](O)[C@@H](O)[C@@H](O)[C@@H]1O SHZGCJCMOBCMKK-PQMKYFCFSA-N 0.000 claims 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 claims 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 claims 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 claims 1
- WQZGKKKJIJFFOK-ZZWDRFIYSA-N L-glucose Chemical compound OC[C@@H]1OC(O)[C@@H](O)[C@H](O)[C@H]1O WQZGKKKJIJFFOK-ZZWDRFIYSA-N 0.000 claims 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 claims 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 claims 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 claims 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 claims 1
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 claims 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims 1
- 239000004472 Lysine Substances 0.000 claims 1
- 101710084933 Miraculin Proteins 0.000 claims 1
- 108050004114 Monellin Proteins 0.000 claims 1
- 108010093901 N-(N-(3-(3-hydroxy-4-methoxyphenyl) propyl)-alpha-aspartyl)-L-phenylalanine 1-methyl ester Proteins 0.000 claims 1
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 claims 1
- 239000004384 Neotame Substances 0.000 claims 1
- 244000061176 Nicotiana tabacum Species 0.000 claims 1
- 235000002637 Nicotiana tabacum Nutrition 0.000 claims 1
- 240000007594 Oryza sativa Species 0.000 claims 1
- 235000007164 Oryza sativa Nutrition 0.000 claims 1
- QZOALWMSYRBZSA-UHFFFAOYSA-N Osladin Natural products C1CC(C)C(OC2C(C(O)C(O)C(C)O2)O)OC1C(C)C(C1(CCC2C3(C)CC4)C)CCC1C2CC(=O)C3CC4OC1OC(CO)C(O)C(O)C1OC1OC(C)C(O)C(O)C1O QZOALWMSYRBZSA-UHFFFAOYSA-N 0.000 claims 1
- 208000001132 Osteoporosis Diseases 0.000 claims 1
- 101000865553 Pentadiplandra brazzeana Defensin-like protein Proteins 0.000 claims 1
- XCOJIVIDDFTHGB-UEUZTHOGSA-N Perillartine Chemical compound CC(=C)[C@H]1CCC(\C=N\O)=CC1 XCOJIVIDDFTHGB-UEUZTHOGSA-N 0.000 claims 1
- 244000046052 Phaseolus vulgaris Species 0.000 claims 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 claims 1
- 229940126902 Phlorizin Drugs 0.000 claims 1
- OFFJUHSISSNBNT-UHFFFAOYSA-N Polypodoside A Natural products C1CC(C)C(OC2C(C(O)C(O)C(C)O2)O)OC1C(C)C(C1(CCC2C3(C)CC4)C)CCC1C2=CC(=O)C3CC4OC1OC(CO)C(O)C(O)C1OC1OC(C)C(O)C(O)C1O OFFJUHSISSNBNT-UHFFFAOYSA-N 0.000 claims 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 claims 1
- 108010009736 Protein Hydrolysates Proteins 0.000 claims 1
- PMDYNLFGCCRGRX-IJCRGVQFSA-N Selligueain A Natural products O[C@@H]1Cc2c(O)cc(O)c([C@@H]3[C@@H](O)[C@H](Oc4c3c(O)cc5O[C@@]6(Oc7cc(O)cc(O)c7[C@@H]([C@H]6O)c45)c8ccc(O)cc8)c9ccc(O)cc9)c2O[C@H]1c%10ccc(O)cc%10 PMDYNLFGCCRGRX-IJCRGVQFSA-N 0.000 claims 1
- 229920002680 Selligueain A Polymers 0.000 claims 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 claims 1
- 239000004376 Sucralose Substances 0.000 claims 1
- 244000299461 Theobroma cacao Species 0.000 claims 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 claims 1
- 239000004473 Threonine Substances 0.000 claims 1
- 229930182647 Trilobatin Natural products 0.000 claims 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 claims 1
- SPFBVQWRJFUDBB-FYBFSNJASA-N Ziziphin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O[C@@H]2C([C@H]3[C@]([C@@H]4[C@@]([C@@]56C[C@]7([C@H]([C@@](C[C@@H](O7)C=C(C)C)(C)O[C@H]7[C@@H]([C@H](OC(C)=O)[C@@H](O)[C@H](C)O7)OC(C)=O)[C@H]6CC4)OC5)(C)CC3)(C)CC2)(C)C)OC1 SPFBVQWRJFUDBB-FYBFSNJASA-N 0.000 claims 1
- QLVJDGJNRIPOSF-UHFFFAOYSA-N Ziziphin Natural products CC1OC(COCC2COC(COC3CCC4(C)C(CCC5(C)C4CCC6C7C(C)(CC(OC78CC56CO8)C=C(C)C)OC9OC(C)C(O)C(OC(=O)C)C9OC(=O)C)C3(C)C)C(O)C2O)C(O)C(O)C1O QLVJDGJNRIPOSF-UHFFFAOYSA-N 0.000 claims 1
- HINSNOJRHFIMKB-DJDMUFINSA-N [(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl] (1R,4S,5R,9S,10R,13S)-13-[(2S,3R,4S,5R,6R)-5-hydroxy-6-(hydroxymethyl)-3,4-bis[[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy]oxan-2-yl]oxy-5,9-dimethyl-14-methylidenetetracyclo[11.2.1.01,10.04,9]hexadecane-5-carboxylate Chemical compound [H][C@@]1(O[C@@H]2[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]2OC(=O)[C@]2(C)CCC[C@@]3(C)[C@]4([H])CC[C@@]5(C[C@]4(CC5=C)CC[C@]23[H])O[C@]2([H])O[C@H](CO)[C@@H](O)[C@H](O[C@]3([H])O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)[C@H]2O[C@]2([H])O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)O[C@@H](C)[C@H](O)[C@@H](O)[C@H]1O HINSNOJRHFIMKB-DJDMUFINSA-N 0.000 claims 1
- 239000002253 acid Substances 0.000 claims 1
- 150000007513 acids Chemical class 0.000 claims 1
- 239000000654 additive Substances 0.000 claims 1
- 230000000996 additive effect Effects 0.000 claims 1
- 235000019453 advantame Nutrition 0.000 claims 1
- 235000004279 alanine Nutrition 0.000 claims 1
- 125000001931 aliphatic group Chemical group 0.000 claims 1
- 235000019409 alitame Nutrition 0.000 claims 1
- 108010009985 alitame Proteins 0.000 claims 1
- 239000000605 aspartame Substances 0.000 claims 1
- 235000010357 aspartame Nutrition 0.000 claims 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 claims 1
- 229960003438 aspartame Drugs 0.000 claims 1
- 235000003704 aspartic acid Nutrition 0.000 claims 1
- JOKKBOSZTVHKSH-UHFFFAOYSA-N baiyunoside Natural products CC12CCC(OC3C(C(O)C(O)C(CO)O3)OC3C(C(O)C(O)CO3)O)C(C)(C)C1CCC(C)=C2CCC=1C=COC=1 JOKKBOSZTVHKSH-UHFFFAOYSA-N 0.000 claims 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 claims 1
- UWHUTZOCTZJUKC-JKSUJKDBSA-N brazilin Chemical compound C12=CC(O)=C(O)C=C2C[C@]2(O)[C@H]1C1=CC=C(O)C=C1OC2 UWHUTZOCTZJUKC-JKSUJKDBSA-N 0.000 claims 1
- UWHUTZOCTZJUKC-CVEARBPZSA-N brazilin Natural products C12=CC(O)=C(O)C=C2C[C@@]2(O)[C@@H]1C1=CC=C(O)C=C1OC2 UWHUTZOCTZJUKC-CVEARBPZSA-N 0.000 claims 1
- 235000008429 bread Nutrition 0.000 claims 1
- 235000013736 caramel Nutrition 0.000 claims 1
- 235000012174 carbonated soft drink Nutrition 0.000 claims 1
- 229930187149 carnosifloside Natural products 0.000 claims 1
- 229940112822 chewing gum Drugs 0.000 claims 1
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 claims 1
- 229940074393 chlorogenic acid Drugs 0.000 claims 1
- 235000001368 chlorogenic acid Nutrition 0.000 claims 1
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 claims 1
- 235000019219 chocolate Nutrition 0.000 claims 1
- 229940117916 cinnamic aldehyde Drugs 0.000 claims 1
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 claims 1
- 239000006071 cream Substances 0.000 claims 1
- 108010010165 curculin Proteins 0.000 claims 1
- 235000021438 curry Nutrition 0.000 claims 1
- 229940109275 cyclamate Drugs 0.000 claims 1
- 229930193831 cyclocarioside Natural products 0.000 claims 1
- 229950009125 cynarine Drugs 0.000 claims 1
- YDDUMTOHNYZQPO-BKUKFAEQSA-N cynarine Natural products O[C@H]1C[C@@](C[C@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)(OC(=O)C=Cc3ccc(O)c(O)c3)C(=O)O YDDUMTOHNYZQPO-BKUKFAEQSA-N 0.000 claims 1
- 235000014113 dietary fatty acids Nutrition 0.000 claims 1
- 235000013325 dietary fiber Nutrition 0.000 claims 1
- 239000008126 dulcin Substances 0.000 claims 1
- NWNUTSZTAUGIGA-UHFFFAOYSA-N dulcin Natural products C12CC(C)(C)CCC2(C(=O)OC2C(C(O)C(O)C(COC3C(C(O)C(O)CO3)O)O2)O)C(O)CC(C2(CCC3C4(C)C)C)(C)C1=CCC2C3(C)CCC4OC1OCC(O)C(O)C1OC1OC(CO)C(O)C(O)C1O NWNUTSZTAUGIGA-UHFFFAOYSA-N 0.000 claims 1
- 230000002708 enhancing effect Effects 0.000 claims 1
- 229930195729 fatty acid Natural products 0.000 claims 1
- 239000000194 fatty acid Substances 0.000 claims 1
- 150000004665 fatty acids Chemical class 0.000 claims 1
- 235000013332 fish product Nutrition 0.000 claims 1
- 229930003935 flavonoid Natural products 0.000 claims 1
- 150000002215 flavonoids Chemical class 0.000 claims 1
- 235000017173 flavonoids Nutrition 0.000 claims 1
- 239000006260 foam Substances 0.000 claims 1
- 235000013611 frozen food Nutrition 0.000 claims 1
- 235000012055 fruits and vegetables Nutrition 0.000 claims 1
- 229930195712 glutamate Natural products 0.000 claims 1
- GLLUYNRFPAMGQR-PPNXFBDMSA-N glycyphyllin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC1=CC(O)=CC(O)=C1C(=O)CCC1=CC=C(O)C=C1 GLLUYNRFPAMGQR-PPNXFBDMSA-N 0.000 claims 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 claims 1
- 239000001685 glycyrrhizic acid Substances 0.000 claims 1
- 229960004949 glycyrrhizic acid Drugs 0.000 claims 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 claims 1
- 235000019410 glycyrrhizin Nutrition 0.000 claims 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 claims 1
- 229930183009 gymnemic acid Natural products 0.000 claims 1
- 230000036571 hydration Effects 0.000 claims 1
- 238000006703 hydration reaction Methods 0.000 claims 1
- 235000015243 ice cream Nutrition 0.000 claims 1
- 229910052500 inorganic mineral Inorganic materials 0.000 claims 1
- 235000021539 instant coffee Nutrition 0.000 claims 1
- 235000015110 jellies Nutrition 0.000 claims 1
- 239000008274 jelly Substances 0.000 claims 1
- 235000008960 ketchup Nutrition 0.000 claims 1
- LUEWUZLMQUOBSB-OUBHKODOSA-N maltotetraose Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@H](CO)O[C@@H](O[C@@H]2[C@@H](O[C@@H](O[C@@H]3[C@@H](O[C@@H](O)[C@H](O)[C@H]3O)CO)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O LUEWUZLMQUOBSB-OUBHKODOSA-N 0.000 claims 1
- 235000010746 mayonnaise Nutrition 0.000 claims 1
- 239000008268 mayonnaise Substances 0.000 claims 1
- 229940126601 medicinal product Drugs 0.000 claims 1
- 239000011707 mineral Substances 0.000 claims 1
- 150000007522 mineralic acids Chemical class 0.000 claims 1
- TVJXHJAWHUMLLG-UHFFFAOYSA-N mogroside V Natural products CC(CCC(OC1OC(COC2OC(CO)C(O)C(O)C2OC3OC(CO)C(O)C(O)C3O)C(O)C(O)C1O)C(C)(C)O)C4CCC5(C)C6CC=C7C(CCC(OC8OC(COC9OC(CO)C(O)C(O)C9O)C(O)C(O)C8O)C7(C)C)C6(C)C(O)CC45C TVJXHJAWHUMLLG-UHFFFAOYSA-N 0.000 claims 1
- ITVGXXMINPYUHD-CUVHLRMHSA-N neohesperidin dihydrochalcone Chemical compound C1=C(O)C(OC)=CC=C1CCC(=O)C(C(=C1)O)=C(O)C=C1O[C@H]1[C@H](O[C@H]2[C@@H]([C@H](O)[C@@H](O)[C@H](C)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 ITVGXXMINPYUHD-CUVHLRMHSA-N 0.000 claims 1
- 229940089953 neohesperidin dihydrochalcone Drugs 0.000 claims 1
- 235000010434 neohesperidine DC Nutrition 0.000 claims 1
- 235000019412 neotame Nutrition 0.000 claims 1
- HLIAVLHNDJUHFG-HOTGVXAUSA-N neotame Chemical compound CC(C)(C)CCN[C@@H](CC(O)=O)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 HLIAVLHNDJUHFG-HOTGVXAUSA-N 0.000 claims 1
- 108010070257 neotame Proteins 0.000 claims 1
- 239000002773 nucleotide Substances 0.000 claims 1
- 125000003729 nucleotide group Chemical group 0.000 claims 1
- 229930183085 periandrin Natural products 0.000 claims 1
- IOUVKUPGCMBWBT-UHFFFAOYSA-N phloridzosid Natural products OC1C(O)C(O)C(CO)OC1OC1=CC(O)=CC(O)=C1C(=O)CCC1=CC=C(O)C=C1 IOUVKUPGCMBWBT-UHFFFAOYSA-N 0.000 claims 1
- IOUVKUPGCMBWBT-GHRYLNIYSA-N phlorizin Chemical compound O[C@@H]1[C@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC(O)=CC(O)=C1C(=O)CCC1=CC=C(O)C=C1 IOUVKUPGCMBWBT-GHRYLNIYSA-N 0.000 claims 1
- 235000019139 phlorizin Nutrition 0.000 claims 1
- 239000003075 phytoestrogen Substances 0.000 claims 1
- 229940068065 phytosterols Drugs 0.000 claims 1
- 150000003085 polypodoside A derivatives Polymers 0.000 claims 1
- 235000008476 powdered milk Nutrition 0.000 claims 1
- 235000013406 prebiotics Nutrition 0.000 claims 1
- 239000006041 probiotic Substances 0.000 claims 1
- 235000018291 probiotics Nutrition 0.000 claims 1
- 239000003531 protein hydrolysate Substances 0.000 claims 1
- 235000018102 proteins Nutrition 0.000 claims 1
- 102000004169 proteins and genes Human genes 0.000 claims 1
- 229930185946 pterocaryoside Natural products 0.000 claims 1
- NNXQSUSEFPRCRS-UHFFFAOYSA-N pterocaryoside A Natural products OC1C(O)C(O)C(C)OC1OC1C2C(C(C)(O)CC=CC(C)(C)O)CCC2(C)C2(C)CCC(C(C)=C)C(C)(CCC(O)=O)C2C1 NNXQSUSEFPRCRS-UHFFFAOYSA-N 0.000 claims 1
- SODWWCZKQRRZTG-UHFFFAOYSA-N pterocaryoside B Natural products OC(=O)CCC1(C)C(C(=C)C)CCC(C2(CCC(C22)C(C)(O)CC=CC(C)(C)O)C)(C)C1CC2OC1OCC(O)C(O)C1O SODWWCZKQRRZTG-UHFFFAOYSA-N 0.000 claims 1
- 235000011962 puddings Nutrition 0.000 claims 1
- QRGRAFPOLJOGRV-UHFFFAOYSA-N rebaudioside F Natural products CC12CCCC(C)(C1CCC34CC(=C)C(CCC23)(C4)OC5OC(CO)C(O)C(OC6OCC(O)C(O)C6O)C5OC7OC(CO)C(O)C(O)C7O)C(=O)OC8OC(CO)C(O)C(O)C8O QRGRAFPOLJOGRV-UHFFFAOYSA-N 0.000 claims 1
- 235000009566 rice Nutrition 0.000 claims 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 claims 1
- 235000019204 saccharin Nutrition 0.000 claims 1
- 229940081974 saccharin Drugs 0.000 claims 1
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 claims 1
- 229930182490 saponin Natural products 0.000 claims 1
- 150000007949 saponins Chemical class 0.000 claims 1
- 235000017709 saponins Nutrition 0.000 claims 1
- 229920006395 saturated elastomer Polymers 0.000 claims 1
- 235000015067 sauces Nutrition 0.000 claims 1
- PMDYNLFGCCRGRX-HMQYECKYSA-N selligueain a Chemical compound C1([C@]23OC=4C=C(O)C5=C(C=4[C@H]([C@H]2O)C2=C(O)C=C(O)C=C2O3)O[C@@H]([C@H](O)[C@H]5C=2C(O)=CC(O)=C3C[C@@H]([C@H](OC3=2)C=2C=CC(O)=CC=2)O)C=2C=CC(O)=CC=2)=CC=C(O)C=C1 PMDYNLFGCCRGRX-HMQYECKYSA-N 0.000 claims 1
- 229930190082 siamenoside Natural products 0.000 claims 1
- SKORRGYRKQDXRS-UHFFFAOYSA-M sodium;2-(4-methoxyphenoxy)propanoate Chemical compound [Na+].COC1=CC=C(OC(C)C([O-])=O)C=C1 SKORRGYRKQDXRS-UHFFFAOYSA-M 0.000 claims 1
- 235000014347 soups Nutrition 0.000 claims 1
- 235000019408 sucralose Nutrition 0.000 claims 1
- BAQAVOSOZGMPRM-QBMZZYIRSA-N sucralose Chemical compound O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](CO)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 BAQAVOSOZGMPRM-QBMZZYIRSA-N 0.000 claims 1
- MYMZLBHZVRWYRE-UHFFFAOYSA-N suosan Chemical compound OC(=O)CCNC(=O)NC1=CC=C([N+]([O-])=O)C=C1 MYMZLBHZVRWYRE-UHFFFAOYSA-N 0.000 claims 1
- 239000004094 surface-active agent Substances 0.000 claims 1
- 235000010436 thaumatin Nutrition 0.000 claims 1
- 239000000892 thaumatin Substances 0.000 claims 1
- GSTCPEBQYSOEHV-QNDFHXLGSA-N trilobatin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC(C=C1O)=CC(O)=C1C(=O)CCC1=CC=C(O)C=C1 GSTCPEBQYSOEHV-QNDFHXLGSA-N 0.000 claims 1
- 229930003231 vitamin Natural products 0.000 claims 1
- 229940088594 vitamin Drugs 0.000 claims 1
- 239000011782 vitamin Substances 0.000 claims 1
- 235000013343 vitamin Nutrition 0.000 claims 1
- 230000037221 weight management Effects 0.000 claims 1
- 235000008924 yoghurt drink Nutrition 0.000 claims 1
- 239000010272 ziziphin Substances 0.000 claims 1
- 235000013615 non-nutritive sweetener Nutrition 0.000 abstract description 3
- 229940079919 digestives enzyme preparation Drugs 0.000 abstract description 2
- 235000015173 baked goods and baking mixes Nutrition 0.000 abstract 1
- 235000014510 cooky Nutrition 0.000 abstract 1
- 235000019264 food flavour enhancer Nutrition 0.000 abstract 1
- 101710204244 Processive diacylglycerol beta-glucosyltransferase Proteins 0.000 description 898
- 230000008569 process Effects 0.000 description 260
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 224
- 230000002210 biocatalytic effect Effects 0.000 description 183
- HSCJRCZFDFQWRP-JZMIEXBBSA-N UDP-alpha-D-glucose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OP(O)(=O)OP(O)(=O)OC[C@@H]1[C@@H](O)[C@@H](O)[C@H](N2C(NC(=O)C=C2)=O)O1 HSCJRCZFDFQWRP-JZMIEXBBSA-N 0.000 description 122
- HSCJRCZFDFQWRP-UHFFFAOYSA-N Uridindiphosphoglukose Natural products OC1C(O)C(O)C(CO)OC1OP(O)(=O)OP(O)(=O)OCC1C(O)C(O)C(N2C(NC(=O)C=C2)=O)O1 HSCJRCZFDFQWRP-UHFFFAOYSA-N 0.000 description 120
- 229940088598 enzyme Drugs 0.000 description 63
- 235000011073 invertase Nutrition 0.000 description 16
- 230000000813 microbial effect Effects 0.000 description 14
- 239000000758 substrate Substances 0.000 description 12
- 108010043934 Sucrose synthase Proteins 0.000 description 11
- GIPHUOWOTCAJSR-UHFFFAOYSA-N Rebaudioside A. Natural products C1CC2C3(C)CCCC(C)(C(=O)OC4C(C(O)C(O)C(CO)O4)O)C3CCC2(C2)CC(=C)C21OC1OC(CO)C(O)C(O)C1OC(C1O)OC(CO)C(O)C1OC1OC(CO)C(O)C(O)C1O GIPHUOWOTCAJSR-UHFFFAOYSA-N 0.000 description 10
- XCCTYIAWTASOJW-XVFCMESISA-N Uridine-5'-Diphosphate Chemical compound O[C@@H]1[C@H](O)[C@@H](COP(O)(=O)OP(O)(O)=O)O[C@H]1N1C(=O)NC(=O)C=C1 XCCTYIAWTASOJW-XVFCMESISA-N 0.000 description 10
- 238000004128 high performance liquid chromatography Methods 0.000 description 7
- 244000228451 Stevia rebaudiana Species 0.000 description 6
- 108010051210 beta-Fructofuranosidase Proteins 0.000 description 6
- 239000003054 catalyst Substances 0.000 description 6
- 229930182470 glycoside Natural products 0.000 description 6
- 150000002338 glycosides Chemical class 0.000 description 6
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 6
- 238000001228 spectrum Methods 0.000 description 6
- 241000490645 Yarrowia sp. Species 0.000 description 5
- 150000001719 carbohydrate derivatives Chemical class 0.000 description 5
- 125000000524 functional group Chemical group 0.000 description 5
- 150000007523 nucleic acids Chemical class 0.000 description 5
- 102000039446 nucleic acids Human genes 0.000 description 5
- 108020004707 nucleic acids Proteins 0.000 description 5
- 229920001184 polypeptide Polymers 0.000 description 5
- 108090000765 processed proteins & peptides Proteins 0.000 description 5
- 102000004196 processed proteins & peptides Human genes 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 238000000926 separation method Methods 0.000 description 5
- 108010025880 Cyclomaltodextrin glucanotransferase Proteins 0.000 description 4
- 108010055629 Glucosyltransferases Proteins 0.000 description 4
- 102000000340 Glucosyltransferases Human genes 0.000 description 4
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 4
- 230000014759 maintenance of location Effects 0.000 description 4
- 239000012528 membrane Substances 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 3
- 230000036983 biotransformation Effects 0.000 description 3
- 239000006285 cell suspension Substances 0.000 description 3
- 238000005119 centrifugation Methods 0.000 description 3
- 238000013375 chromatographic separation Methods 0.000 description 3
- 238000002425 crystallisation Methods 0.000 description 3
- 230000008025 crystallization Effects 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 150000004676 glycans Polymers 0.000 description 3
- 229910052739 hydrogen Inorganic materials 0.000 description 3
- 239000006166 lysate Substances 0.000 description 3
- 239000005017 polysaccharide Substances 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- VRYALKFFQXWPIH-PBXRRBTRSA-N (3r,4s,5r)-3,4,5,6-tetrahydroxyhexanal Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)CC=O VRYALKFFQXWPIH-PBXRRBTRSA-N 0.000 description 2
- 238000004791 1D NOESY Methods 0.000 description 2
- 238000003979 3D HSQC-TOCSY Methods 0.000 description 2
- 239000004382 Amylase Substances 0.000 description 2
- 108010065511 Amylases Proteins 0.000 description 2
- 102000013142 Amylases Human genes 0.000 description 2
- 241000208838 Asteraceae Species 0.000 description 2
- 101710184309 Probable sucrose-6-phosphate hydrolase Proteins 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- 235000006092 Stevia rebaudiana Nutrition 0.000 description 2
- 102400000472 Sucrase Human genes 0.000 description 2
- 101710112652 Sucrose-6-phosphate hydrolase Proteins 0.000 description 2
- 150000001299 aldehydes Chemical class 0.000 description 2
- 229940024606 amino acid Drugs 0.000 description 2
- 235000019418 amylase Nutrition 0.000 description 2
- 230000003197 catalytic effect Effects 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 238000005100 correlation spectroscopy Methods 0.000 description 2
- 235000012041 food component Nutrition 0.000 description 2
- 239000005417 food ingredient Substances 0.000 description 2
- 238000001052 heteronuclear multiple bond coherence spectrum Methods 0.000 description 2
- 238000000990 heteronuclear single quantum coherence spectrum Methods 0.000 description 2
- 239000008123 high-intensity sweetener Substances 0.000 description 2
- 150000004677 hydrates Chemical class 0.000 description 2
- 239000011147 inorganic material Substances 0.000 description 2
- 238000001819 mass spectrum Methods 0.000 description 2
- 239000011368 organic material Substances 0.000 description 2
- 150000004804 polysaccharides Polymers 0.000 description 2
- 238000000425 proton nuclear magnetic resonance spectrum Methods 0.000 description 2
- 239000012429 reaction media Substances 0.000 description 2
- 239000012453 solvate Substances 0.000 description 2
- 125000000185 sucrose group Chemical group 0.000 description 2
- 244000144725 Amygdalus communis Species 0.000 description 1
- 229920000856 Amylose Polymers 0.000 description 1
- 244000099147 Ananas comosus Species 0.000 description 1
- 235000007119 Ananas comosus Nutrition 0.000 description 1
- 235000004936 Bromus mango Nutrition 0.000 description 1
- 244000223760 Cinnamomum zeylanicum Species 0.000 description 1
- 235000008733 Citrus aurantifolia Nutrition 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- 235000016795 Cola Nutrition 0.000 description 1
- 241001634499 Cola Species 0.000 description 1
- 235000011824 Cola pachycarpa Nutrition 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- PNNNRSAQSRJVSB-SLPGGIOYSA-N Fucose Natural products C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C=O PNNNRSAQSRJVSB-SLPGGIOYSA-N 0.000 description 1
- 239000005913 Maltodextrin Substances 0.000 description 1
- 240000007228 Mangifera indica Species 0.000 description 1
- 235000014826 Mangifera indica Nutrition 0.000 description 1
- 229920000881 Modified starch Polymers 0.000 description 1
- 240000008790 Musa x paradisiaca Species 0.000 description 1
- 235000018290 Musa x paradisiaca Nutrition 0.000 description 1
- XSEQBUVOXWTHGU-UHFFFAOYSA-N Pieristoxin G Natural products CC1(O)CC2(C(C(O)C3(O)C4(C)C)O)C(O)C1CCC2(O)C(C)(O)C3C1C4O1 XSEQBUVOXWTHGU-UHFFFAOYSA-N 0.000 description 1
- 235000003893 Prunus dulcis var amara Nutrition 0.000 description 1
- 235000014443 Pyrus communis Nutrition 0.000 description 1
- 240000001987 Pyrus communis Species 0.000 description 1
- MUPFEKGTMRGPLJ-RMMQSMQOSA-N Raffinose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 MUPFEKGTMRGPLJ-RMMQSMQOSA-N 0.000 description 1
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 1
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 1
- 235000009184 Spondias indica Nutrition 0.000 description 1
- 235000011941 Tilia x europaea Nutrition 0.000 description 1
- XSTXAVWGXDQKEL-UHFFFAOYSA-N Trichloroethylene Chemical compound ClC=C(Cl)Cl XSTXAVWGXDQKEL-UHFFFAOYSA-N 0.000 description 1
- DRQXUCVJDCRJDB-UHFFFAOYSA-N Turanose Natural products OC1C(CO)OC(O)(CO)C1OC1C(O)C(O)C(O)C(CO)O1 DRQXUCVJDCRJDB-UHFFFAOYSA-N 0.000 description 1
- MUPFEKGTMRGPLJ-UHFFFAOYSA-N UNPD196149 Natural products OC1C(O)C(CO)OC1(CO)OC1C(O)C(O)C(O)C(COC2C(C(O)C(O)C(CO)O2)O)O1 MUPFEKGTMRGPLJ-UHFFFAOYSA-N 0.000 description 1
- 235000009499 Vanilla fragrans Nutrition 0.000 description 1
- 244000263375 Vanilla tahitensis Species 0.000 description 1
- 235000012036 Vanilla tahitensis Nutrition 0.000 description 1
- 235000009754 Vitis X bourquina Nutrition 0.000 description 1
- 235000012333 Vitis X labruscana Nutrition 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 125000004423 acyloxy group Chemical group 0.000 description 1
- 125000003545 alkoxy group Chemical group 0.000 description 1
- 125000003282 alkyl amino group Chemical group 0.000 description 1
- HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 description 1
- LUEWUZLMQUOBSB-ZLBHSGTGSA-N alpha-maltotetraose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)O[C@H](O[C@@H]2[C@H](O[C@H](O[C@@H]3[C@H](O[C@H](O)[C@H](O)[C@H]3O)CO)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O LUEWUZLMQUOBSB-ZLBHSGTGSA-N 0.000 description 1
- 125000003368 amide group Chemical group 0.000 description 1
- 125000004397 aminosulfonyl group Chemical group NS(=O)(=O)* 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 125000001769 aryl amino group Chemical group 0.000 description 1
- 125000004104 aryloxy group Chemical group 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- 235000021028 berry Nutrition 0.000 description 1
- 239000004067 bulking agent Substances 0.000 description 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 1
- 125000005518 carboxamido group Chemical group 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 235000017803 cinnamon Nutrition 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 125000004663 dialkyl amino group Chemical group 0.000 description 1
- 150000002009 diols Chemical class 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- 238000005538 encapsulation Methods 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 239000003349 gelling agent Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 230000002641 glycemic effect Effects 0.000 description 1
- 125000001188 haloalkyl group Chemical group 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002367 halogens Chemical group 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- BJHIKXHVCXFQLS-PQLUHFTBSA-N keto-D-tagatose Chemical compound OC[C@@H](O)[C@H](O)[C@H](O)C(=O)CO BJHIKXHVCXFQLS-PQLUHFTBSA-N 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 239000004571 lime Substances 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 229940035034 maltodextrin Drugs 0.000 description 1
- 229960001855 mannitol Drugs 0.000 description 1
- 229910044991 metal oxide Inorganic materials 0.000 description 1
- 150000004706 metal oxides Chemical class 0.000 description 1
- 235000019426 modified starch Nutrition 0.000 description 1
- 239000003607 modifier Substances 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 125000005646 oximino group Chemical group 0.000 description 1
- FVZVCSNXTFCBQU-UHFFFAOYSA-N phosphanyl Chemical group [PH2] FVZVCSNXTFCBQU-UHFFFAOYSA-N 0.000 description 1
- 125000005328 phosphinyl group Chemical group [PH2](=O)* 0.000 description 1
- 125000000394 phosphonato group Chemical group [O-]P([O-])(*)=O 0.000 description 1
- 125000005499 phosphonyl group Chemical group 0.000 description 1
- LFGREXWGYUGZLY-UHFFFAOYSA-N phosphoryl Chemical group [P]=O LFGREXWGYUGZLY-UHFFFAOYSA-N 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- MUPFEKGTMRGPLJ-ZQSKZDJDSA-N raffinose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)O1 MUPFEKGTMRGPLJ-ZQSKZDJDSA-N 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 239000007790 solid phase Substances 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 125000004646 sulfenyl group Chemical group S(*)* 0.000 description 1
- 235000019605 sweet taste sensations Nutrition 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 150000007970 thio esters Chemical group 0.000 description 1
- 150000003568 thioethers Chemical group 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/20—Carbocyclic rings
- C07H15/24—Condensed ring systems having three or more rings
- C07H15/256—Polyterpene radicals
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
- A23L2/60—Sweeteners
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
- A23L27/30—Artificial sweetening agents
Definitions
- the present invention relates to a process for preparing compositions comprising steviol glycosides, including highly purified steviol glycoside compositions.
- High intensity sweeteners possess a sweetness level that is many times greater than the sweetness level of sucrose. They are essentially non-caloric and are commonly used in diet and reduced-calorie products, including foods and beverages. High intensity sweeteners do not elicit a glycemic response, making them suitable for use in products targeted to diabetics and others interested in controlling for their intake of carbohydrates.
- Steviol glycosides are a class of compounds found in the leaves of Stevia rebaudiana Bertoni, a perennial shrub of the Asteraceae ( Compositae ) family native to certain regions of South America. They are characterized structurally by a single base, steviol, differing by the presence of carbohydrate residues at positions C 13 and C 19. They accumulate in Stevia leaves, composing approximately 10% - 20% of the total dry weight. On a dry weight basis, the four major glycosides found in the leaves of Stevia typically include stevioside (9.1%), rebaudioside A (3.8%), rebaudioside C (0.6-1.0%) and dulcoside A (0.3%).
- steviol glycosides include rebaudioside B, C, D, E, F and M, steviolbioside and rubusoside. Although methods are known for preparing steviol glycosides from Stevia rebaudiana, many of these methods are unsuitable for use commercially.
- biocatalysis or“biocatalytic” refers to the use of natural or genetically engineered biocatalysts, such as enzymes, or cells comprising one or more enzyme, capable of single or multiple step chemical transformations on organic compounds.
- Biocatalysis processes include fermentation, biosynthesis, bioconversion and biotransformation processes. Both isolated enzymes, and whole-cell biocatalysis methods are known in the art.
- Biocatalyst protein enzymes can be naturally occurring or recombinant proteins.
- steviol glycoside(s) refers to a glycoside of steviol, including, but not limited to, naturally occurring steviol glycosides, e.g. steviolmonoside, steviolmonoside A, steviolbioside, steviolbioside D, rubusoside, steviolbioside A, steviolbioside B, rebaudioside B, stevioside, rebaudioside G, stevioside A, stevioside B, stevioside C, rebaudioside A, rebaudioside E, rebaudioside E2, rebaudioside E4, rebaudioside E6, rebaudioside E3, rebaudioside D, rebaudioside 7, rebaudioside AM, rebaudioside D7, rebaudioside M, rebaudioside M4, rebaudioside la, rebaudioside lb, rebaudioside 7c, rebaudioside Id, re
- SvG7 refers to any naturally occurring steviol glycosides or any synthetic steviol glycosides, including enzymatically glucosylated steviol glycosides and combinations thereof, specifically a molecule comprising steviol having seven glucose residues attached covalently including, but not limited to reb la, reb lb, reb 7c, reb Id, reb le, reb If reb Ig, reb lh, reb li, reb lj, reb lk, reb 11, reb lm, reb In, reb lo, reb lp, reb lq, reb Ir, reb Is, reb It, reb 2a, reb 2b, reb 2c, reb 2d, reb 2e, reb 2f reb 2g, reb 2h, reb 2i, re
- SvG7 can refer to a single steviol glycoside having seven glucose residues attached covalently or a mixture of steviol glycosides having seven glucose residues attached covalently.
- the present invention provides a process for preparing a composition comprising a target steviol glycoside by contacting a starting composition comprising an organic substrate with a microbial cell and/or enzyme preparation, thereby producing a composition comprising a target steviol glycoside.
- the starting composition can be any organic compound comprising at least one carbon atom.
- the starting composition is selected from the group consisting of steviol glycosides, polyols or sugar alcohols, various carbohydrates.
- the target steviol glycoside can be any steviol glycoside.
- the target steviol glycoside is steviolmonoside, steviolmonoside A, steviolbioside, steviolbioside D, rubusoside, steviolbioside A, steviolbioside B, rebaudioside B, stevioside, rebaudioside G, stevioside A, stevioside B, stevioside C, rebaudioside A, rebaudioside E, rebaudioside E2, rebaudioside E4, rebaudioside E6, rebaudioside E3, rebaudioside D, rebaudioside I, rebaudioside AM, rebaudioside D7, rebaudioside M, rebaudioside M4, rebaudioside la, rebaudioside lb, rebaudioside lc, rebaudioside Id, rebaudioside le, rebaudioside If, rebaudioside Ig
- the target steviol glycoside is rebaudioside la.
- the target steviol glycoside is rebaudioside lb.
- the target steviol glycoside is rebaudioside lc.
- the target steviol glycoside is rebaudioside Id.
- the target steviol glycoside is rebaudioside le.
- the target steviol glycoside is rebaudioside If.
- the target steviol glycoside is rebaudioside Ig. In one embodiment, the target steviol glycoside is rebaudioside Ih. In one embodiment, the target steviol glycoside is rebaudioside li. In one embodiment, the target steviol glycoside is rebaudioside lj. In one embodiment, the target steviol glycoside is rebaudioside lk. In one embodiment, the target steviol glycoside is rebaudioside 11. In one embodiment, the target steviol glycoside is rebaudioside lm. In one embodiment, the target steviol glycoside is rebaudioside In. In one embodiment, the target steviol glycoside is rebaudioside lo.
- the target steviol glycoside is rebaudioside lp. In one embodiment, the target steviol glycoside is rebaudioside lq. In one embodiment, the target steviol glycoside is rebaudioside Ir. In one embodiment, the target steviol glycoside is rebaudioside Is. In one embodiment, the target steviol glycoside is rebaudioside It. In one embodiment, the target steviol glycoside is rebaudioside 2a. In one embodiment, the target steviol glycoside is rebaudioside 2b. In one embodiment, the target steviol glycoside is rebaudioside 2c. In one embodiment, the target steviol glycoside is rebaudioside 2d.
- the target steviol glycoside is rebaudioside 2e. In one embodiment, the target steviol glycoside is rebaudioside 2f. In one embodiment, the target steviol glycoside is rebaudioside 2g. In one embodiment, the target steviol glycoside is rebaudioside 2h. In one embodiment, the target steviol glycoside is rebaudioside 2i.
- the target steviol glycoside is rebaudioside 2j.
- the target steviol glycoside is rebaudioside 2k.
- the target steviol glycoside is rebaudioside 21.
- the target steviol glycoside is rebaudioside 2m.
- the target steviol glycoside is rebaudioside 2n.
- the target steviol glycoside is rebaudioside 2o.
- the target steviol glycoside is rebaudioside 2p.
- the target steviol glycoside is rebaudioside 2q.
- the target steviol glycoside is rebaudioside 2r.
- the target steviol glycoside is rebaudioside 2s.
- the target steviol glycoside is rebaudioside M4.
- the target steviol glycoside is SvG7.
- enzyme preparation comprising one or more enzymes, or a microbial cell comprising one or more enzymes, capable of converting the starting composition to target steviol glycosides are used.
- the enzyme can be located on the surface and/or inside the cell.
- the enzyme preparation can be provided in the form of a whole cell suspension, a crude lysate or as purified enzyme(s).
- the enzyme preparation can be in free form or immobilized to a solid support made from inorganic or organic materials.
- a microbial cell comprises the necessary enzymes and genes encoding thereof for converting the starting composition to target steviol glycosides. Accordingly, the present invention also provides a process for preparing a composition comprising a target steviol glycoside by contacting a starting composition comprising an organic substrate with a microbial cell comprising at least one enzyme capable of converting the starting composition to target steviol glycosides, thereby producing a medium comprising at least one target steviol glycoside.
- the enzymes necessary for converting the starting composition to target steviol glycosides include the steviol biosynthesis enzymes, NDP-glucosyltransferases (NGTs), ADP-glucosyltransferases (AGTs), CDP-glucosyltransferases (CGTs), GDP- glucosyltransferases (GGTs), TDP-glucosyltransferases (TDPs), UDP- glucosyltransferases (UGTs) and/or NDP-recycling enzyme, ADP-recycling enzyme, CDP-recycling enzyme, GDP-recycling enzyme, TDP-recycling enzyme, and/or UDP- recycling enzyme.
- NDP-glucosyltransferases NDP-glucosyltransferases
- ADP-glucosyltransferases ADP-glucosyltransferases
- ADP-glucosyltransferases ADP-glucosyltransferases
- ADP-glucosyltransferases ADP-glucosyl
- the steviol biosynthesis enzymes include mevalonate (MV A) pathway enzymes.
- the steviol biosynthesis enzymes include non-mevalonate 2-C-methyl-D-erythritol-4-phosphate pathway (MEP/DOXP) enzymes.
- the steviol biosynthesis enzymes are selected from the group including geranylgeranyl diphosphate synthase, copalyl diphosphate synthase, kaurene synthase, kaurene oxidase, kaurenoic acid 13-hydroxylase (KAH), steviol synthetase, deoxyxylulose 5 -phosphate synthase (DXS), D-l-deoxyxylulose 5 -phosphate reductoisomerase (DXR), 4-diphosphocytidyl-2-C-methyl-D-erythritol synthase (CMS), 4- diphosphocytidyl-2-C-methyl-D-erythritol kinase (CMK), 4-diphosphocytidyl-2-C- methyl-D-erythritol 2,4- cyclodiphosphate synthase (MCS), l-hydroxy-2-methyl-2(E)- buten
- the UDP-glucosyltransferase can be any UDP-glucosyltransferase capable of adding at least one glucose unit to steviol and/or a steviol glycoside substrate to provide the target steviol glycoside.
- sucrose synthase having amino-acid sequence“SEQ ID 1” as described in Example 1, or a polypetide having substantial (>85%, >86%, >87%, >88%, >89%, >90%, >91%, >92%, >93%, >94%, >95%, >96%, >97%, >98%, >99%) amino-acid sequence identity to the SEQ ID 1 polypeptide as well as isolated nucleic acid molecules that code for those polypetides.
- UGTS12 refers to UDP-glucosyltransferase having amino-acid sequence “SEQ ID 2” as described in Example 1 or a polypetide having substantial (>85%, >86%, >87%, >88%, >89%, >90%, >91%, >92%, >93%, >94%, >95%, >96%, >97%, >98%, >99%) amino-acid sequence identity to the SEQ ID 2 polypeptide as well as isolated nucleic acid molecules that code for those polypetides.
- UDP-glucosyltransferase having amino-acid sequence “SEQ ID 3” as described in Example 1 or a polypetide having substantial (>85%, >86%, >87%, >88%, >89%, >90%, >91%, >92%, >93%, >94%, >95%, >96%, >97%, >98%, >99%) amino-acid sequence identity to the SEQ ID 3 polypeptide as well as isolated nucleic acid molecules that code for those polypetides.
- steviol biosynthesis enzymes and UDP-glucosyltransferases are produced in a microbial cell.
- the microbial cell may be, for example, E. coli, Saccharomyces sp., Aspergillus sp., Pichia sp., Bacillus sp., Yarrowia sp. etc.
- the UDP-glucosyltransferases are synthesized.
- the UDP-glucosyltransferase is selected from group including UGT74G1, UGT85C2, UGT76G1, UGT91D2, UGTS12, EUGT11 and UGTs having substantial (>85%, >86%, >87%, >88%, >89%, >90%, >91%, >92%, >93%, >94%, >95%, >96%, >97%, >98%, >99%) amino-acid sequence identity to these polypeptides as well as isolated nucleic acid molecules that code for these UGTs.
- steviol biosynthesis enzymes are present in one microorganism (microbial cell).
- the microorganism may be for example, E. coli, Saccharomyces sp., Aspergillus sp., Pichia sp., Bacillus sp., Yarrowia sp.
- the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to steviol or any starting steviol glycoside bearing an -OH functional group at C 13 to give a target steviol glycoside having an -O- glucose beta glucopyranoside glycosidic linkage at Cl 3.
- the UDP-glucosyltransferase is UGT85C2, or a UGT having >85% amino-acid sequence identity with UGT85C2.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to steviol or any starting steviol glycoside bearing a -COOH functional group at C19 to give a target steviol glycoside having a -COO-glucose beta-glucopyranoside glycosidic linkage at Cl 9.
- the UDP-glucosyltransferase is UGT74G1, or a UGT having >85% amino-acid sequence identity with UGT74G1.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to any existing glucose on the C19 side of any starting steviol glycoside to give a target steviol glycoside with at least one additional glucose bearing at least one beta 1— >2 glucopyranoside glycosidic linkage(s) at the newly formed glycosidic bond(s).
- the UDP- glucosyltransferase is UGTS12, or a UGT having >85% amino-acid sequence identity with UGTS12.
- the UDP-glucosyltransferase is EUGT11, or a UGT having >85% amino-acid sequence identity with EUGT11.
- the UDP-glucosyltransferase is UGT91D2, or a UGT having >85% amino- acid sequence identity with UGT91D2.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to any existing glucose on the C19 side of any starting steviol glycoside to give a target steviol glycoside with at least one additional glucose bearing at least one beta l->3 glucopyranoside glycosidic linkage(s) at the newly formed bond glycosidic bond(s).
- the UDP-glucosyltransferase is UGT76G1, or a UGT having >85% amino-acid sequence identity with UGT76G1.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to any existing glucose on the C 19 side of any starting steviol glycoside to give a target steviol glycoside with at least one additional glucose bearing at least one beta 1— >4 glucopyranoside glycosidic linkage(s) at the newly formed glycosidic bond(s).
- the UDP- glucosyltransferase is UGTS12, or a UGT having >85% amino-acid sequence identity with UGTS12.
- the UDP-glucosyltransferase is EUGT11, or a UGT having >85% amino-acid sequence identity with EUGT11.
- the UDP-glucosyltransferase is UGT91D2, or a UGT having >85% amino- acid sequence identity with UGT91D2.
- the UDP- glucosyltransferase is UGT76G1, or a UGT having >85% amino-acid sequence identity with UGT76G1.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to any existing glucose on the Cl 9 side of any starting steviol glycoside to give a target steviol glycoside with at least one additional glucose bearing at least one beta l->6 glucopyranoside glycosidic linkage(s) at the newly formed glycosidic bond(s).
- the UDP- glucosyltransferase is UGTS12, or a UGT having >85% amino-acid sequence identity with UGTS12.
- the UDP-glucosyltransferase is EUGT11, or a UGT having >85% amino-acid sequence identity with EUGT11.
- the UDP-glucosyltransferase is UGT91D2, or a UGT having >85% amino- acid sequence identity with UGT91D2.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to any existing glucose on the C13 side of any starting steviol glycoside to give a target steviol glycoside with at least one additional glucose bearing at least one beta 1— >2 glucopyranoside glycosidic linkage(s) at the newly formed glycosidic bond(s).
- the UDP- glucosyltransferase is UGTS12, or a UGT having >85% amino-acid sequence identity with UGTS12.
- the UDP-glucosyltransferase is EUGT11, or a UGT having >85% amino-acid sequence identity with EUGT11.
- the UDP-glucosyltransferase is UGT91D2, or a UGT having >85% amino- acid sequence identity with UGT91D2.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to any existing glucose on the C13 side of any starting steviol glycoside to give a target steviol glycoside with at least one additional glucose bearing at least one beta 1— >3 glucopyranoside glycosidic linkage(s) at the newly formed bond glycosidic bond(s).
- the UDP-glucosyltransferase is UGT76G1, or a UGT having >85% amino-acid sequence identity with UGT76G1.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to any existing glucose on the C 13 side of any starting steviol glycoside to give a target steviol glycoside with at least one additional glucose bearing at least one beta l- 4 glucopyranoside glycosidic linkage(s) at the newly formed glycosidic bond(s).
- the UDP- glucosyltransferase is UGTS12, or a UGT having >85% amino-acid sequence identity with UGTS12.
- the UDP-glucosyltransferase is EUGT11, or a UGT having >85% amino-acid sequence identity with EUGT11.
- the UDP-glucosyltransferase is UGT91D2, or a UGT having >85% amino- acid sequence identity with UGT91D2.
- the UDP- glucosyltransferase is UGT76G1, or a UGT having >85% amino-acid sequence identity with UGT76G1.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to any existing glucose on the C13 side of any starting steviol glycoside to give a target steviol glycoside with at least one additional glucose bearing at least one beta l-»6 glucopyranoside glycosidic linkage(s) at the newly formed glycosidic bond(s).
- the UDP- glucosyltransferase is UGTS12, or a UGT having >85% amino-acid sequence identity with UGTS12.
- the UDP-glucosyltransferase is EUGT11, or a UGT having >85% amino-acid sequence identity with EUGT11.
- the UDP-glucosyltransferase is UGT91D2, or a UGT having >85% amino- acid sequence identity with UGT91D2.
- the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to steviol to form steviolmonoside.
- the UDP-glucosyltransferase is UGT85C2 or a UGT having >85% amino-acid sequence identity with UGT85C2 or a UGT having >85% amino-acid sequence identity with UGT85C2.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to steviol to form steviolmonoside A.
- the UDP-glucosyltransferase is UGT74G1 or a UGT having >85% amino-acid sequence identity with UGT74G1.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to steviolmonoside to form steviolbioside.
- the UDP-glucosyltransferase is UGTS12 or a UGT having >85% amino-acid sequence identity with UGTS12.
- the UDP-glucosyltransferase is EUGT11, or a UGT having >85% amino- acid sequence identity with EUGT11.
- the UDP- glucosyltransferase is UGT91D2, or a UGT having >85% amino-acid sequence identity with UGT91D2.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to steviolmonoside to form steviolbioside D.
- the UDP-glucosyltransferase is UGT76G1 or a UGT having >85% amino-acid sequence identity with UGT76G1.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to steviolmonoside to form rubusoside.
- the UDP-glucosyltransferase is UGT74G1 or a UGT having >85% amino-acid sequence identity with UGT74G1.
- the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to steviolmonoside A to form rubusoside.
- the UDP-glucosyltransferase is UGT85C2 or a UGT having >85% amino-acid sequence identity with UGT85C2 or a UGT having >85% amino-acid sequence identity with UGT85C2.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to steviolmonoside A to form steviolbioside A.
- the UDP-glucosyltransferase is UGTS12 or a UGT having >85% amino-acid sequence identity with UGTS12.
- the UDP-glucosyltransferase is EUGT11, or a UGT having >85% amino-acid sequence identity with EUGT11.
- the UDP-glucosyltransferase is UGT91D2, or a UGT having >85% amino-acid sequence identity with UGT91D2.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to steviolmonoside A to form steviolbioside B.
- the UDP-glucosyltransferase is UGT76G1 or a UGT having >85% amino-acid sequence identity with UGT76G1.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to steviolbioside to form rebaudioside B.
- the UDP-glucosyltransferase is UGT76G1 or a UGT having >85% amino-acid sequence identity with UGT76G1.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to steviolbioside to form stevioside.
- the UDP-glucosyltransferase is UGT74G1 or a UGT having >85% amino-acid sequence identity with UGT74G1.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to steviolbioside D to form rebaudioside B.
- the UDP-glucosyltransferase is UGTS12 or a UGT having >85% amino-acid sequence identity with UGTS12.
- the UDP-glucosyltransferase is EUGT11, or a UGT having >85% amino- acid sequence identity with EUGT11.
- the UDP- glucosyltransferase is UGT91D2, or a UGT having >85% amino-acid sequence identity with UGT91D2.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to steviolbioside D to form rebaudioside G.
- the UDP-glucosyltransferase is UGT74G1 or a UGT having >85% amino-acid sequence identity with UGT74G1.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to rubusoside to form stevioside.
- the UDP-glucosyltransferase is UGTSI2 or a UGT having >85% amino-acid sequence identity with UGTS12.
- the UDP-glucosyltransferase is EUGT11, or a UGT having >85% amino- acid sequence identity with EUGT11.
- the UDP- glucosyltransferase is UGT91D2, or a UGT having >85% amino-acid sequence identity with UGT91D2.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to rubusoside to form rebaudioside G.
- the UDP-glucosyltransferase is UGT76G1 or a UGT having >85% amino-acid sequence identity with UGT76G1.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to rubusoside to form stevioside A.
- the UDP-glucosyltransferase is UGTS12 or a UGT having >85% amino-acid sequence identity with UGTS12.
- the UDP-glucosyltransferase is EUGT11, or a UGT having >85% amino- acid sequence identity with EUGT11.
- the UDP- glucosyltransferase is UGT91D2, or a UGT having >85% amino-acid sequence identity with UGT91D2.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to rubusoside to form stevioside B.
- the UDP-glucosyltransferase is UGT76G1 or a UGT having >85% amino-acid sequence identity with UGT76G1.
- the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to steviolbioside A to form stevioside A.
- the UDP-glucosyltransferase is UGT85C2 or a UGT having >85% amino-acid sequence identity with UGT85C2 or a UGT having >85% amino-acid sequence identity with UGT85C2.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to steviolbioside A to form stevioside C.
- the UDP-glucosyltransferase is UGT76G1 or a UGT having >85% amino-acid sequence identity with UGT76G1.
- the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to steviolbioside B to form stevioside B.
- the UDP-glucosyltransferase is UGT85C2 or a UGT having >85% amino-acid sequence identity with UGT85C2 or a UGT having >85% amino-acid sequence identity with UGT85C2.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to steviolbioside B to form stevioside C.
- the UDP-glucosyltransferase is UGTS12 or a UGT having >85% amino-acid sequence identity with UGTS12.
- the UDP-glucosyltransferase is EUGT11, or a UGT having >85% amino- acid sequence identity with EUGT11.
- the UDP- glucosyltransferase is UGT91D2, or a UGT having >85% amino-acid sequence identity with UGT91D2.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to rebaudioside B to form rebaudioside A.
- the UDP-glucosyltransferase is UGT74G1 or a UGT having >85% amino-acid sequence identity with UGT74G1.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to stevioside to form rebaudioside A.
- the UDP-glucosyltransferase is UGT76G1 or a UGT having >85% amino-acid sequence identity with UGT76G1.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to stevioside to form rebaudioside E.
- the UDP-glucosyltransferase is UGTS12 or a UGT having >85% amino-acid sequence identity with UGTS12.
- the UDP-glucosyltransferase is EUGT11, or a UGT having >85% amino- acid sequence identity with EUGT11.
- the UDP- glucosyltransferase is UGT91D2, or a UGT having >85% amino-acid sequence identity with UGT91D2.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to stevioside to form rebaudioside E2.
- the UDP-glucosyltransferase is UGT76G1 or a UGT having >85% amino-acid sequence identity with UGT76G1.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to rebaudioside G to form rebaudioside A.
- the UDP-glucosyltransferase is UGTS12 or a UGT having >85% amino-acid sequence identity with UGTS12.
- the UDP-glucosyltransferase is EUGT11, or a UGT having >85% amino- acid sequence identity with EUGT11.
- the UDP- glucosyltransferase is UGT91D2, or a UGT having >85% amino-acid sequence identity with UGT91D2.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to rebaudioside G to form rebaudioside E4.
- the UDP-glucosyltransferase is UGTS12 or a UGT having >85% amino-acid sequence identity with UGTS12.
- the UDP-glucosyltransferase is EUGT11, or a UGT having >85% amino- acid sequence identity with EUGT11.
- the UDP- glucosyltransferase is UGT91D2, or a UGT having >85% amino-acid sequence identity with UGT91D2.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to rebaudioside G to form rebaudioside E6.
- the UDP-glucosyltransferase is UGT76G1 or a UGT having >85% amino-acid sequence identity with UGT76G1.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to stevioside A to form rebaudioside E.
- the UDP-glucosyltransferase is UGTS12 or a UGT having >85% amino-acid sequence identity with UGTS12.
- the UDP-glucosyltransferase is EUGT11, or a UGT having >85% amino- acid sequence identity with EUGT11.
- the UDP- glucosyltransferase is UGT91D2, or a UGT having >85% amino-acid sequence identity with UGT91D2.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to stevioside A to form rebaudioside E4.
- the UDP-glucosyltransferase is UGT76G1 or a UGT having >85% amino-acid sequence identity with UGT76G1.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to stevioside A to form rebaudioside E3.
- the UDP-glucosyltransferase is UGT76G1 or a UGT having >85% amino-acid sequence identity with UGT76G1.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to stevioside B to form rebaudioside E2.
- the UDP-glucosyltransferase is UGTS12 or a UGT having >85% amino-acid sequence identity with UGTS12.
- the UDP-glucosyltransferase is EUGT11, or a UGT having >85% amino- acid sequence identity with EUGT11.
- the UDP- glucosyltransferase is UGT91D2, or a UGT having >85% amino-acid sequence identity with UGT91D2.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to stevioside B to form rebaudioside E6.
- the UDP-glucosyltransferase is UGT76G1 or a UGT having >85% amino-acid sequence identity with UGT76G1.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to stevioside B to form rebaudioside E3.
- the UDP-glucosyltransferase is UGTS12 or a UGT having >85% amino-acid sequence identity with UGTS12.
- the UDP-glucosyltransferase is EUGT11, or a UGT having >85% amino- acid sequence identity with EUGT11.
- the UDP- glucosyltransferase is UGT91D2, or a UGT having >85% amino-acid sequence identity with UGT91D2.
- the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to steviolbioside C to form rebaudioside E3.
- the UDP-glucosyltransferase is UGT85C2 or a UGT having >85% amino-acid sequence identity with UGT85C2 or a UGT having >85% amino-acid sequence identity with UGT85C2.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to rebaudioside A to form rebaudioside D.
- the UDP-glucosyltransferase is UGTS12 or a UGT having >85% amino-acid sequence identity with UGTS12.
- the UDP-glucosyltransferase is EUGT11, or a UGT having >85% amino- acid sequence identity with EUGT11.
- the UDP- glucosyltransferase is UGT91D2, or a UGT having >85% amino-acid sequence identity with UGT91D2.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to rebaudioside A to form rebaudioside /.
- the UDP-glucosyltransferase is UGT76G1 or a UGT having >85% amino-acid sequence identity with UGT76G1.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to rebaudioside E to form rebaudioside D.
- the UDP-glucosyltransferase is UGT76G1 or a UGT having >85% amino-acid sequence identity with UGT76G1.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to rebaudioside E to form rebaudioside AM.
- the UDP-glucosyltransferase is UGT76G1 or a UGT having >85% amino-acid sequence identity with UGT76G1.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to rebaudioside E2 to form rebaudioside I.
- the UDP-glucosyltransferase is UGT76G1 or a UGT having >85% amino-acid sequence identity with UGT76G1.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to rebaudioside E2 to form rebaudioside AM.
- the UDP-glucosyltransferase is UGTS12 or a UGT having >85% amino-acid sequence identity with UGTS12.
- the UDP-glucosyltransferase is EUGT11, or a UGT having >85% amino- acid sequence identity with EUGT11.
- the UDP- glucosyltransferase is UGT91D2, or a UGT having >85% amino-acid sequence identity with UGT91D2.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to rebaudioside E4 to form rebaudioside D.
- the UDP-glucosyltransferase is UGTS12 or a UGT having >85% amino-acid sequence identity with UGTS12.
- the UDP-glucosyltransferase is EUGT11, or a UGT having >85% amino- acid sequence identity with EUGT11.
- the UDP- glucosyltransferase is UGT91D2, or a UGT having >85% amino-acid sequence identity with UGT91D2.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to rebaudioside E4 to form rebaudioside D7.
- the UDP-glucosyltransferase is UGT76G1 or a UGT having >85% amino-acid sequence identity with UGT76G1.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to rebaudioside E6 to form rebaudioside I.
- the UDP-glucosyltransferase is UGTS12 or a UGT having >85% amino-acid sequence identity with UGTS12.
- the UDP-glucosyltransferase is EUGT11, or a UGT having >85% amino- acid sequence identity with EUGT11.
- the UDP- glucosyltransferase is UGT91D2, or a UGT having >85% amino-acid sequence identity with UGT91D2.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to rebaudioside E6 to form rebaudioside D7.
- the UDP-glucosyltransferase is UGTS12 or a UGT having >85% amino-acid sequence identity with UGTS12.
- the UDP-glucosyltransferase is EUGT11, or a UGT having >85% amino- acid sequence identity with EUGT11.
- the UDP- glucosyltransferase is UGT91D2, or a UGT having >85% amino-acid sequence identity with UGT91D2.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to rebaudioside E3 to form rebaudioside AM.
- the UDP-glucosyltransferase is UGTS12 or a UGT having >85% amino-acid sequence identity with UGTS12.
- the UDP-glucosyltransferase is EUGT11, or a UGT having >85% amino- acid sequence identity with EUGT11.
- the UDP- glucosyltransferase is UGT91D2, or a UGT having >85% amino-acid sequence identity with UGT91D2.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to rebaudioside E3 to form rebaudioside D7.
- the UDP-glucosyltransferase is UGT76G1 or a UGT having >85% amino-acid sequence identity with UGT76G1.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to rebaudioside D to form rebaudioside M
- the UDP-glucosyltransferase is UGT76G1 or a UGT having >85% amino-acid sequence identity with UGT76G1.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to rebaudioside / to form rebaudioside M
- the UDP-glucosyltransferase is UGTS12 or a UGT having >85% amino-acid sequence identity with UGTS12.
- the UDP-glucosyltransferase is EUGT11, or a UGT having >85% amino- acid sequence identity with EUGT11.
- the UDP- glucosyltransferase is UGT91D2, or a UGT having >85% amino-acid sequence identity with UGT91D2.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to rebaudioside AM to form rebaudioside M
- the UDP-glucosyltransferase is UGT76G1 or a UGT having >85% amino-acid sequence identity with UGT76G1.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to rebaudioside AM to form rebaudioside M4.
- the UDP-glucosyltransferase is UGTS12 or a UGT having >85% amino-acid sequence identity with UGTS12.
- the UDP-glucosyltransferase is EUGT11, or a UGT having >85% amino- acid sequence identity with EUGT11.
- the UDP- glucosyltransferase is UGT91D2, or a UGT having >85% amino-acid sequence identity with UGT91D2.
- the UDP-glucosyltransferase is UGT76G1 or a UGT having >85% amino-acid sequence identity with UGT76G1.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to rebaudioside D7 to form rebaudioside M
- the UDP-glucosyltransferase is UGTS12 or a UGT having >85% amino-acid sequence identity with UGTS12.
- the UDP-glucosyltransferase is EUGT11, or a UGT having >85% amino- acid sequence identity with EUGT11.
- the UDP- glucosyltransferase is UGT91D2, or a UGT having >85% amino-acid sequence identity with UGT91D2.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to rebaudioside M to form rebaudioside la.
- the UDP-glucosyltransferase is UGTS12 or a UGT having >85% amino-acid sequence identity with UGTS12.
- the UDP-glucosyltransferase is EUGT11, or a UGT having >85% amino- acid sequence identity with EUGT11.
- the UDP- glucosyltransferase is UGT91D2, or a UGT having >85% amino-acid sequence identity with UGT91D2.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to rebaudioside M to form rebaudioside lb.
- the UDP-glucosyltransferase is UGT76G1 or a UGT having >85% amino-acid sequence identity with UGT76G1.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to rebaudioside M to form rebaudioside lc.
- the UDP-glucosyltransferase is UGTS12 or a UGT having >85% amino-acid sequence identity with UGTS12.
- the UDP-glucosyltransferase is EUGT1 1, or a UGT having >85% amino- acid sequence identity with EUGT11.
- the UDP- glucosyltransferase is UGT91D2, or a UGT having >85% amino-acid sequence identity with UGT91D2.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to rebaudioside M to form rebaudioside Id.
- the UDP-glucosyltransferase is UGTS12 or a UGT having >85% amino-acid sequence identity with UGTS12.
- the UDP-glucosyltransferase is EUGT11, or a UGT having >85% amino- acid sequence identity with EUGT11.
- the UDP- glucosyltransferase is UGT91D2, or a UGT having >85% amino-acid sequence identity with UGT91D2.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to rebaudioside M to form rebaudioside le.
- the UDP-glucosyltransferase is UGT76G1 or a UGT having >85% amino-acid sequence identity with UGT76G1.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to rebaudioside M to form rebaudioside If.
- the UDP-glucosyltransferase is UGTS12 or a UGT having >85% amino-acid sequence identity with UGTS12.
- the UDP-glucosyltransferase is EUGT11, or a UGT having >85% amino- acid sequence identity with EUGT11.
- the UDP- glucosyltransferase is UGT91D2, or a UGT having >85% amino-acid sequence identity with UGT91D2.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to rebaudioside M to form rebaudioside Ig.
- the UDP-glucosyltransferase is UGTS12 or a UGT having >85% amino-acid sequence identity with UGTS12.
- the UDP-glucosyltransferase is EUGT11, or a UGT having >85% amino- acid sequence identity with EUGT11.
- the UDP- glucosyltransferase is UGT91D2, or a UGT having >85% amino-acid sequence identity with UGT91D2.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to rebaudioside M to form rebaudioside lh.
- the UDP-glucosyltransferase is UGT76G1 or a UGT having >85% amino-acid sequence identity with UGT76G1.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to rebaudioside M to form rebaudioside li.
- the UDP-glucosyltransferase is UGTS12 or a UGT having >85% amino-acid sequence identity with UGTS12.
- the UDP-glucosyltransferase is EUGT11, or a UGT having >85% amino- acid sequence identity with EUGT1 1.
- the UDP- glucosyltransferase is UGT91D2, or a UGT having >85% amino-acid sequence identity with UGT91D2.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to rebaudioside M to form rebaudioside lj.
- the UDP-glucosyltransferase is UGTS12 or a UGT having >85% amino-acid sequence identity with UGTS12.
- the UDP-glucosyltransferase is EUGT11, or a UGT having >85% amino- acid sequence identity with EUGT11.
- the UDP- glucosyltransferase is UGT91D2, or a UGT having >85% amino-acid sequence identity with UGT91D2.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to rebaudioside M to form rebaudioside Ik.
- the UDP-glucosyltransferase is UGT76G1 or a UGT having >85% amino-acid sequence identity with UGT76G1.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to rebaudioside M to form rebaudioside 11.
- the UDP-glucosyltransferase is UGTS12 or a UGT having >85% amino-acid sequence identity with UGTS12.
- the UDP-glucosyltransferase is EUGT11, or a UGT having >85% amino- acid sequence identity with EUGT11.
- the UDP- glucosyltransferase is UGT91D2, or a UGT having >85% amino-acid sequence identity with UGT91D2.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to rebaudioside M to form rebaudioside lm.
- the UDP-glucosyltransferase is UGTS12 or a UGT having >85% amino-acid sequence identity with UGTS12.
- the UDP-glucosyltransferase is EUGT11, or a UGT having >85% amino- acid sequence identity with EUGT11.
- the UDP- glucosyltransferase is UGT91D2, or a UGT having >85% amino-acid sequence identity with UGT91D2.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to rebaudioside M to form rebaudioside In.
- the UDP-glucosyltransferase is UGTS12 or a UGT having >85% amino-acid sequence identity with UGTS12.
- the UDP-glucosyltransferase is EUGT11, or a UGT having >85% amino- acid sequence identity with EUGT11.
- the UDP- glucosyltransferase is UGT91D2, or a UGT having >85% amino-acid sequence identity with UGT91D2.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to rebaudioside Mto form rebaudioside lo.
- the UDP-glucosyltransferase is UGTS12 or a UGT having >85% amino-acid sequence identity with UGTS12.
- the UDP-glucosyltransferase is EUGT11, or a UGT having >85% amino- acid sequence identity with EUGT11.
- the UDP- glucosyltransferase is UGT91D2, or a UGT having >85% amino-acid sequence identity with UGT91D2.
- the UDP-glucosyltransferase is UGT76G1 or a UGT having >85% amino-acid sequence identity with UGT76G1.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to rebaudioside M to form rebaudioside lp.
- the UDP-glucosyltransferase is UGTS12 or a UGT having >85% amino-acid sequence identity with UGTS12.
- the UDP-glucosyltransferase is EUGT11, or a UGT having >85% amino- acid sequence identity with EUGT11.
- the UDP- glucosyltransferase is UGT91D2, or a UGT having >85% amino-acid sequence identity with UGT91D2.
- the UDP-glucosyltransferase is UGT76G1 or a UGT having >85% amino-acid sequence identity with UGT76G1.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to rebaudioside M to form rebaudioside Iq.
- the UDP-glucosyltransferase is UGTS12 or a UGT having >85% amino-acid sequence identity with UGTS12.
- the UDP-glucosyltransferase is EUGT11, or a UGT having >85% amino- acid sequence identity with EUGT11.
- the UDP- glucosyltransferase is UGT91D2, or a UGT having >85% amino-acid sequence identity with UGT91D2.
- the UDP-glucosyltransferase is UGT76G1 or a UGT having >85% amino-acid sequence identity with UGT76G1.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to rebaudioside M to form rebaudioside lr.
- the UDP-glucosyltransferase is UGTS12 or a UGT having >85% amino-acid sequence identity with UGTS12.
- the UDP-glucosyltransferase is EUGT11, or a UGT having >85% amino- acid sequence identity with EUGT11.
- the UDP- glucosyltransferase is UGT91D2, or a UGT having >85% amino-acid sequence identity with UGT91D2.
- the UDP-glucosyltransferase is UGT76G1 or a UGT having >85% amino-acid sequence identity with UGT76G1.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to rebaudioside M to form rebaudioside Is.
- the UDP-glucosyltransferase is UGTS12 or a UGT having >85% amino-acid sequence identity with UGTS12.
- the UDP-glucosyltransferase is EUGT11, or a UGT having >85% amino- acid sequence identity with EUGT11.
- the UDP- glucosyltransferase is UGT91D2, or a UGT having >85% amino-acid sequence identity with UGT91D2.
- the UDP-glucosyltransferase is UGT76G1 or a UGT having >85% amino-acid sequence identity with UGT76G1.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to rebaudioside M to form rebaudioside It.
- the UDP-glucosyltransferase is UGTS12 or a UGT having >85% amino-acid sequence identity with UGTS12.
- the UDP-glucosyltransferase is EUGT11, or a UGT having >85% amino- acid sequence identity with EUGT11.
- the UDP- glucosyltransferase is UGT91D2, or a UGT having >85% amino-acid sequence identity with UGT91D2.
- the UDP-glucosyltransferase is UGT76G1 or a UGT having >85% amino-acid sequence identity with UGT76G1.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to rebaudioside M4 to form rebaudioside 2a.
- the UDP-glucosyltransferase is UGTS12 or a UGT having >85% amino-acid sequence identity with UGTS12.
- the UDP-glucosyltransferase is EUGT11, or a UGT having >85% amino- acid sequence identity with EUGT11.
- the UDP- glucosyltransferase is UGT91D2, or a UGT having >85% amino-acid sequence identity with UGT91D2.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to rebaudioside M4 to form rebaudioside 2b.
- the UDP-glucosyltransferase is UGT76G1 or a UGT having >85% amino-acid sequence identity with UGT76G1.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to rebaudioside M4 to form rebaudioside 2c.
- the UDP-glucosyltransferase is UGTS12 or a UGT having >85% amino-acid sequence identity with UGTS12.
- the UDP-glucosyltransferase is EUGT11, or a UGT having >85% amino- acid sequence identity with EUGT11.
- the UDP- glucosyltransferase is UGT91D2, or a UGT having >85% amino-acid sequence identity with UGT91D2.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to rebaudioside M4 to form rebaudioside 2d.
- the UDP-glucosyltransferase is UGTS12 or a UGT having >85% amino-acid sequence identity with UGTS12.
- the UDP-glucosyltransferase is EUGT11, or a UGT having >85% amino- acid sequence identity with EUGT11.
- the UDP- glucosyltransferase is UGT91D2, or a UGT having >85% amino-acid sequence identity with UGT91D2.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to rebaudioside M4 to form rebaudioside 2e.
- the UDP-glucosyltransferase is UGT76G1 or a UGT having >85% amino-acid sequence identity with UGT76G1.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to rebaudioside M4 to form rebaudioside 2f.
- the UDP-glucosyltransferase is UGTS12 or a UGT having >85% amino-acid sequence identity with UGTS12.
- the UDP-glucosyltransferase is EUGT11, or a UGT having >85% amino- acid sequence identity with EUGT11.
- the UDP- glucosyltransferase is UGT91D2, or a UGT having >85% amino-acid sequence identity with UGT91D2.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to rebaudioside M4 to form rebaudioside 2g.
- the UDP-glucosyltransferase is UGTS12 or a UGT having >85% amino-acid sequence identity with UGTS12.
- the UDP-glucosyltransferase is EUGT11, or a UGT having >85% amino- acid sequence identity with EUGT11.
- the UDP- glucosyltransferase is UGT91D2, or a UGT having >85% amino-acid sequence identity with UGT91D2.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to rebaudioside M4 to form rebaudioside 2h.
- the UDP-glucosyltransferase is UGT76G1 or a UGT having >85% amino-acid sequence identity with UGT76G1.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to rebaudioside M4 to form rebaudioside 21
- the UDP-glucosyltransferase is UGTS12 or a UGT having >85% amino-acid sequence identity with UGTS12.
- the UDP-glucosyltransferase is EUGT11, or a UGT having >85% amino- acid sequence identity with EUGT11.
- the UDP- glucosyltransferase is UGT91D2, or a UGT having >85% amino-acid sequence identity with UGT91D2.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to rebaudioside M4 to form rebaudioside 2j.
- the UDP-glucosyltransferase is UGTS12 or a UGT having >85% amino-acid sequence identity with UGTS12.
- the UDP-glucosyltransferase is EUGT11, or a UGT having >85% amino- acid sequence identity with EUGT11.
- the UDP- glucosyltransferase is UGT91D2, or a UGT having >85% amino-acid sequence identity with UGT91D2.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to rebaudioside M4 to form rebaudioside 2k.
- the UDP-glucosyltransferase is UGT76G1 or a UGT having >85% amino-acid sequence identity with UGT76G1.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to rebaudioside M4 to form rebaudioside 21.
- the UDP-glucosyltransferase is UGTS12 or a UGT having >85% amino-acid sequence identity with UGTS12.
- the UDP-glucosyltransferase is EUGT11, or a UGT having >85% amino- acid sequence identity with EUGT11.
- the UDP- glucosyltransferase is UGT91D2, or a UGT having >85% amino-acid sequence identity with UGT91D2.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to rebaudioside M4 to form rebaudioside 2m.
- the UDP-glucosyltransferase is UGTS12 or a UGT having >85% amino-acid sequence identity with UGTS12.
- the UDP-glucosyltransferase is EUGT11, or a UGT having >85% amino- acid sequence identity with EUGT11.
- the UDP- glucosyltransferase is UGT91D2, or a UGT having >85% amino-acid sequence identity with UGT91D2.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to rebaudioside M4 to form rebaudioside 2n.
- the UDP-glucosyltransferase is UGTS12 or a UGT having >85% amino-acid sequence identity with UGTS12.
- the UDP-glucosyltransferase is EUGT11, or a UGT having >85% amino- acid sequence identity with EUGT11.
- the UDP- glucosyltransferase is UGT91D2, or a UGT having >85% amino-acid sequence identity with UGT91D2.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to rebaudioside M4 to form rebaudioside 2o.
- the UDP-glucosyltransferase is UGTS12 or a UGT having >85% amino-acid sequence identity with UGTS12.
- the UDP-glucosyltransferase is EUGT11, or a UGT having >85% amino- acid sequence identity with EUGT1 1.
- the UDP- glucosyltransferase is UGT91D2, or a UGT having >85% amino-acid sequence identity with UGT91D2.
- the UDP-glucosyltransferase is UGT76G1 or a UGT having >85% amino-acid sequence identity with UGT76G1.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to rebaudioside M4 to form rebaudioside 2p.
- the UDP-glucosyltransferase is UGTS12 or a UGT having >85% amino-acid sequence identity with UGTS12.
- the UDP-glucosyltransferase is EUGT11, or a UGT having >85% amino- acid sequence identity with EUGT11.
- the UDP- glucosyltransferase is UGT91D2, or a UGT having >85% amino-acid sequence identity with UGT91D2, In a particular embodiment, the UDP-glucosyltransferase is UGT76G1 or a UGT having >85% amino-acid sequence identity with UGT76G1.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to rebaudioside M4 to form rebaudioside 2q.
- the UDP-glucosyltransferase is UGTS12 or a UGT having >85% amino-acid sequence identity with UGTS12.
- the UDP-glucosyltransferase is EUGT11, or a UGT having >85% amino- acid sequence identity with EUGT11.
- the UDP- glucosyltransferase is UGT91D2, or a UGT having >85% amino-acid sequence identity with UGT91D2.
- the UDP-glucosyltransferase is UGT76G1 or a UGT having >85% amino-acid sequence identity with UGT76G1.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to rebaudioside M4 to form rebaudioside 2r.
- the UDP-glucosyltransferase is UGTS12 or a UGT having >85% amino-acid sequence identity with UGTS12.
- the UDP-glucosyltransferase is EUGT11, or a UGT having >85% amino- acid sequence identity with EUGT11.
- the UDP- glucosyltransferase is UGT91D2, or a UGT having >85% amino-acid sequence identity with UGT91D2.
- the UDP-glucosyltransferase is UGT76G1 or a UGT having >85% amino-acid sequence identity with UGT76G1.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to rebaudioside M4 to form rebaudioside 2s.
- the UDP-glucosyltransferase is UGTS12 or a UGT having >85% amino-acid sequence identity with UGTS12.
- the UDP-glucosyltransferase is EUGT11, or a UGT having >85% amino- acid sequence identity with EUGT11.
- the UDP- glucosyltransferase is UGT91D2, or a UGT having >85% amino-acid sequence identity with UGT91D2.
- the UDP-glucosyltransferase is UGT76G1 or a UGT having >85% amino-acid sequence identity with UGT76G1.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to rebaudioside M4 to form rebaudioside lq.
- the UDP-glucosyltransferase is UGTS12 or a UGT having >85% amino-acid sequence identity with UGTS12.
- the UDP-glucosyltransferase is EUGT11, or a UGT having >85% amino- acid sequence identity with EUGT11.
- the UDP- glucosyltransferase is UGT91D2, or a UGT having >85% amino-acid sequence identity with UGT91D2.
- the UDP-glucosyltransferase is UGT76G1 or a UGT having >85% amino-acid sequence identity with UGT76G1.
- the method of the present invention further comprises recycling UDP to provide UDP-glucose.
- the method comprises recycling UDP by providing a recycling catalyst and a recycling substrate, such that the biotransformation of steviol and/or the steviol glycoside substrate to the target steviol glycoside is carried out using catalytic amounts of UDP- glucosyltransferase and UDP-glucose.
- the recycling catalyst is sucrose synthase SuSy_At or a sucrose synthase having >85% amino-acid sequence identity with SuSy_At.
- the recycling substrate for UDP-glucose recycling catalyst is sucrose.
- the method of the present invention further comprises the use of transglycosidases that use oligo- or poly-saccharides as the sugar donor to modify recipient target steviol glycoside molecules.
- transglycosidases that use oligo- or poly-saccharides as the sugar donor to modify recipient target steviol glycoside molecules.
- Non-limiting examples include cyclodextrin glycosyltransferase (CGTase), fructofuranosidase, amylase, saccharase, glucosucrase, beta-h-fructosidase, beta-fructosidase, sucrase, fructosylinvertase, alkaline invertase, acid invertase, fructofuranosidase.
- CGTase cyclodextrin glycosyltransferase
- fructofuranosidase amylase
- saccharase glucosucrase
- glucose and sugar(s) other than glucose including but not limited to fructose, xylose, rhamnose, arabinose, deoxyglucose, galactose are transferred to the recipient target steviol glycosides.
- the recipient steviol glycoside is rebaudioside la, rebaudioside lb, rebaudioside lc, rebaudioside lcl, rebaudioside le, rebaudioside If, rebaudioside Ig, rebaudioside lh, rebaudioside li, rebaudioside Ij, rebaudioside lk, rebaudioside 11, rebaudioside lm, rebaudioside In, rebaudioside lo, rebaudioside Ip, rebaudioside lq, rebaudioside lr, rebaudioside Is, rebaudioside It, rebaudioside 2a, rebaudioside 2b, rebaudioside 2c, rebaudioside 2d, rebaudioside 2e, rebaudioside 2f rebaudioside 2g, rebaudioside 2h, rebaudioside 2i, rebaudioside 2j, rebaudioside
- the method of the present invention further comprises separating the target steviol glycoside from the medium to provide a highly purified target steviol glycoside composition.
- the target steviol glycoside can be separated by at least one suitable method, such as, for example, crystallization, separation by membranes, centrifugation, extraction, chromatographic separation or a combination of such methods.
- the target steviol glycoside can be produced within the microorganism. In another embodiment, the target steviol glycoside can be secreted out in the medium. In one another embodiment, the released steviol glycoside can be continuously removed from the medium. In yet another embodiment, the target steviol glycoside is separated after the completion of the conversion reaction.
- separation produces a composition comprising greater than about 80% by weight of the target steviol glycoside on an anhydrous basis, i.e., a highly purified steviol glycoside composition.
- separation produces a composition comprising greater than about 90% by weight of the target steviol glycoside.
- the composition comprises greater than about 95% by weight of the target steviol glycoside.
- the composition comprises greater than about 99% by weight of the target steviol glycoside.
- the target steviol glycoside can be in any polymorphic or amorphous form, including hydrates, solvates, anhydrous or combinations thereof.
- Purified target steviol glycosides can be used in consumable products as a sweetener, flavor modifier, flavor with modifying properties and/or foaming suppressor.
- Suitable consumer products include, but are not limited to, food, beverages, pharmaceutical compositions, tobacco products, nutraceutical compositions, oral hygiene compositions, and cosmetic compositions.
- FIG. la through FIG. lt show the chemical structure of some SvG7 steviol glycosides rebaudioside la, rebaudioside lb, rebaudioside lc, rebaudioside lcl, rebaudioside le, rebaudioside If, rebaudioside lg, rebaudioside lh, rebaudioside li, rebaudioside lj, rebaudioside lk, rebaudioside 11, rebaudioside lm, rebaudioside In, rebaudioside lo, rebaudioside lp, rebaudioside lq, rebaudioside lr, rebaudioside Is and rebaudioside It respectively.
- FIG. 2a through FIG. 2s show the chemical structure of some SvG7 steviol glycosides rebaudioside 2a, rebaudioside 2b, rebaudioside 2c, rebaudioside 2d, rebaudioside 2e, rebaudioside 2f rebaudioside 2g, rebaudioside 2h, rebaudioside 2i, rebaudioside 2j, rebaudioside 2k, rebaudioside 21, rebaudioside 2m, rebaudioside 2n, rebaudioside 2o, rebaudioside 2p, rebaudioside 2q, rebaudioside 2r and rebaudioside 2s respectively.
- FIG. 3 shows the chemical structure of rebaudioside M4.
- FIG. 4a through FIG. 4s show the pathways of producing rebaudioside la, rebaudioside lb, rebaudioside lc, rebaudioside Id, rebaudioside le, rebaudioside If, rebaudioside Ig, rebaudioside lh, rebaudioside li, rebaudioside lj, rebaudioside lk, rebaudioside 11, rebaudioside lm, rebaudioside In, rebaudioside lo, rebaudioside lp, rebaudioside lq, rebaudioside lr, rebaudioside Is and rebaudioside It, rebaudioside 2a, rebaudioside 2b, rebaudioside 2c, rebaudioside 2d, rebaudioside 2e, rebaudioside 2f rebaudioside 2g, rebaudioside 2h, rebaudioside 2i, rebaudioside 2j
- FIG. 5a through FIG. 5t show the biocatalytic production of rebaudioside la, rebaudioside lb, rebaudioside lc, rebaudioside Id, rebaudioside le, rebaudioside If rebaudioside lg, rebaudioside lh, rebaudioside li, rebaudioside lj, rebaudioside lk, rebaudioside 11, rebaudioside lm and rebaudioside In, rebaudioside lo, rebaudioside lp, rebaudioside lq, rebaudioside lr, rebaudioside Is and rebaudioside It respectively, from rebaudioside A using the enzymes UGTS12 and UGT76G1 and concomitant recycling of UDP to UDP- glucose via sucrose synthase SuSy_At.
- FIG. 6a through FIG. 6t show the biocatalytic production of rebaudioside 2a, rebaudioside 2b, rebaudioside 2c, rebaudioside 2d, rebaudioside 2e, rebaudioside 2f rebaudioside 2g, rebaudioside 2h, rebaudioside 2i, rebaudioside 2j, rebaudioside 2k, rebaudioside 21, rebaudioside 2m, rebaudioside 2n, rebaudioside 2o, rebaudioside 2p, rebaudioside 2q, rebaudioside 2r, rebaudioside 2s and rebaudioside lq, respectively, from stevioside using the enzymes UGTS12 and UGT76G1 and concomitant recycling of UDP to UDP-glucose via sucrose synthase SuSy_At.
- FIG. 7 shows the biocatalytic production of rebaudioside M4 from stevioside using the enzymes UGTS12 and UGT76G1 and concomitant recycling of UDP to UDP-glucose via sucrose synthase SuSy_At.
- FIG. 8a through FIG. 8t show the biocatalytic production of rebaudioside 2a, rebaudioside 2b, rebaudioside 2c, rebaudioside 2d, rebaudioside 2e, rebaudioside 2f rebaudioside 2g, rebaudioside 2h, rebaudioside 2i, rebaudioside 2j, rebaudioside 2k, rebaudioside 21, rebaudioside 2m, rebaudioside 2n, rebaudioside 2o, rebaudioside 2p, rebaudioside 2q, rebaudioside 2r, rebaudioside 2s and rebaudioside lq, respectively from rebaudioside AM using the enzymes UGTS12 and UGT76G1 and concomitant recycling of UDP to UDP- glucose via sucrose synthase SuSy_At.
- FIG. 9 shows the biocatalytic production of rebaudioside M4 from rebaudioside A using the enzymes UGTS12 and UGT76G1 and concomitant recycling of UDP to UDP-glucose via sucrose synthase SuSy_At.
- FIG. lOa through FIG. lOt show the biocatalytic production of rebaudioside 2a rebaudioside 2b, rebaudioside 2c, rebaudioside 2d, rebaudioside 2e, rebaudioside 2f rebaudioside 2g, rebaudioside 2h, rebaudioside 2i, rebaudioside 2j, rebaudioside 2k, rebaudioside 21, rebaudioside 2m, rebaudioside 2n, rebaudioside 2o, rebaudioside 2p, rebaudioside 2q, rebaudioside 2r, rebaudioside 2s and rebaudioside lq, respectively, from rebaudioside M4 using the enzymes UGTS12 and UGT76G1 and concomitant recycling of UDP to UDP-glucose via sucrose synthase SuSy_At.
- FIG. 1 la shows the HPLC chromatogram of stevioside.
- the peak with retention time of 20.958 minutes corresponds to stevioside.
- the peak with retention time 20.725 minutes corresponds to rebaudioside A.
- the peak at 32.925 minutes corresponds to rebaudioside B.
- the peak at 33.930 minutes corresponds to steviolbioside.
- FIG. 1 lb shows the HPLC chromatogram of the product of the biocatalytic production of SvG7 molecules from stevioside.
- the peak at 5.089 minutes corresponds to rebaudioside 2m.
- the peak at 6.459 minutes corresponds to rebaudioside 2a.
- the peak at 9.825 minutes corresponds to rebaudioside AM.
- the peak at 13.845 minutes corresponds to rebaudioside M.
- the peak at 32.974 minutes corresponds to rebaudioside B.
- the peak at 33.979 minutes corresponds to steviolbioside.
- FIG. 1 lc shows the HPLC chromatogram of rebaudioside 2a after purification by HPLC. The peak with retention time of 6.261 minutes correspond to rebaudioside 2a.
- FIG. 1 ld shows the HPLC chromatogram of rebaudioside 2m after purification by HPLC. The peak with retention time of 5.197 minutes correspond to rebaudioside 2m.
- FIG. l2a shows the 1H NMR spectrum of rebaudioside 2a (500 MHz, pyridine-i/5).
- FIG. l2b shows the HSQC spectrum of rebaudioside 2a (500 MHz, pyridine-c/5).
- FIG. l2c shows the H,H COSY spectrum of rebaudioside 2a (500 MHz, pyridine-r/5).
- FIG. l2d shows the HMBC spectrum of rebaudioside 2a (500 MHz, pyridine-i/5).
- FIG. l2e shows the HSQC-TOCSY spectrum of rebaudioside 2a (500 MHz, pyridine-r/5).
- FIG. l2f shows the 1D-NOESY spectrum of rebaudioside 2a (500 MHz, pyridine-c/5).
- FIG. l2g shows the LC chromatogram of rebaudioside 2a.
- FIG. l2h shows the mass spectrum of rebaudioside 2a.
- FIG. l3a shows the 1H NMR spectrum of rebaudioside 2m (500 MHz, pyridine-r/5).
- FIG. 13b shows the HSQC spectrum of rebaudioside 2m (500 MHz, pyridine- 5).
- FIG. l3c shows the H,H COSY spectrum of rebaudioside 2m (500 MHz, pyridine-r/5).
- FIG. l3d shows the HMBC spectrum of rebaudioside 2m (500 MHz, pyridine- 5).
- FIG. l3e shows the HSQC-TOCSY spectrum of rebaudioside 2m (500 MHz, pyridine- ⁇ 75).
- FIG. l3f shows the 1D-NOESY spectrum of rebaudioside 2m (500 MHz, pyridine- ⁇ 75).
- FIG. l3g shows the LC chromatogram of rebaudioside 2m.
- FIG. l3h shows the mass spectrum of rebaudioside 2m.
- the present invention provides a process for preparing a composition comprising a target steviol glycoside by contacting a starting composition comprising an organic substrate with a microbial cell and/or enzyme preparation, thereby producing a composition comprising a target steviol glycoside.
- One object of the invention is to provide an efficient biocatalytic method for preparing target steviol glycosides, particularly steviolmonoside, steviolmonoside A, steviolbioside, steviolbioside D, rubusoside, steviolbioside A, steviolbioside B, rebaudioside B, stevioside, rebaudioside G, stevioside A, stevioside B, stevioside C, rebaudioside A, rebaudioside E, rebaudioside E2, rebaudioside E4, rebaudioside E6, rebaudioside E3, rebaudioside D, rebaudioside I, rebaudioside AM, rebaudioside D7, rebaudioside M, rebaudioside M4, rebaudioside la, rebaudioside lb, rebaudioside lc, rebaudioside Id, rebaudioside le, rebaudioside If, rebaudioside Ig
- starting composition refers to any composition (generally an aqueous solution) containing one or more organic compound comprising at least one carbon atom.
- the starting composition is selected from the group consisting of steviol, steviol glycosides, polyols and various carbohydrates.
- the starting composition steviol glycoside is selected from the group consisting of steviol, steviolmonoside, steviolmonoside A, steviolbioside, steviolbioside D, rubusoside, steviolbioside A, steviolbioside B, rebaudioside B, stevioside, rebaudioside G, stevioside A, stevioside B, stevioside C, rebaudioside A, rebaudioside E, rebaudioside E2, rebaudioside E4, rebaudioside E6, rebaudioside E3, rebaudioside D, rebaudioside /, rebaudioside AM, rebaudioside D7, rebaudioside M, and/or rebaudioside M4 or other glycoside of steviol occurring in Stevia rebaudiana plant, synthetic steviol glycosides, e.g. enzymatically glucosylated steviol glycosides and combinations thereof.
- the starting composition steviol glycoside is steviolmonoside.
- the starting composition steviol glycoside is steviolmonoside ⁇ . In another embodiment, the starting composition steviol glycoside is steviolbioside.
- the starting composition steviol glycoside is steviolbioside D.
- the starting composition steviol glycoside is rubusoside.
- the starting composition steviol glycoside is rubusoside. In another embodiment, the starting composition steviol glycoside is steviolbioside
- the starting composition steviol glycoside is steviolbioside
- the starting composition steviol glycoside is rebaudioside B. In another embodiment, the starting composition steviol glycoside is stevioside.
- the starting composition steviol glycoside is rebaudioside G. In another embodiment, the starting composition steviol glycoside is stevioside
- the starting composition steviol glycoside is stevioside B.
- the starting composition steviol glycoside is stevioside C. In another embodiment, the starting composition steviol glycoside is rebaudioside A.
- the starting composition steviol glycoside is rebaudioside E.
- the starting composition steviol glycoside is rebaudioside E2. In another embodiment, the starting composition steviol glycoside is rebaudioside
- the starting composition steviol glycoside is rebaudioside
- the starting composition steviol glycoside is rebaudioside E3.
- the starting composition steviol glycoside is rebaudioside D. In another embodiment, the starting composition steviol glycoside is rebaudioside I. In another embodiment, the starting composition steviol glycoside is rebaudioside
- the starting composition steviol glycoside is rebaudioside
- the starting composition steviol glycoside is rebaudioside M.
- the starting composition steviol glycoside is rebaudioside
- polyol refers to a molecule that contains more than one hydroxyl group.
- a polyol may be a diol, triol, or a tetraol which contain 2, 3, and 4 hydroxyl groups, respectively.
- a polyol also may contain more than four hydroxyl groups, such as a pentaol, hexaol, heptaol, or the like, which contain 5, 6, or 7 hydroxyl groups, respectively.
- a polyol also may be a sugar alcohol, polyhydric alcohol, or polyalcohol which is a reduced form of carbohydrate, wherein the carbonyl group (aldehyde or ketone, reducing sugar) has been reduced to a primary or secondary hydroxyl group.
- polyols include, but are not limited to, erythritol, maltitol, mannitol, sorbitol, lactitol, xylitol, inositol, isomalt, propylene glycol, glycerol, threitol, galactitol, hydrogenated isomaltulose, reduced isomalto-oligosaccharides, reduced xylo- oligosaccharides, reduced gentio-oligosaccharides, reduced maltose syrup, reduced glucose syrup, hydrogenated starch hydrolyzates, polyglycitols and sugar alcohols or any other carbohydrates capable of being reduced.
- carbohydrate refers to aldehyde or ketone compounds substituted with multiple hydroxyl groups, of the general formula (O3 ⁇ 40) h , wherein n is 3-30, as well as their oligomers and polymers.
- the carbohydrates of the present invention can, in addition, be substituted or deoxygenated at one or more positions.
- Carbohydrates, as used herein, encompass unmodified carbohydrates, carbohydrate derivatives, substituted carbohydrates, and modified carbohydrates.
- the phrases“carbohydrate derivatives”, “substituted carbohydrate”, and“modified carbohydrates” are synonymous.
- Modified carbohydrate means any carbohydrate wherein at least one atom has been added, removed, or substituted, or combinations thereof.
- carbohydrate derivatives or substituted carbohydrates include substituted and unsubstituted monosaccharides, disaccharides, oligosaccharides, and polysaccharides.
- the carbohydrate derivatives or substituted carbohydrates optionally can be deoxygenated at any corresponding C-position, and/or substituted with one or more moieties such as hydrogen, halogen, haloalkyl, carboxyl, acyl, acyloxy, amino, amido, carboxyl derivatives, alkylamino, dialkylamino, arylamino, alkoxy, aryloxy, nitro, cyano, sulfo, mercapto, imino, sulfonyl, sulfenyl, sulfmyl, sulfamoyl, carboalkoxy, carboxamido, phosphonyl, phosphinyl, phosphoryl, phosphino, thioester, thioether, oximin
- the starting composition may be synthetic or purified (partially or entirely), commercially available or prepared.
- the starting composition is glycerol.
- the starting composition is glucose
- the starting composition is rhamnose.
- the starting composition is sucrose.
- the starting composition is starch.
- the starting composition is maltodextrin.
- the starting composition is cellulose.
- the starting composition is amylose.
- the organic compound(s) of starting composition serve as a substrate(s) for the production of the target steviol glycoside(s), as described herein.
- the target steviol glycoside of the present method can be any steviol glycoside that can be prepared by the process disclosed herein.
- the target steviol glycoside is selected from the group consisting of steviolmonoside, steviolmonoside A, steviolbioside, steviolbioside D, rubusoside, steviolbioside A, steviolbioside B, rebaudioside B, stevioside, rebaudioside G, stevioside A, stevioside B, stevioside C, rebaudioside A, rebaudioside E, rebaudioside E2, rebaudioside E4, rebaudioside E6, rebaudioside E3, rebaudioside D, rebaudioside /, rebaudioside AM, rebaudioside D7, rebaudioside M, rebaudioside M4, rebaudioside la, rebaudioside lb, rebaudioside lc, rebaudioside Id
- the target steviol glycoside is steviolmonoside.
- the target steviol glycoside is steviolmonoside A.
- the target steviol glycoside is steviolbioside.
- the target steviol glycoside is steviolbioside D.
- the target steviol glycoside is rubusoside.
- the target steviol glycoside is steviolbioside
- the target steviol glycoside is steviolbioside B.
- the target steviol glycoside is rebaudioside B.
- the target steviol glycoside is stevioside.
- the target steviol glycoside is rebaudioside G.
- the target steviol glycoside is stevioside A.
- the target steviol glycoside is stevioside B.
- the target steviol glycoside is stevioside C. In another embodiment, the target steviol glycoside is rebaudioside A. In another embodiment, the target steviol glycoside is rebaudioside E. In another embodiment, the target steviol glycoside is rebaudioside E2. In another embodiment, the target steviol glycoside is rebaudioside E4. In another embodiment, the target steviol glycoside is rebaudioside E6.
- the target steviol glycoside is rebaudioside E3. In another embodiment, the target steviol glycoside is rebaudioside D. In another embodiment, the target steviol glycoside is rebaudioside I. In another embodiment, the target steviol glycoside is rebaudioside AM. In another embodiment, the target steviol glycoside is rebaudioside D7.
- the target steviol glycoside is rebaudioside M. In another embodiment, the target steviol glycoside is rebaudioside M4. In another embodiment, the target steviol glycoside is rebaudioside la. In another embodiment, the target steviol glycoside is rebaudioside lb. In another embodiment, the target steviol glycoside is rebaudioside lc.
- the target steviol glycoside is rebaudioside Id. In another embodiment, the target steviol glycoside is rebaudioside le. In another embodiment, the target steviol glycoside is rebaudioside If. In another embodiment, the target steviol glycoside is rebaudioside lg. In another embodiment, the target steviol glycoside is rebaudioside lh.
- the target steviol glycoside is rebaudioside li. In another embodiment, the target steviol glycoside is rebaudioside lj. In another embodiment, the target steviol glycoside is rebaudioside lk. In another embodiment, the target steviol glycoside is rebaudioside 11. In another embodiment, the target steviol glycoside is rebaudioside lm. In another embodiment, the target steviol glycoside is rebaudioside In.
- the target steviol glycoside is rebaudioside lo. In another embodiment, the target steviol glycoside is rebaudioside lp. In another embodiment, the target steviol glycoside is rebaudioside lq. In another embodiment, the target steviol glycoside is rebaudioside lr. In another embodiment, the target steviol glycoside is rebaudioside Is.
- the target steviol glycoside is rebaudioside It. In another embodiment, the target steviol glycoside is rebaudioside 2a. In another embodiment, the target steviol glycoside is rebaudioside 2b. In another embodiment, the target steviol glycoside is rebaudioside 2c. In another embodiment, the target steviol glycoside is rebaudioside 2d.
- the target steviol glycoside is rebaudioside 2e. In another embodiment, the target steviol glycoside is rebaudioside 2f. In another embodiment, the target steviol glycoside is rebaudioside 2g. In another embodiment, the target steviol glycoside is rebaudioside 2h. In another embodiment, the target steviol glycoside is rebaudioside 2i.
- the target steviol glycoside is rebaudioside 2j. In another embodiment, the target steviol glycoside is rebaudioside 2k.
- the target steviol glycoside is rebaudioside 21.
- the target steviol glycoside is rebaudioside 2m.
- the target steviol glycoside is rebaudioside 2n. In another embodiment, the target steviol glycoside is rebaudioside 2o.
- the target steviol glycoside is rebaudioside 2p.
- the target steviol glycoside is rebaudioside 2q.
- the target steviol glycoside is rebaudioside 2r.
- the target steviol glycoside is rebaudioside 2s. In another embodiment, the target steviol glycoside is SvG7.
- the target steviol glycoside can be in any polymorphic or amorphous form, including hydrates, solvates, anhydrous or combinations thereof.
- the present invention is a biocatalytic process for the production of steviolmonoside. In one embodiment, the present invention is a biocatalytic process for the production of steviolmonoside A.
- the present invention is a biocatalytic process for the production of steviolbioside.
- the present invention is a biocatalytic process for the production of steviolbioside D.
- the present invention is a biocatalytic process for the production of rubusoside.
- the present invention is a biocatalytic process for the production of steviolbioside In one embodiment, the present invention is a biocatalytic process for the production of steviolbioside B.
- the present invention is a biocatalytic process for the production of rebaudioside B.
- the present invention is a biocatalytic process for the production of stevioside.
- the present invention is a biocatalytic process for the production of rebaudioside G.
- the present invention is a biocatalytic process for the production of stevioside A.
- the present invention is a biocatalytic process for the production of stevioside B.
- the present invention is a biocatalytic process for the production of stevioside C.
- the present invention is a biocatalytic process for the production of rebaudioside A.
- the present invention is a biocatalytic process for the production of rebaudioside E.
- the present invention is a biocatalytic process for the production of rebaudioside E2.
- the present invention is a biocatalytic process for the production of rebaudioside E4.
- the present invention is a biocatalytic process for the production of rebaudioside E6.
- the present invention is a biocatalytic process for the production of rebaudioside E3. In one embodiment, the present invention is a biocatalytic process for the production of rebaudioside D.
- the present invention is a biocatalytic process for the production of rebaudioside I. In one embodiment, the present invention is a biocatalytic process for the production of rebaudioside AM.
- the present invention is a biocatalytic process for the production of rebaudioside D7.
- the present invention is a biocatalytic process for the production of rebaudioside E3.
- the present invention is a biocatalytic process for the production of rebaudioside M.
- the present invention is a biocatalytic process for the production of rebaudioside M4. In one embodiment, the present invention is a biocatalytic process for the production of rebaudioside la.
- the present invention is a biocatalytic process for the production of rebaudioside lb.
- the present invention is a biocatalytic process for the production of rebaudioside lc.
- the present invention is a biocatalytic process for the production of rebaudioside Id.
- the present invention is a biocatalytic process for the production of rebaudioside 1 e. In one embodiment, the present invention is a biocatalytic process for the production of rebaudioside If. In one embodiment, the present invention is a biocatalytic process for the production of rebaudioside Ig.
- the present invention is a biocatalytic process for the production of rebaudioside Ih. In one embodiment, the present invention is a biocatalytic process for the production of rebaudioside 11
- the present invention is a biocatalytic process for the production of rebaudioside lj.
- the present invention is a biocatalytic process for the production of rebaudioside lk.
- the present invention is a biocatalytic process for the production of rebaudioside 11.
- the present invention is a biocatalytic process for the production of rebaudioside lm. In one embodiment, the present invention is a biocatalytic process for the production of rebaudioside In.
- the present invention is a biocatalytic process for the production of rebaudioside lo.
- the present invention is a biocatalytic process for the production of rebaudioside Ip.
- the present invention is a biocatalytic process for the production of rebaudioside lq.
- the present invention is a biocatalytic process for the production of rebaudioside lr. In one embodiment, the present invention is a biocatalytic process for the production of rebaudioside Is. In one embodiment, the present invention is a biocatalytic process for the production of rebaudioside It.
- the present invention is a biocatalytic process for the production of rebaudioside 2a.
- the present invention is a biocatalytic process for the production of rebaudioside 2b.
- the present invention is a biocatalytic process for the production of rebaudioside 2c.
- the present invention is a biocatalytic process for the production of rebaudioside 2d.
- the present invention is a biocatalytic process for the production of rebaudioside 2e.
- the present invention is a biocatalytic process for the production of rebaudioside 2f.
- the present invention is a biocatalytic process for the production of rebaudioside 2g.
- the present invention is a biocatalytic process for the production of rebaudioside 2h.
- the present invention is a biocatalytic process for the production of rebaudioside 2i.
- the present invention is a biocatalytic process for the production of rebaudioside 2j.
- the present invention is a biocatalytic process for the production of rebaudioside 2k.
- the present invention is a biocatalytic process for the production of rebaudioside 21. In one embodiment, the present invention is a biocatalytic process for the production of rebaudioside 2m.
- the present invention is a biocatalytic process for the production of rebaudioside 2n.
- the present invention is a biocatalytic process for the production of rebaudioside 2o.
- the present invention is a biocatalytic process for the production of rebaudioside 2p.
- the present invention is a biocatalytic process for the production of rebaudioside 2q.
- the present invention is a biocatalytic process for the production of rebaudioside 2r.
- the present invention is a biocatalytic process for the production of rebaudioside 2s.
- the present invention is a biocatalytic process for the production of SvG7.
- the present invention provides for the biocatalytic process for the production of rebaudioside la from a starting composition comprising rebaudioside A and UDP-glucose.
- the present invention provides for the biocatalytic process for the production of rebaudioside lb from a starting composition comprising rebaudioside A and UDP-glucose.
- the present invention provides for the biocatalytic process for the production of rebaudioside lc from a starting composition comprising rebaudioside A and UDP-glucose.
- the present invention provides for the biocatalytic process for the production of rebaudioside Id from a starting composition comprising rebaudioside A and UDP-glucose.
- the present invention provides for the biocatalytic process for the production of rebaudioside le from a starting composition comprising rebaudioside A and UDP-glucose.
- the present invention provides for the biocatalytic process for the production of rebaudioside If from a starting composition comprising rebaudioside A and UDP-glucose.
- the present invention provides for the biocatalytic process for the production of rebaudioside Ig from a starting composition comprising rebaudioside A and UDP-glucose.
- the present invention provides for the biocatalytic process for the production of rebaudioside lh from a starting composition comprising rebaudioside A and UDP-glucose.
- the present invention provides for the biocatalytic process for the production of rebaudioside li from a starting composition comprising rebaudioside A and UDP-glucose.
- the present invention provides for the biocatalytic process for the production of rebaudioside lj from a starting composition comprising rebaudioside A and UDP-glucose.
- the present invention provides for the biocatalytic process for the production of rebaudioside lk from a starting composition comprising rebaudioside A and UDP-glucose.
- the present invention provides for the biocatalytic process for the production of rebaudioside 11 from a starting composition comprising rebaudioside A and UDP-glucose.
- the present invention provides for the biocatalytic process for the production of rebaudioside lm from a starting composition comprising rebaudioside A and UDP-glucose.
- the present invention provides for the biocatalytic process for the production of rebaudioside In from a starting composition comprising rebaudioside A and UDP-glucose.
- the present invention provides for the biocatalytic process for the production of rebaudioside lo from a starting composition comprising rebaudioside A and UDP-glucose.
- the present invention provides for the biocatalytic process for the production of rebaudioside lp from a starting composition comprising rebaudioside A and UDP-glucose.
- the present invention provides for the biocatalytic process for the production of rebaudioside lq from a starting composition comprising rebaudioside A and UDP-glucose.
- the present invention provides for the biocatalytic process for the production of rebaudioside lr from a starting composition comprising rebaudioside A and UDP-glucose.
- the present invention provides for the biocatalytic process for the production of rebaudioside Is from a starting composition comprising rebaudioside A and UDP-glucose.
- the present invention provides for the biocatalytic process for the production of rebaudioside It from a starting composition comprising rebaudioside A and UDP-glucose.
- the present invention provides for the biocatalytic process for the production of rebaudioside 2a from a starting composition comprising stevioside and UDP-glucose. In a particular embodiment, the present invention provides for the biocatalytic process for the production of rebaudioside 2b from a starting composition comprising stevioside and UDP-glucose.
- the present invention provides for the biocatalytic process for the production of rebaudioside 2c from a starting composition comprising stevioside and UDP-glucose.
- the present invention provides for the biocatalytic process for the production of rebaudioside 2d from a starting composition comprising stevioside and UDP-glucose.
- the present invention provides for the biocatalytic process for the production of rebaudioside 2e from a starting composition comprising stevioside and UDP-glucose.
- the present invention provides for the biocatalytic process for the production of rebaudioside 2/ from a starting composition comprising stevioside and UDP-glucose.
- the present invention provides for the biocatalytic process for the production of rebaudioside 2g from a starting composition comprising stevioside and UDP-glucose.
- the present invention provides for the biocatalytic process for the production of rebaudioside 2h from a starting composition comprising stevioside and UDP-glucose.
- the present invention provides for the biocatalytic process for the production of rebaudioside 2i from a starting composition comprising stevioside and UDP-glucose.
- the present invention provides for the biocatalytic process for the production of rebaudioside 2j from a starting composition comprising stevioside and UDP-glucose. In a particular embodiment, the present invention provides for the biocatalytic process for the production of rebaudioside 2k from a starting composition comprising stevioside and UDP-glucose.
- the present invention provides for the biocatalytic process for the production of rebaudioside 21 from a starting composition comprising stevioside and UDP-glucose.
- the present invention provides for the biocatalytic process for the production of rebaudioside 2m from a starting composition comprising stevioside and UDP-glucose.
- the present invention provides for the biocatalytic process for the production of rebaudioside 2n from a starting composition comprising stevioside and UDP-glucose.
- the present invention provides for the biocatalytic process for the production of rebaudioside 2o from a starting composition comprising stevioside and UDP-glucose.
- the present invention provides for the biocatalytic process for the production of rebaudioside 2p from a starting composition comprising stevioside and UDP-glucose.
- the present invention provides for the biocatalytic process for the production of rebaudioside 2q from a starting composition comprising stevioside and UDP-glucose.
- the present invention provides for the biocatalytic process for the production of rebaudioside 2r from a starting composition comprising stevioside and UDP-glucose.
- the present invention provides for the biocatalytic process for the production of rebaudioside 2s from a starting composition comprising stevioside and UDP-glucose. In a particular embodiment, the present invention provides for the biocatalytic process for the production of rebaudioside lq from a starting composition comprising stevioside and UDP-glucose.
- the present invention provides for the biocatalytic process for the production of rebaudioside M4 from a starting composition comprising stevioside and UDP-glucose.
- the present invention provides for the biocatalytic process for the production of rebaudioside 2a from a starting composition comprising rebaudioside AM and UDP-glucose. In a particular embodiment, the present invention provides for the biocatalytic process for the production of rebaudioside 2b from a starting composition comprising rebaudioside rebaudioside AM and UDP-glucose.
- the present invention provides for the biocatalytic process for the production of rebaudioside 2c from a starting composition comprising rebaudioside AM and UDP-glucose.
- the present invention provides for the biocatalytic process for the production of rebaudioside 2d from a starting composition comprising rebaudioside AM and UDP-glucose.
- the present invention provides for the biocatalytic process for the production of rebaudioside 2e from a starting composition comprising rebaudioside AM and UDP-glucose.
- the present invention provides for the biocatalytic process for the production of rebaudioside 2f from a starting composition comprising rebaudioside AM and UDP-glucose.
- the present invention provides for the biocatalytic process for the production of rebaudioside 2g from a starting composition comprising rebaudioside AM and UDP-glucose.
- the present invention provides for the biocatalytic process for the production of rebaudioside 2h from a starting composition comprising rebaudioside AM and UDP-glucose.
- the present invention provides for the biocatalytic process for the production of rebaudioside 2i from a starting composition comprising rebaudioside AMmd UDP-glucose.
- the present invention provides for the biocatalytic process for the production of rebaudioside 2j from a starting composition comprising rebaudioside AM and UDP-glucose.
- the present invention provides for the biocatalytic process for the production of rebaudioside 2k from a starting composition comprising rebaudioside AM and UDP-glucose.
- the present invention provides for the biocatalytic process for the production of rebaudioside 21 from a starting composition comprising rebaudioside AM and UDP-glucose.
- the present invention provides for the biocatalytic process for the production of rebaudioside 2m from a starting composition comprising rebaudioside AM and UDP-glucose.
- the present invention provides for the biocatalytic process for the production of rebaudioside 2n from a starting composition comprising rebaudioside AM and UDP-glucose.
- the present invention provides for the biocatalytic process for the production of rebaudioside 2o from a starting composition comprising rebaudioside AM and UDP-glucose.
- the present invention provides for the biocatalytic process for the production of rebaudioside 2p from a starting composition comprising rebaudioside AM and UDP-glucose. In a particular embodiment, the present invention provides for the biocatalytic process for the production of rebaudioside 2q from a starting composition comprising rebaudioside AM and UDP-glucose.
- the present invention provides for the biocatalytic process for the production of rebaudioside 2r from a starting composition comprising rebaudioside AM and UDP-glucose.
- the present invention provides for the biocatalytic process for the production of rebaudioside 2s from a starting composition comprising rebaudioside AM and UDP-glucose.
- the present invention provides for the biocatalytic process for the production of rebaudioside lq from a starting composition comprising rebaudioside AM and UDP-glucose.
- the present invention provides for the biocatalytic process for the production of rebaudioside M4 from a starting composition comprising rebaudioside AM and UDP-glucose.
- the present invention provides for the biocatalytic process for the production of rebaudioside 2a from a starting composition comprising rebaudioside M4 and UDP-glucose.
- the present invention provides for the biocatalytic process for the production of rebaudioside 2b from a starting composition comprising rebaudioside M4 and UDP-glucose.
- the present invention provides for the biocatalytic process for the production of rebaudioside 2c from a starting composition comprising rebaudioside M4 and UDP-glucose.
- the present invention provides for the biocatalytic process for the production of rebaudioside 2d from a starting composition comprising rebaudioside M4 and UDP-glucose. In a particular embodiment, the present invention provides for the biocatalytic process for the production of rebaudioside 2e from a starting composition comprising rebaudioside M4 and UDP-glucose.
- the present invention provides for the biocatalytic process for the production of rebaudioside 2/ from a starting composition comprising rebaudioside M4 and UDP-glucose.
- the present invention provides for the biocatalytic process for the production of rebaudioside 2g from a starting composition comprising rebaudioside M4 and UDP-glucose. In a particular embodiment, the present invention provides for the biocatalytic process for the production of rebaudioside 2h from a starting composition comprising rebaudioside M4 and UDP-glucose.
- the present invention provides for the biocatalytic process for the production of rebaudioside 2i from a starting composition comprising rebaudioside M4 and UDP-glucose.
- the present invention provides for the biocatalytic process for the production of rebaudioside 2j from a starting composition comprising rebaudioside M4 and UDP-glucose.
- the present invention provides for the biocatalytic process for the production of rebaudioside 2k from a starting composition comprising rebaudioside M4 and UDP-glucose.
- the present invention provides for the biocatalytic process for the production of rebaudioside 21 from a starting composition comprising rebaudioside M4 and UDP-glucose.
- the present invention provides for the biocatalytic process for the production of rebaudioside 2m from a starting composition comprising rebaudioside M4 and UDP-glucose.
- the present invention provides for the biocatalytic process for the production of rebaudioside 2n from a starting composition comprising rebaudioside M4 and UDP-glucose.
- the present invention provides for the biocatalytic process for the production of rebaudioside 2o from a starting composition comprising rebaudioside M4 and UDP-glucose.
- the present invention provides for the biocatalytic process for the production of rebaudioside 2p from a starting composition comprising rebaudioside M4 and UDP-glucose.
- the present invention provides for the biocatalytic process for the production of rebaudioside 2q from a starting composition comprising rebaudioside M4 and UDP-glucose.
- the present invention provides for the biocatalytic process for the production of rebaudioside 2r from a starting composition comprising rebaudioside M4 and UDP-glucose.
- the present invention provides for the biocatalytic process for the production of rebaudioside 2s from a starting composition comprising rebaudioside M4 and UDP-glucose.
- the present invention provides for the biocatalytic process for the production of rebaudioside lq from a starting composition comprising rebaudioside M4 and UDP-glucose.
- the present invention provides for the biocatalytic process for the production of rebaudioside la from a starting composition comprising rebaudioside M and UDP-glucose.
- the present invention provides for the biocatalytic process for the production of rebaudioside lb from a starting composition comprising rebaudioside M and UDP-glucose. In a particular embodiment, the present invention provides for the biocatalytic process for the production of rebaudioside lc from a starting composition comprising rebaudioside Mand UDP-glucose.
- the present invention provides for the biocatalytic process for the production of rebaudioside Id from a starting composition comprising rebaudioside and UDP-glucose.
- the present invention provides for the biocatalytic process for the production of rebaudioside le from a starting composition comprising rebaudioside and UDP-glucose.
- the present invention provides for the biocatalytic process for the production of rebaudioside If from a starting composition comprising rebaudioside Mand UDP-glucose.
- the present invention provides for the biocatalytic process for the production of rebaudioside Ig from a starting composition comprising rebaudioside Mand UDP-glucose.
- the present invention provides for the biocatalytic process for the production of rebaudioside lh from a starting composition comprising rebaudioside Mand UDP-glucose.
- the present invention provides for the biocatalytic process for the production of rebaudioside li from a starting composition comprising rebaudioside Mand UDP-glucose.
- the present invention provides for the biocatalytic process for the production of rebaudioside lj from a starting composition comprising rebaudioside Mand UDP-glucose.
- the present invention provides for the biocatalytic process for the production of rebaudioside lk from a starting composition comprising rebaudioside Mand UDP-glucose. In a particular embodiment, the present invention provides for the biocatalytic process for the production of rebaudioside 11 from a starting composition comprising rebaudioside Mand UDP-glucose.
- the present invention provides for the biocatalytic process for the production of rebaudioside lm from a starting composition comprising rebaudioside Mand UDP-glucose.
- the present invention provides for the biocatalytic process for the production of rebaudioside In from a starting composition comprising rebaudioside and UDP-glucose.
- the present invention provides for the biocatalytic process for the production of rebaudioside lo from a starting composition comprising rebaudioside Mand UDP-glucose.
- the present invention provides for the biocatalytic process for the production of rebaudioside Ip from a starting composition comprising rebaudioside Mand UDP-glucose.
- the present invention provides for the biocatalytic process for the production of rebaudioside lq from a starting composition comprising rebaudioside M and UDP-glucose.
- the present invention provides for the biocatalytic process for the production of rebaudioside lr from a starting composition comprising rebaudioside Mand UDP-glucose.
- the present invention provides for the biocatalytic process for the production of rebaudioside Is from a starting composition comprising rebaudioside M and UDP-glucose.
- the present invention provides for the biocatalytic process for the production of rebaudioside It from a starting composition comprising rebaudioside Mand UDP-glucose.
- the present invention provides for the biocatalytic process for the production of SvG7 from a starting composition comprising stevioside and UDP-glucose.
- the present invention provides for the biocatalytic process for the production of SvG7 from a starting composition comprising rebaudioside A and UDP-glucose.
- the present invention provides for the biocatalytic process for the production of SvG7 from a starting composition comprising stevioside, rebaudioside A and UDP-glucose.
- the present invention provides for the biocatalytic process for the production of SvG7 from a starting composition comprising rebaudioside AM and UDP-glucose.
- the present invention provides for the biocatalytic process for the production of SvG7 from a starting composition comprising rebaudioside and UDP-glucose.
- the present invention provides for the biocatalytic process for the production of SvG7 from a starting composition comprising rebaudioside M4 and UDP-glucose.
- the method of the present invention further comprises separating the target steviol glycoside from the medium to provide a highly purified target steviol glycoside composition.
- the target steviol glycoside can be separated by any suitable method, such as, for example, crystallization, separation by membranes, centrifugation, extraction, chromatographic separation or a combination of such methods.
- the process described herein results in a highly purified target steviol glycoside composition.
- the term“highly purified”, as used herein, refers to a composition having greater than about 80% by weight of the target steviol glycoside on an anhydrous (dried) basis.
- the highly purified target steviol glycoside composition contains greater than about 90% by weight of the target steviol glycoside on an anhydrous (dried) basis, such as, for example, greater than about 91%, greater than about 92%, greater than about 93%, greater than about 94%, greater than about 95%, greater than about 96%, greater than about 97%, greater than about 98% or greater than about 99% target steviol glycoside content on a dried basis.
- the process described herein when the target steviol glycoside is rebaudioside M4, the process described herein provides a composition having greater than about 90% rebaudioside M4 content by weight on a dried basis. In another particular embodiment, when the target steviol glycoside is rebaudioside M4, the process described herein provides a composition comprising greater than about 95% content by weight on a dried basis.
- the process described herein when the target steviol glycoside is rebaudioside la, the process described herein provides a composition having greater than about 90% rebaudioside la content by weight on a dried basis. In another particular embodiment, when the target steviol glycoside is rebaudioside la, the process described herein provides a composition comprising greater than about 95% content by weight on a dried basis.
- the process described herein when the target steviol glycoside is rebaudioside lb, the process described herein provides a composition having greater than about 90% rebaudioside lb content by weight on a dried basis. In another particular embodiment, when the target steviol glycoside is rebaudioside lb, the process described herein provides a composition comprising greater than about 95% content by weight on a dried basis.
- the process described herein when the target steviol glycoside is rebaudioside lc, the process described herein provides a composition having greater than about 90% rebaudioside lc content by weight on a dried basis. In another particular embodiment, when the target steviol glycoside is rebaudioside lc, the process described herein provides a composition comprising greater than about 95% content by weight on a dried basis.
- the process described herein when the target steviol glycoside is rebaudioside Id, the process described herein provides a composition having greater than about 90% rebaudioside Id content by weight on a dried basis. In another particular embodiment, when the target steviol glycoside is rebaudioside Id, the process described herein provides a composition comprising greater than about 95% content by weight on a dried basis. In one embodiment, when the target steviol glycoside is rebaudioside le, the process described herein provides a composition having greater than about 90% rebaudioside le content by weight on a dried basis. In another particular embodiment, when the target steviol glycoside is rebaudioside le, the process described herein provides a composition comprising greater than about 95% content by weight on a dried basis.
- the process described herein provides a composition having greater than about 90% rebaudioside 2/ content by weight on a dried basis. In another particular embodiment, when the target steviol glycoside is rebaudioside If the process described herein provides a composition comprising greater than about 95% content by weight on a dried basis.
- the process described herein when the target steviol glycoside is rebaudioside Ig, the process described herein provides a composition having greater than about 90% rebaudioside Ig content by weight on a dried basis. In another particular embodiment, when the target steviol glycoside is rebaudioside lg, the process described herein provides a composition comprising greater than about 95% content by weight on a dried basis.
- the process described herein when the target steviol glycoside is rebaudioside lh, the process described herein provides a composition having greater than about 90% rebaudioside lh content by weight on a dried basis. In another particular embodiment, when the target steviol glycoside is rebaudioside lh, the process described herein provides a composition comprising greater than about 95% content by weight on a dried basis.
- the process described herein when the target steviol glycoside is rebaudioside li, the process described herein provides a composition having greater than about 90% rebaudioside li content by weight on a dried basis. In another particular embodiment, when the target steviol glycoside is rebaudioside li, the process described herein provides a composition comprising greater than about 95% content by weight on a dried basis.
- the process described herein when the target steviol glycoside is rebaudioside lj, the process described herein provides a composition having greater than about 90% rebaudioside lj content by weight on a dried basis. In another particular embodiment, when the target steviol glycoside is rebaudioside lj, the process described herein provides a composition comprising greater than about 95% content by weight on a dried basis. In one embodiment, when the target steviol glycoside is rebaudioside lk, the process described herein provides a composition having greater than about 90% rebaudioside lk content by weight on a dried basis. In another particular embodiment, when the target steviol glycoside is rebaudioside lk, the process described herein provides a composition comprising greater than about 95% content by weight on a dried basis.
- the process described herein when the target steviol glycoside is rebaudioside 11, the process described herein provides a composition having greater than about 90% rebaudioside 11 content by weight on a dried basis. In another particular embodiment, when the target steviol glycoside is rebaudioside 11, the process described herein provides a composition comprising greater than about 95% content by weight on a dried basis.
- the process described herein when the target steviol glycoside is rebaudioside 1m, the process described herein provides a composition having greater than about 90% rebaudioside 1m content by weight on a dried basis. In another particular embodiment, when the target steviol glycoside is rebaudioside 1m, the process described herein provides a composition comprising greater than about 95% content by weight on a dried basis.
- the process described herein when the target steviol glycoside is rebaudioside In, the process described herein provides a composition having greater than about 90% rebaudioside In content by weight on a dried basis. In another particular embodiment, when the target steviol glycoside is rebaudioside In, the process described herein provides a composition comprising greater than about 95% content by weight on a dried basis.
- the process described herein when the target steviol glycoside is rebaudioside lo, provides a composition having greater than about 90% rebaudioside lo content by weight on a dried basis. In another particular embodiment, when the target steviol glycoside is rebaudioside lo, the process described herein provides a composition comprising greater than about 95% content by weight on a dried basis.
- the process described herein when the target steviol glycoside is rebaudioside lp, the process described herein provides a composition having greater than about 90% rebaudioside lp content by weight on a dried basis. In another particular embodiment, when the target steviol glycoside is rebaudioside lp, the process described herein provides a composition comprising greater than about 95% content by weight on a dried basis. In one embodiment, when the target steviol glycoside is rebaudioside lq, the process described herein provides a composition having greater than about 90% rebaudioside lq content by weight on a dried basis. In another particular embodiment, when the target steviol glycoside is rebaudioside lq, the process described herein provides a composition comprising greater than about 95% content by weight on a dried basis.
- the process described herein when the target steviol glycoside is rebaudioside lr, the process described herein provides a composition having greater than about 90% rebaudioside lr content by weight on a dried basis. In another particular embodiment, when the target steviol glycoside is rebaudioside lr, the process described herein provides a composition comprising greater than about 95% content by weight on a dried basis.
- the process described herein when the target steviol glycoside is rebaudioside Is, the process described herein provides a composition having greater than about 90% rebaudioside Is content by weight on a dried basis. In another particular embodiment, when the target steviol glycoside is rebaudioside Is, the process described herein provides a composition comprising greater than about 95% content by weight on a dried basis.
- the process described herein when the target steviol glycoside is rebaudioside It, the process described herein provides a composition having greater than about 90% rebaudioside It content by weight on a dried basis. In another particular embodiment, when the target steviol glycoside is rebaudioside It, the process described herein provides a composition comprising greater than about 95% content by weight on a dried basis.
- the process described herein when the target steviol glycoside is rebaudioside 2a, the process described herein provides a composition having greater than about 90% rebaudioside 2a content by weight on a dried basis. In another particular embodiment, when the target steviol glycoside is rebaudioside 2a, the process described herein provides a composition comprising greater than about 95% content by weight on a dried basis.
- the process described herein when the target steviol glycoside is rebaudioside 2b, the process described herein provides a composition having greater than about 90% rebaudioside 2b content by weight on a dried basis. In another particular embodiment, when the target steviol glycoside is rebaudioside 2b, the process described herein provides a composition comprising greater than about 95% content by weight on a dried basis. In one embodiment, when the target steviol glycoside is rebaudioside 2c, the process described herein provides a composition having greater than about 90% rebaudioside 2c content by weight on a dried basis. In another particular embodiment, when the target steviol glycoside is rebaudioside 2c, the process described herein provides a composition comprising greater than about 95% content by weight on a dried basis.
- the process described herein when the target steviol glycoside is rebaudioside 2d, the process described herein provides a composition having greater than about 90% rebaudioside 2d content by weight on a dried basis. In another particular embodiment, when the target steviol glycoside is rebaudioside 2d, the process described herein provides a composition comprising greater than about 95% content by weight on a dried basis.
- the process described herein when the target steviol glycoside is rebaudioside 2e, the process described herein provides a composition having greater than about 90% rebaudioside 2e content by weight on a dried basis. In another particular embodiment, when the target steviol glycoside is rebaudioside 2e, the process described herein provides a composition comprising greater than about 95% content by weight on a dried basis.
- the process described herein when the target steviol glycoside is rebaudioside 2/ the process described herein provides a composition having greater than about 90% rebaudioside 2f content by weight on a dried basis. In another particular embodiment, when the target steviol glycoside is rebaudioside 2f the process described herein provides a composition comprising greater than about 95% content by weight on a dried basis.
- the process described herein when the target steviol glycoside is rebaudioside 2g, the process described herein provides a composition having greater than about 90% rebaudioside 2g content by weight on a dried basis. In another particular embodiment, when the target steviol glycoside is rebaudioside 2g, the process described herein provides a composition comprising greater than about 95% content by weight on a dried basis.
- the process described herein when the target steviol glycoside is rebaudioside 2h, the process described herein provides a composition having greater than about 90% rebaudioside 2h content by weight on a dried basis. In another particular embodiment, when the target steviol glycoside is rebaudioside 2h, the process described herein provides a composition comprising greater than about 95% content by weight on a dried basis. In one embodiment, when the target steviol glycoside is rebaudioside 2i, the process described herein provides a composition having greater than about 90% rebaudioside 2i content by weight on a dried basis. In another particular embodiment, when the target steviol glycoside is rebaudioside 2i, the process described herein provides a composition comprising greater than about 95% content by weight on a dried basis.
- the process described herein when the target steviol glycoside is rebaudioside 2j, the process described herein provides a composition having greater than about 90% rebaudioside 2j content by weight on a dried basis. In another particular embodiment, when the target steviol glycoside is rebaudioside 2j, the process described herein provides a composition comprising greater than about 95% content by weight on a dried basis.
- the process described herein when the target steviol glycoside is rebaudioside 2k, the process described herein provides a composition having greater than about 90% rebaudioside 2k content by weight on a dried basis. In another particular embodiment, when the target steviol glycoside is rebaudioside 2k, the process described herein provides a composition comprising greater than about 95% content by weight on a dried basis.
- the process described herein when the target steviol glycoside is rebaudioside 21, provides a composition having greater than about 90% rebaudioside 21 content by weight on a dried basis. In another particular embodiment, when the target steviol glycoside is rebaudioside 21, the process described herein provides a composition comprising greater than about 95% content by weight on a dried basis.
- the process described herein when the target steviol glycoside is rebaudioside 2m, the process described herein provides a composition having greater than about 90% rebaudioside 2m content by weight on a dried basis. In another particular embodiment, when the target steviol glycoside is rebaudioside 2m, the process described herein provides a composition comprising greater than about 95% content by weight on a dried basis.
- the process described herein when the target steviol glycoside is rebaudioside 2n, the process described herein provides a composition having greater than about 90% rebaudioside 2n content by weight on a dried basis. In another particular embodiment, when the target steviol glycoside is rebaudioside 2n, the process described herein provides a composition comprising greater than about 95% content by weight on a dried basis. In one embodiment, when the target steviol glycoside is rebaudioside 2o, the process described herein provides a composition having greater than about 90% rebaudioside 2o content by weight on a dried basis. In another particular embodiment, when the target steviol glycoside is rebaudioside 2o, the process described herein provides a composition comprising greater than about 95% content by weight on a dried basis.
- the process described herein when the target steviol glycoside is rebaudioside 2p, the process described herein provides a composition having greater than about 90% rebaudioside 2p content by weight on a dried basis. In another particular embodiment, when the target steviol glycoside is rebaudioside 2p, the process described herein provides a composition comprising greater than about 95% content by weight on a dried basis.
- the process described herein when the target steviol glycoside is rebaudioside 2q, the process described herein provides a composition having greater than about 90% rebaudioside 2q content by weight on a dried basis. In another particular embodiment, when the target steviol glycoside is rebaudioside 2q, the process described herein provides a composition comprising greater than about 95% content by weight on a dried basis.
- the process described herein when the target steviol glycoside is rebaudioside 2r, the process described herein provides a composition having greater than about 90% rebaudioside 2r content by weight on a dried basis. In another particular embodiment, when the target steviol glycoside is rebaudioside 2r, the process described herein provides a composition comprising greater than about 95% content by weight on a dried basis.
- the process described herein when the target steviol glycoside is rebaudioside 2s, the process described herein provides a composition having greater than about 90% rebaudioside 2s content by weight on a dried basis. In another particular embodiment, when the target steviol glycoside is rebaudioside 2s, the process described herein provides a composition comprising greater than about 95% content by weight on a dried basis.
- the process described herein when the target steviol glycoside is SvG7, the process described herein provides a composition having greater than about 90% SvG7 content by weight on a dried basis. In another particular embodiment, when the target steviol glycoside is SvG7, the process described herein provides a composition comprising greater than about 95% SvG7 content by weight on a dried basis.
- a microorganism (microbial cell) and/or enzyme preparation is contacted with a medium containing the starting composition to produce target steviol glycosides.
- the enzyme can be provided in the form of a whole cell suspension, a crude lysate, a purified enzyme or a combination thereof.
- the biocatalyst is a purified enzyme capable of converting the starting composition to the target steviol glycoside.
- the biocatalyst is a crude lysate comprising at least one enzyme capable of converting the starting composition to the target steviol glycoside.
- the biocatalyst is a whole cell suspension comprising at least one enzyme capable of converting the starting composition to the target steviol glycoside.
- the biocatalyst is one or more microbial cells comprising enzyme(s) capable of converting the starting composition to the target steviol glycoside.
- the enzyme can be located on the surface of the cell, inside the cell or located both on the surface of the cell and inside the cell.
- Suitable enzymes for converting the starting composition to target steviol glycosides include, but are not limited to, the steviol biosynthesis enzymes, NDP- glucosyltransferases (NGTs), ADP-glucosyltransferases (AGTs), CDP- glucosyltransferases (CGTs), GDP-glucosyltransferases (GGTs), TDP- glucosyltransferases (TDPs), UDP-glucosyltransferases (UGTs).
- the steviol biosynthesis enzymes include mevalonate (MV A) pathway enzymes.
- the steviol biosynthesis enzymes include non-mevalonate 2-C-methyl-D-erythritol-4-phosphate pathway (MEP/DOXP) enzymes.
- the steviol biosynthesis enzymes are selected from the group including geranylgeranyl diphosphate synthase, copalyl diphosphate synthase, kaurene synthase, kaurene oxidase, kaurenoic acid 13-hydroxylase (KAH), steviol synthetase, deoxyxylulose 5 -phosphate synthase (DXS), D-l-deoxyxylulose 5-phosphate reductoisomerase (DXR), 4-diphosphocytidyl-2-C-methyl-D-erythritol synthase (CMS), 4- diphosphocytidyl-2-C-methyl-D-erythritol kinase (CMK), 4-diphosphocytidyl-2-C- methyl-D-erythritol 2,4- cyclodiphosphate synthase (MCS), l-hydroxy-2-methyl-2(E)- butenyl
- the UDP-glucosyltransferase can be any UDP-glucosyltransferase capable of adding at least one glucose unit to steviol and/or a steviol glycoside substrate to provide the target steviol glycoside.
- steviol biosynthesis enzymes and UDP-glucosyltransferases are produced in a microbial cell.
- the microbial cell may be, for example, E. coli, Saccharomyces sp., Aspergillus sp., Pichia sp., Bacillus sp., Yarrowia sp. etc.
- the UDP-glucosyltransferases are synthesized.
- the UDP-glucosyltransferase is selected from group including UGT74G1, UGT85C2, UGT76G1, UGT91D2, UGTS12, EUGT11 and UGTs having substantial (>85%, >86%, >87%, >88%, >89%, >90%, >91%, >92%, >93%, >94%, >95%, >96%, >97%, >98%, >99%) amino-acid sequence identity to these polypeptides as well as isolated nucleic acid molecules that code for these UGTs.
- steviol biosynthesis enzymes, UGTs and UDP-glucose recycling system are present in one microorganism (microbial cell).
- the microorganism may be for example, E. coli, Saccharomyces sp., Aspergillus sp., Pichia sp., Bacillus sp., Yarrowia sp.
- the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to steviol or any starting steviol glycoside bearing an -OH functional group at Cl 3 to give a target steviol glycoside having an -O- glucose beta glucopyranoside glycosidic linkage at Cl 3.
- the UDP-glucosyltransferase is UGT85C2, or a UGT having >85% amino-acid sequence identity with UGT85C2.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to steviol or any starting steviol glycoside bearing a -COOH functional group at C19 to give a target steviol glycoside having a -COO-glucose beta-glucopyranoside glycosidic linkage at Cl 9.
- the UDP-glucosyltransferase is UGT74G1, or a UGT having >85% amino-acid sequence identity with UGT74G1.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to any existing glucose on the C19 side of any starting steviol glycoside to give a target steviol glycoside with at least one additional glucose bearing at least one beta l-»2 glucopyranoside glycosidic linkage(s) at the newly formed glycosidic bond(s).
- the UDP- glucosyltransferase is UGTS12, or a UGT having >85% amino-acid sequence identity with UGTS12.
- the UDP-glucosyltransferase is EUGT11, or a UGT having >85% amino-acid sequence identity with EUGT11.
- the UDP-glucosyltransferase is UGT91D2, or a UGT having >85% amino- acid sequence identity with UGT91D2.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to any existing glucose on the C19 side of any starting steviol glycoside to give a target steviol glycoside with at least one additional glucose bearing at least one beta 1— >3 glucopyranoside glycosidic linkage(s) at the newly formed bond glycosidic bond(s).
- the UDP-glucosyltransferase is UGT76G1, or a UGT having >85% amino-acid sequence identity with UGT76G1.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to any existing glucose on the C 19 side of any starting steviol glycoside to give a target steviol glycoside with at least one additional glucose bearing at least one beta l-»4 glucopyranoside glycosidic linkage(s) at the newly formed glycosidic bond(s).
- the UDP- glucosyltransferase is UGTS12, or a UGT having >85% amino-acid sequence identity with UGTS12.
- the UDP-glucosyltransferase is EUGT11, or a UGT having >85% amino-acid sequence identity with EUGT11.
- the UDP-glucosyltransferase is UGT91D2, or a UGT having >85% amino- acid sequence identity with UGT91D2.
- the UDP- glucosyltransferase is UGT76G1, or a UGT having >85% amino-acid sequence identity with UGT76G1.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to any existing glucose on the C19 side of any starting steviol glycoside to give a target steviol glycoside with at least one additional glucose bearing at least one beta l-»6 glucopyranoside glycosidic linkage(s) at the newly formed glycosidic bond(s).
- the UDP- glucosyltransferase is UGTS12, or a UGT having >85% amino-acid sequence identity with UGTS12.
- the UDP-glucosyltransferase is EUGT11, or a UGT having >85% amino-acid sequence identity with EUGT11.
- the UDP-glucosyltransferase is UGT91D2, or a UGT having >85% amino- acid sequence identity with UGT91D2.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to any existing glucose on the C13 side of any starting steviol glycoside to give a target steviol glycoside with at least one additional glucose bearing at least one beta l®2 glucopyranoside glycosidic linkage(s) at the newly formed glycosidic bond(s).
- the UDP- glucosyltransferase is UGTS12, or a UGT having >85% amino-acid sequence identity with UGTS12.
- the UDP-glucosyltransferase is EUGT11, or a UGT having >85% amino-acid sequence identity with EUGT11.
- the UDP-glucosyltransferase is UGT91D2, or a UGT having >85% amino- acid sequence identity with UGT91D2.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to any existing glucose on the C 13 side of any starting steviol glycoside to give a target steviol glycoside with at least one additional glucose bearing at least one beta 1— >3 glucopyranoside glycosidic linkage(s) at the newly formed bond glycosidic bond(s).
- the UDP-glucosyltransferase is UGT76G1, or a UGT having >85% amino-acid sequence identity with UGT76G1.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to any existing glucose on the C13 side of any starting steviol glycoside to give a target steviol glycoside with at least one additional glucose bearing at least one beta 1— >4 glucopyranoside glycosidic linkage(s) at the newly formed glycosidic bond(s).
- the UDP- glucosyltransferase is UGTS12, or a UGT having >85% amino-acid sequence identity with UGTS12.
- the UDP-glucosyltransferase is EUGT11, or a UGT having >85% amino-acid sequence identity with EUGT11.
- the UDP-glucosyltransferase is UGT91D2, or a UGT having >85% amino- acid sequence identity with UGT91D2.
- the UDP- glucosyltransferase is UGT76G1, or a UGT having >85% amino-acid sequence identity with UGT76G1.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to any existing glucose on the C13 side of any starting steviol glycoside to give a target steviol glycoside with at least one additional glucose bearing at least one beta l- 6 glucopyranoside glycosidic linkage(s) at the newly formed glycosidic bond(s).
- the UDP- glucosyltransferase is UGTS12, or a UGT having >85% amino-acid sequence identity with UGTS12.
- the UDP-glucosyltransferase is EUGT11, or a UGT having >85% amino-acid sequence identity with EUGT11.
- the UDP-glucosyltransferase is UGT91D2, or a UGT having >85% amino- acid sequence identity with UGT91D2.
- the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to steviol to form steviolmonoside.
- the UDP-glucosyltransferase is UGT85C2 or a UGT having >85% amino-acid sequence identity with UGT85C2 or a UGT having >85% amino-acid sequence identity with UGT85C2.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to steviol to form steviolmonoside A.
- the UDP-glucosyltransferase is UGT74G1 or a UGT having >85% amino-acid sequence identity with UGT74G1.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to steviolmonoside to form steviolbioside.
- the UDP-glucosyltransferase is UGTS12 or a UGT having >85% amino-acid sequence identity with UGTS12.
- the UDP-glucosyltransferase is EUGT11, or a UGT having >85% amino- acid sequence identity with EUGT11. In yet another particular embodiment, the UDP- glucosyltransferase is UGT91D2, or a UGT having >85% amino-acid sequence identity with UGT91D2.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to steviolmonoside to form steviolbioside D.
- the UDP-glucosyltransferase is UGT76G1 or a UGT having >85% amino-acid sequence identity with UGT76G1.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to steviolmonoside to form rubusoside.
- the UDP-glucosyltransferase is UGT74G1 or a UGT having >85% amino-acid sequence identity with UGT74G1.
- the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to steviolmonoside A to form rubusoside.
- the UDP-glucosyltransferase is UGT85C2 or a UGT having >85% amino-acid sequence identity with UGT85C2 or a UGT having >85% amino-acid sequence identity with UGT85C2.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to steviolmonoside A to form steviolbioside A.
- the UDP-glucosyltransferase is UGTS12 or a UGT having >85% amino-acid sequence identity with UGTS12.
- the UDP-glucosyltransferase is EUGT11, or a UGT having >85% amino-acid sequence identity with EUGT11.
- the UDP-glucosyltransferase is UGT91D2, or a UGT having >85% amino-acid sequence identity with UGT91D2.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to steviolmonoside A to form steviolbioside B.
- the UDP-glucosyltransferase is UGT76G1 or a UGT having >85% amino-acid sequence identity with UGT76G1.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to steviolbioside to form rebaudioside B.
- the UDP-glucosyltransferase is UGT76G1 or a UGT having >85% amino-acid sequence identity with UGT76G1.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to steviolbioside to form stevioside.
- the UDP-glucosyltransferase is UGT74G1 or a UGT having >85% amino-acid sequence identity with UGT74G1.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to steviolbioside D to form rebaudioside B.
- the UDP-glucosyltransferase is UGTS12 or a UGT having >85% amino-acid sequence identity with UGTS12.
- the UDP-glucosyltransferase is EUGT11, or a UGT having >85% amino- acid sequence identity with EUGT11.
- the UDP- glucosyltransferase is UGT91D2, or a UGT having >85% amino-acid sequence identity with UGT91D2.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to steviolbioside D to form rebaudioside G.
- the UDP-glucosyltransferase is UGT74G1 or a UGT having >85% amino-acid sequence identity with UGT74G1.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to rubusoside to form stevioside.
- the UDP-glucosyltransferase is UGTS12 or a UGT having >85% amino-acid sequence identity with UGTS12.
- the UDP-glucosyltransferase is EUGT11, or a UGT having >85% amino- acid sequence identity with EUGT11.
- the UDP- glucosyltransferase is UGT91D2, or a UGT having >85% amino-acid sequence identity with UGT91D2.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to rubusoside to form rebaudioside G.
- the UDP-glucosyltransferase is UGT76G1 or a UGT having >85% amino-acid sequence identity with UGT76G1.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to rubusoside to form stevioside A.
- the UDP-glucosyltransferase is UGTS12 or a UGT having >85% amino-acid sequence identity with UGTS12.
- the UDP-glucosyltransferase is EUGT11, or a UGT having >85% amino- acid sequence identity with EUGT11.
- the UDP- glucosyltransferase is UGT91D2, or a UGT having >85% amino-acid sequence identity with UGT91D2.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to rubusoside to form stevioside B.
- the UDP-glucosyltransferase is UGT76G1 or a UGT having >85% amino-acid sequence identity with UGT76G1.
- the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to steviolbioside A to form stevioside A.
- the UDP-glucosyltransferase is UGT85C2 or a UGT having >85% amino-acid sequence identity with UGT85C2 or a UGT having >85% amino-acid sequence identity with UGT85C2.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to steviolbioside A to form stevioside C.
- the UDP-glucosyltransferase is UGT76G1 or a UGT having >85% amino-acid sequence identity with UGT76G1.
- the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to steviolbioside B to form stevioside B.
- the UDP-glucosyltransferase is UGT85C2 or a UGT having >85% amino-acid sequence identity with UGT85C2 or a UGT having >85% amino-acid sequence identity with UGT85C2.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to steviolbioside B to form stevioside C.
- the UDP-glucosyltransferase is UGTS12 or a UGT having >85% amino-acid sequence identity with UGTS12.
- the UDP-glucosyltransferase is EUGT11, or a UGT having >85% amino- acid sequence identity with EUGT11.
- the UDP- glucosyltransferase is UGT91D2, or a UGT having >85% amino-acid sequence identity with UGT91D2.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to rebaudioside B to form rebaudioside A.
- the UDP-glucosyltransferase is UGT74G1 or a UGT having >85% amino-acid sequence identity with UGT74G1.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to stevioside to form rebaudioside A.
- the UDP-glucosyltransferase is UGT76G1 or a UGT having >85% amino-acid sequence identity with UGT76G1.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to stevioside to form rebaudioside E.
- the UDP-glucosyltransferase is UGTS12 or a UGT having >85% amino-acid sequence identity with UGTS12.
- the UDP-glucosyltransferase is EUGT11, or a UGT having >85% amino- acid sequence identity with EUGT11.
- the UDP- glucosyltransferase is UGT91D2, or a UGT having >85% amino-acid sequence identity with UGT91D2.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to stevioside to form rebaudioside E2.
- the UDP-glucosyltransferase is UGT76G1 or a UGT having >85% amino-acid sequence identity with UGT76G1.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to rebaudioside G to form rebaudioside A.
- the UDP-glucosyltransferase is UGTS12 or a UGT having >85% amino-acid sequence identity with UGTS12.
- the UDP-glucosyltransferase is EUGT11, or a UGT having >85% amino- acid sequence identity with EUGT11.
- the UDP- glucosyltransferase is UGT91D2, or a UGT having >85% amino-acid sequence identity with UGT91D2.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to rebaudioside G to form rebaudioside E4.
- the UDP-glucosyltransferase is UGTS12 or a UGT having >85% amino-acid sequence identity with UGTS12.
- the UDP-glucosyltransferase is EUGT11, or a UGT having >85% amino- acid sequence identity with EUGT11.
- the UDP- glucosyltransferase is UGT91D2, or a UGT having >85% amino-acid sequence identity with UGT91D2.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to rebaudioside G to form rebaudioside E6.
- the UDP-glucosyltransferase is UGT76G1 or a UGT having >85% amino-acid sequence identity with UGT76G1.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to stevioside A to form rebaudioside E.
- the UDP-glucosyltransferase is UGTS12 or a UGT having >85% amino-acid sequence identity with UGTS12.
- the UDP-glucosyltransferase is EUGT11, or a UGT having >85% amino- acid sequence identity with EUGT11.
- the UDP- glucosyltransferase is UGT91D2, or a UGT having >85% amino-acid sequence identity with UGT91D2.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to stevioside A to form rebaudioside E4.
- the UDP-glucosyltransferase is UGT76G1 or a UGT having >85% amino-acid sequence identity with UGT76G1.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to stevioside A to form rebaudioside E3.
- the UDP-glucosyltransferase is UGT76G1 or a UGT having >85% amino-acid sequence identity with UGT76G1.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to stevioside B to form rebaudioside E2.
- the UDP-glucosyltransferase is UGTS12 or a UGT having >85% amino-acid sequence identity with UGTS12.
- the UDP-glucosyltransferase is EUGT11, or a UGT having >85% amino- acid sequence identity with EUGT11.
- the UDP- glucosyltransferase is UGT91D2, or a UGT having >85% amino-acid sequence identity with UGT91D2.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to stevioside B to form rebaudioside E6.
- the UDP-glucosyltransferase is UGT76G1 or a UGT having >85% amino-acid sequence identity with UGT76G1.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to stevioside B to form rebaudioside E3.
- the UDP-glucosyltransferase is UGTS12 or a UGT having >85% amino-acid sequence identity with UGTS12.
- the UDP-glucosyltransferase is EUGT11, or a UGT having >85% amino- acid sequence identity with EUGT11.
- the UDP- glucosyltransferase is UGT91D2, or a UGT having >85% amino-acid sequence identity with UGT91D2.
- the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to steviolbioside C to form rebaudioside E3.
- the UDP-glucosyltransferase is UGT85C2 or a UGT having >85% amino-acid sequence identity with UGT85C2 or a UGT having >85% amino-acid sequence identity with UGT85C2.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to rebaudioside A to form rebaudioside D.
- the UDP-glucosyltransferase is UGTS12 or a UGT having >85% amino-acid sequence identity with UGTS12.
- the UDP-glucosyltransferase is EUGT11, or a UGT having >85% amino- acid sequence identity with EUGT11.
- the UDP- glucosyltransferase is UGT91D2, or a UGT having >85% amino-acid sequence identity with UGT91D2.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to rebaudioside A to form rebaudioside I.
- the UDP-glucosyltransferase is UGT76G1 or a UGT having >85% amino-acid sequence identity with UGT76G1.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to rebaudioside E to form rebaudioside D.
- the UDP-glucosyltransferase is UGT76G1 or a UGT having >85% amino-acid sequence identity with UGT76G1.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to rebaudioside E to form rebaudioside AM.
- the UDP-glucosyltransferase is UGT76G1 or a UGT having >85% amino-acid sequence identity with UGT76G1.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to rebaudioside E2 to form rebaudioside I.
- the UDP-glucosyltransferase is UGT76G1 or a UGT having >85% amino-acid sequence identity with UGT76G1.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to rebaudioside E2 to form rebaudioside AM.
- the UDP-glucosyltransferase is UGTS12 or a UGT having >85% amino-acid sequence identity with UGTS12.
- the UDP-glucosyltransferase is EUGT11, or a UGT having >85% amino- acid sequence identity with EUGT11.
- the UDP- glucosyltransferase is UGT91D2, or a UGT having >85% amino-acid sequence identity with UGT91D2.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to rebaudioside E4 to form rebaudioside D.
- the UDP-glucosyltransferase is UGTS12 or a UGT having >85% amino-acid sequence identity with UGTS12.
- the UDP-glucosyltransferase is EUGT11, or a UGT having >85% amino- acid sequence identity with EUGT11.
- the UDP- glucosyltransferase is UGT91D2, or a UGT having >85% amino-acid sequence identity with UGT91D2.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to rebaudioside E4 to form rebaudioside D7.
- the UDP-glucosyltransferase is UGT76G1 or a UGT having >85% amino-acid sequence identity with UGT76G1.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to rebaudioside E6 to form rebaudioside I.
- the UDP-glucosyltransferase is UGTS12 or a UGT having >85% amino-acid sequence identity with UGTS12.
- the UDP-glucosyltransferase is EUGT11, or a UGT having >85% amino- acid sequence identity with EUGT11.
- the UDP- glucosyltransferase is UGT91D2, or a UGT having >85% amino-acid sequence identity with UGT91D2.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to rebaudioside E6 to form rebaudioside D7.
- the UDP-glucosyltransferase is UGTS12 or a UGT having >85% amino-acid sequence identity with UGTS12.
- the UDP-glucosyltransferase is EUGT11, or a UGT having >85% amino- acid sequence identity with EUGT11.
- the UDP- glucosyltransferase is UGT91D2, or a UGT having >85% amino-acid sequence identity with UGT91D2.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to rebaudioside E3 to form rebaudioside AM.
- the UDP-glucosyltransferase is UGTS12 or a UGT having >85% amino-acid sequence identity with UGTS12.
- the UDP-glucosyltransferase is EUGT11, or a UGT having >85% amino- acid sequence identity with EUGT11.
- the UDP- glucosyltransferase is UGT91D2, or a UGT having >85% amino-acid sequence identity with UGT91D2.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to rebaudioside E3 to form rebaudioside D7.
- the UDP-glucosyltransferase is UGT76G1 or a UGT having >85% amino-acid sequence identity with UGT76G1.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to rebaudioside D to form rebaudioside M.
- the UDP-glucosyltransferase is UGT76G1 or a UGT having >85% amino-acid sequence identity with UGT76G1.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to rebaudioside / to form rebaudioside M.
- the UDP-glucosyltransferase is UGTS12 or a UGT having >85% amino-acid sequence identity with UGTS12.
- the UDP-glucosyltransferase is EUGT11, or a UGT having >85% amino- acid sequence identity with EUGT11.
- the UDP- glucosyltransferase is UGT91D2, or a UGT having >85% amino-acid sequence identity with UGT91D2.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to rebaudioside AM to form rebaudioside M
- the UDP-glucosyltransferase is UGT76G1 or a UGT having >85% amino-acid sequence identity with UGT76G1.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to rebaudioside AM to form rebaudioside M4.
- the UDP-glucosyltransferase is UGTS12 or a UGT having >85% amino-acid sequence identity with UGTS12.
- the UDP-glucosyltransferase is EUGT11, or a UGT having >85% amino- acid sequence identity with EUGT11.
- the UDP- glucosyltransferase is UGT91D2, or a UGT having >85% amino-acid sequence identity with UGT91D2.
- the UDP-glucosyltransferase is UGT76G1 or a UGT having >85% amino-acid sequence identity with UGT76G1.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to rebaudioside D7 to form rebaudioside M.
- the UDP-glucosyltransferase is UGTS12 or a UGT having >85% amino-acid sequence identity with UGTS12.
- the UDP-glucosyltransferase is EUGT11, or a UGT having >85% amino- acid sequence identity with EUGT11.
- the UDP- glucosyltransferase is UGT91D2, or a UGT having >85% amino-acid sequence identity with UGT91D2.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to rebaudioside M to form rebaudioside la.
- the UDP-glucosyltransferase is UGTS12 or a UGT having >85% amino-acid sequence identity with UGTS12.
- the UDP-glucosyltransferase is EUGT11, or a UGT having >85% amino- acid sequence identity with EUGT11.
- the UDP- glucosyltransferase is UGT91D2, or a UGT having >85% amino-acid sequence identity with UGT91D2.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to rebaudioside M to form rebaudioside lb.
- the UDP-glucosyltransferase is UGT76G1 or a UGT having >85% amino-acid sequence identity with UGT76G1.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to rebaudioside M to form rebaudioside lc.
- the UDP-glucosyltransferase is UGTS12 or a UGT having >85% amino-acid sequence identity with UGTS12.
- the UDP-glucosyltransferase is EUGT11, or a UGT having >85% amino- acid sequence identity with EUGT11.
- the UDP- glucosyltransferase is UGT91D2, or a UGT having >85% amino-acid sequence identity with UGT91D2.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to rebaudioside M to form rebaudioside Id.
- the UDP-glucosyltransferase is UGTS12 or a UGT having >85% amino-acid sequence identity with UGTS12.
- the UDP-glucosyltransferase is EUGT11, or a UGT having >85% amino- acid sequence identity with EUGT11.
- the UDP- glucosyltransferase is UGT91D2, or a UGT having >85% amino-acid sequence identity with UGT91D2.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to rebaudioside M to form rebaudioside le.
- the UDP-glucosyltransferase is UGT76G1 or a UGT having >85% amino-acid sequence identity with UGT76G1.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to rebaudioside M to form rebaudioside If.
- the UDP-glucosyltransferase is UGTS12 or a UGT having >85% amino-acid sequence identity with UGTS12.
- the UDP-glucosyltransferase is EUGT11, or a UGT having >85% amino- acid sequence identity with EUGT11.
- the UDP- glucosyltransferase is UGT91D2, or a UGT having >85% amino-acid sequence identity with UGT91D2.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to rebaudioside M to form rebaudioside Ig.
- the UDP-glucosyltransferase is UGTS12 or a UGT having >85% amino-acid sequence identity with UGTS12.
- the UDP-glucosyltransferase is EUGT11, or a UGT having >85% amino- acid sequence identity with EUGT11.
- the UDP- glucosyltransferase is UGT91D2, or a UGT having >85% amino-acid sequence identity with UGT91D2.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to rebaudioside M to form rebaudioside Ih.
- the UDP-glucosyltransferase is UGT76G1 or a UGT having >85% amino-acid sequence identity with UGT76G1.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to rebaudioside M to form rebaudioside li.
- the UDP-glucosyltransferase is UGTS12 or a UGT having >85% amino-acid sequence identity with UGTS12.
- the UDP-glucosyltransferase is EUGT11, or a UGT having >85% amino- acid sequence identity with EUGT11.
- the UDP- glucosyltransferase is UGT91D2, or a UGT having >85% amino-acid sequence identity with UGT91D2.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to rebaudioside M to form rebaudioside lj.
- the UDP-glucosyltransferase is UGTS12 or a UGT having >85% amino-acid sequence identity with UGTS12.
- the UDP-glucosyltransferase is EUGT11, or a UGT having >85% amino- acid sequence identity with EUGT11.
- the UDP- glucosyltransferase is UGT91D2, or a UGT having >85% amino-acid sequence identity with UGT91D2.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to rebaudioside M to form rebaudioside Ik.
- the UDP-glucosyltransferase is UGT76G1 or a UGT having >85% amino-acid sequence identity with UGT76G1.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to rebaudioside M to form rebaudioside 11.
- the UDP-glucosyltransferase is UGTS12 or a UGT having >85% amino-acid sequence identity with UGTS12.
- the UDP-glucosyltransferase is EUGT11, or a UGT having >85% amino- acid sequence identity with EUGT11.
- the UDP- glucosyltransferase is UGT91D2, or a UGT having >85% amino-acid sequence identity with UGT91D2.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to rebaudioside M to form rebaudioside lm.
- the UDP-glucosyltransferase is UGTS12 or a UGT having >85% amino-acid sequence identity with UGTS12.
- the UDP-glucosyltransferase is EUGT11, or a UGT having >85% amino- acid sequence identity with EUGT11.
- the UDP- glucosyltransferase is UGT91D2, or a UGT having >85% amino-acid sequence identity with UGT91D2.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to rebaudioside M to form rebaudioside In.
- the UDP-glucosyltransferase is UGTS12 or a UGT having >85% amino-acid sequence identity with UGTS12.
- the UDP-glucosyltransferase is EUGT11, or a UGT having >85% amino- acid sequence identity with EUGT11.
- the UDP- glucosyltransferase is UGT91D2, or a UGT having >85% amino-acid sequence identity with UGT91D2.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to rebaudioside M to form rebaudioside lo.
- the UDP-glucosyltransferase is UGTS12 or a UGT having >85% amino-acid sequence identity with UGTS12.
- the UDP-glucosyltransferase is EUGT11, or a UGT having >85% amino- acid sequence identity with EUGT11.
- the UDP- glucosyltransferase is UGT91D2, or a UGT having >85% amino-acid sequence identity with UGT91D2.
- the UDP-glucosyltransferase is UGT76G1 or a UGT having >85% amino-acid sequence identity with UGT76G1.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to rebaudioside M to form rebaudioside lp.
- the UDP-glucosyltransferase is UGTS12 or a UGT having >85% amino-acid sequence identity with UGTS12.
- the UDP-glucosyltransferase is EUGT11, or a UGT having >85% amino- acid sequence identity with EUGT11.
- the UDP- glucosyltransferase is UGT91D2, or a UGT having >85% amino-acid sequence identity with UGT91D2.
- the UDP-glucosyltransferase is UGT76G1 or a UGT having >85% amino-acid sequence identity with UGT76G1.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to rebaudioside M to form rebaudioside lq.
- the UDP-glucosyltransferase is UGTS12 or a UGT having >85% amino-acid sequence identity with UGTS12.
- the UDP-glucosyltransferase is EUGT11, or a UGT having >85% amino- acid sequence identity with EUGT11.
- the UDP- glucosyltransferase is UGT91D2, or a UGT having >85% amino-acid sequence identity with UGT91D2.
- the UDP-glucosyltransferase is UGT76G1 or a UGT having >85% amino-acid sequence identity with UGT76G1.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to rebaudioside M to form rebaudioside lr.
- the UDP-glucosyltransferase is UGTS12 or a UGT having >85% amino-acid sequence identity with UGTS12.
- the UDP-glucosyltransferase is EUGT11, or a UGT having >85% amino- acid sequence identity with EUGT11.
- the UDP- glucosyltransferase is UGT91D2, or a UGT having >85% amino-acid sequence identity with UGT91D2.
- the UDP-glucosyltransferase is UGT76G1 or a UGT having >85% amino-acid sequence identity with UGT76G1.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to rebaudioside M to form rebaudioside Is.
- the UDP-glucosyltransferase is UGTS32 or a UGT having >85% amino-acid sequence identity with UGTS12.
- the UDP-glucosyltransferase is EUGT11, or a UGT having >85% amino- acid sequence identity with EUGT11.
- the UDP- glucosyltransferase is UGT91D2, or a UGT having >85% amino-acid sequence identity with UGT91D2.
- the UDP-glucosyltransferase is UGT76G1 or a UGT having >85% amino-acid sequence identity with UGT76G1.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to rebaudioside M to form rebaudioside It.
- the UDP-glucosyltransferase is UGTS12 or a UGT having >85% amino-acid sequence identity with UGTS12.
- the UDP-glucosyltransferase is EUGT11, or a UGT having >85% amino- acid sequence identity with EUGT11.
- the UDP- glucosyltransferase is UGT91D2, or a UGT having >85% amino-acid sequence identity with UGT91D2.
- the UDP-glucosyltransferase is UGT76G1 or a UGT having >85% amino-acid sequence identity with UGT76G1.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to rebaudioside M4 to form rebaudioside 2a.
- the UDP-glucosyltransferase is UGTS12 or a UGT having >85% amino-acid sequence identity with UGTS12.
- the UDP-glucosyltransferase is EUGT11, or a UGT having >85% amino- acid sequence identity with EUGT11.
- the UDP- glucosyltransferase is UGT91D2, or a UGT having >85% amino-acid sequence identity with UGT91D2.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to rebaudioside M4 to form rebaudioside 2b.
- the UDP-glucosyltransferase is UGT76G1 or a UGT having >85% amino-acid sequence identity with UGT76G1.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to rebaudioside M4 to form rebaudioside 2c.
- the UDP-glucosyltransferase is UGTS12 or a UGT having >85% amino-acid sequence identity with UGTS12.
- the UDP-glucosyltransferase is EUGT11, or a UGT having >85% amino- acid sequence identity with EUGT11.
- the UDP- glucosyltransferase is UGT91D2, or a UGT having >85% amino-acid sequence identity with UGT91D2.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to rebaudioside M4 to form rebaudioside 2d.
- the UDP-glucosyltransferase is UGTS12 or a UGT having >85% amino-acid sequence identity with UGTS12.
- the UDP-glucosyltransferase is EUGT11, or a UGT having >85% amino- acid sequence identity with EUGT11.
- the UDP- glucosyltransferase is UGT91D2, or a UGT having >85% amino-acid sequence identity with UGT91D2.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to rebaudioside M4 to form rebaudioside 2e.
- the UDP-glucosyltransferase is UGT76G1 or a UGT having >85% amino-acid sequence identity with UGT76G1.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to rebaudioside M4 to form rebaudioside 2f
- the UDP-glucosyltransferase is UGTS12 or a UGT having >85% amino-acid sequence identity with UGTS12.
- the UDP-glucosyltransferase is EUGT11, or a UGT having >85% amino- acid sequence identity with EUGT11.
- the UDP- glucosyltransferase is UGT91D2, or a UGT having >85% amino-acid sequence identity with UGT91D2.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to rebaudioside M4 to form rebaudioside 2g.
- the UDP-glucosyltransferase is UGTS12 or a UGT having >85% amino-acid sequence identity with UGTS12.
- the UDP-glucosyltransferase is EUGT11, or a UGT having >85% amino- acid sequence identity with EUGT11.
- the UDP- glucosyltransferase is UGT91D2, or a UGT having >85% amino-acid sequence identity with UGT91D2.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to rebaudioside M4 to form rebaudioside 2h.
- the UDP-glucosyltransferase is UGT76G1 or a UGT having >85% amino-acid sequence identity with UGT76G1.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to rebaudioside M4 to form rebaudioside 2i.
- the UDP-glucosyltransferase is UGTS12 or a UGT having >85% amino-acid sequence identity with UGTS12.
- the UDP-glucosyltransferase is EUGT11, or a UGT having >85% amino- acid sequence identity with EUGT11.
- the UDP- glucosyltransferase is UGT91D2, or a UGT having >85% amino-acid sequence identity with UGT91D2.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to rebaudioside M4 to form rebaudioside 2j.
- the UDP-glucosyltransferase is UGTS12 or a UGT having >85% amino-acid sequence identity with UGTS12.
- the UDP-glucosyltransferase is EUGT11, or a UGT having >85% amino- acid sequence identity with EUGT11.
- the UDP- glucosyltransferase is UGT91D2, or a UGT having >85% amino-acid sequence identity with UGT91D2.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to rebaudioside M4 to form rebaudioside 2k.
- the UDP-glucosyltransferase is UGT76G1 or a UGT having >85% amino-acid sequence identity with UGT76G1.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to rebaudioside M4 to form rebaudioside 21.
- the UDP-glucosyltransferase is UGTS12 or a UGT having >85% amino-acid sequence identity with UGTS12.
- the UDP-glucosyltransferase is EUGT11, or a UGT having >85% amino- acid sequence identity with EUGT11.
- the UDP- glucosyltransferase is UGT91D2, or a UGT having >85% amino-acid sequence identity with UGT91D2.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to rebaudioside M4 to form rebaudioside 2m.
- the UDP-glucosyltransferase is UGTS12 or a UGT having >85% amino-acid sequence identity with UGTS12.
- the UDP-glucosyltransferase is EUGT11, or a UGT having >85% amino- acid sequence identity with EUGT11.
- the UDP- glucosyltransferase is UGT91D2, or a UGT having >85% amino-acid sequence identity with UGT91D2.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to rebaudioside M4 to form rebaudioside 2n.
- the UDP-glucosyltransferase is UGTS12 or a UGT having >85% amino-acid sequence identity with UGTS12.
- the UDP-glucosyltransferase is EUGT11, or a UGT having >85% amino- acid sequence identity with EUGT11.
- the UDP- glucosyltransferase is UGT91D2, or a UGT having >85% amino-acid sequence identity with UGT91D2.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to rebaudioside M4 to form rebaudioside 2o.
- the UDP-glucosyltransferase is UGTS12 or a UGT having >85% amino-acid sequence identity with UGTS12.
- the UDP-glucosyltransferase is EUGT11, or a UGT having >85% amino- acid sequence identity with EUGT11.
- the UDP- glucosyltransferase is UGT91D2, or a UGT having >85% amino-acid sequence identity with UGT91D2.
- the UDP-glucosyltransferase is UGT76G1 or a UGT having >85% amino-acid sequence identity with UGT76G1.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to rebaudioside M4 to form rebaudioside 2p.
- the UDP-glucosyltransferase is UGTS12 or a UGT having >85% amino-acid sequence identity with UGTS12.
- the UDP-glucosyltransferase is EUGT11, or a UGT having >85% amino- acid sequence identity with EUGT11.
- the UDP- glucosyltransferase is UGT91D2, or a UGT having >85% amino-acid sequence identity with UGT91D2.
- the UDP-glucosyltransferase is UGT76G1 or a UGT having >85% amino-acid sequence identity with UGT76G1.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to rebaudioside M4 to form rebaudioside 2q.
- the UDP-glucosyltransferase is UGTS12 or a UGT having >85% amino-acid sequence identity with UGTS12.
- the UDP-glucosyltransferase is EUGT11, or a UGT having >85% amino- acid sequence identity with EUGT11.
- the UDP- glucosyltransferase is UGT91D2, or a UGT having >85% amino-acid sequence identity with UGT91D2.
- the UDP-glucosyltransferase is UGT76G1 or a UGT having >85% amino-acid sequence identity with UGT76G1.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to rebaudioside M4 to form rebaudioside 2r.
- the UDP-glucosyltransferase is UGTS12 or a UGT having >85% amino-acid sequence identity with UGTS12.
- the UDP-glucosyltransferase is EUGT11, or a UGT having >85% amino- acid sequence identity with EUGT11.
- the UDP- glucosyltransferase is UGT91D2, or a UGT having >85% amino-acid sequence identity with UGT91D2.
- the UDP-glucosyltransferase is UGT76G1 or a UGT having >85% amino-acid sequence identity with UGT76G1.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to rebaudioside M4 to form rebaudioside 2s.
- the UDP-glucosyltransferase is UGTS12 or a UGT having >85% amino-acid sequence identity with UGTS12.
- the UDP-glucosyltransferase is EUGT11, or a UGT having >85% amino- acid sequence identity with EUGT11.
- the UDP- glucosyltransferase is UGT91D2, or a UGT having >85% amino-acid sequence identity with UGT91D2.
- the UDP-glucosyltransferase is UGT76G1 or a UGT having >85% amino-acid sequence identity with UGT76G1.
- the UDP-glucosyltransferase is any UDP- glucosyltransferase capable of adding at least one glucose unit to rebaudioside M4 to form rebaudioside lq.
- the UDP-glucosyltransferase is UGTS12 or a UGT having >85% amino-acid sequence identity with UGTS12.
- the UDP-glucosyltransferase is EUGT11, or a UGT having >85% amino- acid sequence identity with EUGT11.
- the UDP- glucosyltransferase is UGT91D2, or a UGT having >85% amino-acid sequence identity with UGT91D2.
- the UDP-glucosyltransferase is UGT76G1 or a UGT having >85% amino-acid sequence identity with UGT76G1.
- the method of the present invention further comprises recycling UDP to provide UDP-glucose.
- the method comprises recycling UDP by providing a recycling catalyst and a recycling substrate, such that the biotransformation of steviol and/or the steviol glycoside substrate to the target steviol glycoside is carried out using catalytic amounts of UDP-glucosyltransferase and UDP-glucose.
- the recycling catalyst is sucrose synthase SuSy_At or a sucrose synthase having >85% amino-acid sequence identity with SuSy_At.
- the recycling substrate for UDP-glucose recycling catalyst is sucrose.
- the method of the present invention further comprises the use of transglycosidases that use oligo- or poly-saccharides as the sugar donor to modify recipient target steviol glycoside molecules.
- transglycosidases that use oligo- or poly-saccharides as the sugar donor to modify recipient target steviol glycoside molecules.
- Non-limiting examples include cyclodextrin glycosyltransferase (CGTase), fructofuranosidase, amylase, saccharase, glucosucrase, beta-h-fructosidase, beta-fructosidase, sucrase, fructosylinvertase, alkaline invertase, acid invertase, fructofuranosidase.
- CGTase cyclodextrin glycosyltransferase
- fructofuranosidase amylase
- saccharase glucosucrase
- glucose and sugar(s) other than glucose including but not limited to fructose, xylose, rhamnose, arabinose, deoxyglucose, galactose are transferred to the recipient target steviol glycosides.
- the recipient steviol glycoside is rebaudioside la, rebaudioside lb, rebaudioside lc, rebaudioside Id, rebaudioside le, rebaudioside If, rebaudioside Ig, rebaudioside lh, rebaudioside li, rebaudioside lj, rebaudioside lk, rebaudioside 11, rebaudioside lm, rebaudioside In, rebaudioside lo, rebaudioside Ip, rebaudioside lq, rebaudioside lr, rebaudioside Is, rebaudioside It, rebaudioside 2a, rebaudioside 2b, rebaudioside 2c, rebaudioside 2d, rebaudioside 2e, rebaudioside 2f rebaudioside 2g, rebaudioside 2h, rebaudioside 2i, rebaudioside 2j, reb
- the UDP-glucosyltransferase capable of adding at least one glucose unit to starting composition steviol glycoside has >85% amino-acid sequence identity with UGTs selected from the following listing of Genlnfo identifier numbers, preferably from the group presented in Table 1, and Table 2.
- One embodiment of the present invention is a microbial cell comprising an enzyme, i.e. an enzyme capable of converting the starting composition to the target steviol glycoside. Accordingly, some embodiments of the present method include contacting a microorganism with a medium containing the starting composition to provide a medium comprising at least one target steviol glycoside.
- the microorganism can be any microorganism possessing the necessary enzyme(s) for converting the starting composition to target steviol glycoside(s). These enzymes are encoded within the microorganism’s genome.
- Suitable microorganisms include, but are not limited to, E.coli, Saccharomyces sp., Aspergillus sp., Pichia sp., Bacillus sp., Yarrowia sp. etc.
- the microorganism is free when contacted with the starting composition.
- the microorganism is immobilized when contacted with the starting composition.
- the microorganism may be immobilized to a solid support made from inorganic or organic materials.
- solid supports suitable to immobilize the microorganism include derivatized cellulose or glass, ceramics, metal oxides or membranes.
- the microorganism may be immobilized to the solid support, for example, by covalent attachment, adsorption, cross-linking, entrapment or encapsulation.
- the enzyme capable of converting the starting composition to the target steviol glycoside is secreted out of the microorganism and into the reaction medium.
- the target steviol glycoside is optionally purified.
- Purification of the target steviol glycoside from the reaction medium can be achieved by at least one suitable method to provide a highly purified target steviol glycoside composition. Suitable methods include crystallization, separation by membranes, centrifugation, extraction (liquid or solid phase), chromatographic separation, HPLC (preparative or analytical) or a combination of such methods.
- target glycoside(s) particularly steviolmonoside, steviolmonoside A, steviolbioside, steviolbioside D, rubusoside, steviolbioside A, steviolbioside B, rebaudioside B, stevioside, rebaudioside G, stevioside A, stevioside B, stevioside C, rebaudioside A, rebaudioside E, rebaudioside E2, rebaudioside E4, rebaudioside E6, rebaudioside E3, rebaudioside D, rebaudioside /, rebaudioside AM, rebaudioside D7, rebaudioside M, rebaudioside M4, rebaudioside la, rebaudioside lb, rebaudioside lc, rebaudioside Id, rebaudioside le, rebaudioside If rebaudioside Ig, rebaudioside lh, rebaudioside li
- Non-limiting examples of flavors include, but are not limited to, lime, lemon, orange, fruit, banana, grape, pear, pineapple, mango, berry, bitter almond, cola, cinnamon, sugar, cotton candy, vanilla and combinations thereof.
- Non-limiting examples of other food ingredients include, but are not limited to, acidulants, organic and amino acids, coloring agents, bulking agents, modified starches, gums, texturizers, preservatives, caffeine, antioxidants, emulsifiers, stabilizers, thickeners, gelling agents and combinations thereof.
- target glycoside(s) particularly steviolmonoside, steviolmonoside A, steviolbioside, steviolbioside D, rubusoside, steviolbioside A, steviolbioside B, rebaudioside B, stevioside, rebaudioside G, stevioside A, stevioside B, stevioside C, rebaudioside A, rebaudioside E, rebaudioside E2, rebaudioside E4, rebaudioside E6, rebaudioside E3, rebaudioside D, rebaudioside /, rebaudioside AM, rebaudioside D7, rebaudioside M, rebaudioside M4, rebaudioside la, rebaudioside lb, rebaudioside lc, rebaudioside Id, rebaudioside le, rebaudioside If rebaudioside lg, rebaudioside lh, rebaudioside l
- target glycoside(s) particularly steviolmonoside, steviolmonoside A, steviolbioside, steviolbioside D, rubusoside, steviolbioside A, steviolbioside B, rebaudioside B, stevioside, rebaudioside G, stevioside A, stevioside B, stevioside C, rebaudioside A, rebaudioside E, rebaudioside E2, rebaudioside E4, rebaudioside E6, rebaudioside E3, rebaudioside D, rebaudioside I, rebaudioside AM, rebaudioside D7, rebaudioside M, rebaudioside M4, rebaudioside la, rebaudioside lb, rebaudioside lc, rebaudioside Id, rebaudioside le, rebaudioside If, rebaudioside lg, rebaudioside lh, rebaudioside l
- the highly purified target glycoside(s) of present invention are present in foodstuffs, beverages, pharmaceutical compositions, cosmetics, chewing gums, table top products, cereals, dairy products, toothpastes and other oral cavity compositions, etc in an amount from about 0.0001% to about 12% by weight, such as, for example, about 0.0001% by weight, about 0.0005% by weight, about 0.001% by weight, about 0.005% by weight, about 0.01% by weight, about 0.05% by weight, about 0.1% by weight, about 0.5% by weight, about 1.0% by weight, about 1.5% by weight, about 2.0% by weight, about 2.5% by weight, about 3.0% by weight, about 3.5% by weight, about 4.0% by weight, about 4.5% by weight, about 5.0% by weight, about 5.5% by weight, about 6.0% by weight, about 6.5% by weight, about 7.0% by weight, about 7.5% by weight, about 8.0% by weight, about 8.5% by weight, about 9.0% by weight, about 9.5% by weight, about 10.0% by weight, about 10.5% by weight,
- the sweetener is present in the beverage in an amount from about 0.0001% by weight to about 8% by weight, such as for example, from about 0.0001% by weight to about 0.0005% by weight, from about 0.0005% by weight to about 0.001% by weight, from about 0.001% by weight to about 0.005% by weight, from about 0.005% by weight to about 0.01% by weight, from about 0.01% by weight to about 0.05% by weight, from about 0.05% by weight to about 0.1% by weight, from about 0.1% by weight to about 0.5% by weight, from about 0.5% by weight to about 1% by weight, from about 1% by weight to about 2% by weight, from about 2% by weight to about 3% by weight, from about 3% by weight to about 4% by weight, from about 4% by weight to about 5% by weight, from about 5% by weight to about 6% by weight, from about 6% by weight to about 7% by weight, and from about 7% by weight to about 8% by weight.
- target glycoside(s) particularly steviolmonoside, steviolmonoside A, steviolbioside, steviolbioside D, rubusoside, steviolbioside A, steviolbioside B, rebaudioside B, stevioside, rebaudioside G, stevioside A, stevioside B, stevioside C, rebaudioside A, rebaudioside E, rebaudioside E2, rebaudioside E4, rebaudioside E6, rebaudioside E3, rebaudioside D, rebaudioside /, rebaudioside AM, rebaudioside D7, rebaudioside M, rebaudioside M4, rebaudioside la, rebaudioside lb, rebaudioside lc, rebaudioside Id, rebaudioside le, rebaudioside If, rebaudioside Ig, rebaudioside Ih, rebaudioside li
- steviolmonoside steviolmonoside, steviolmonoside A, steviolbioside, steviolbioside D, rubusoside, steviolbioside A, steviolbioside B, rebaudioside B, stevioside, rebaudioside G, stevioside A, stevioside B, stevioside C, rebaudioside A, rebaudioside E, rebaudioside E2, rebaudioside E4, rebaudioside E6, rebaudioside E3, rebaudioside D, rebaudioside /, rebaudioside AM, rebaudioside D7, rebaudioside M, rebaudioside M4, rebaudioside la, rebaudioside lb, rebaudioside lc, rebaudioside Id, rebaudioside le, rebaudioside If, rebaudioside Ig, rebaudioside Ih, rebaudioside li, re
- target glycoside(s) particularly steviolmonoside, steviolmonoside A, steviolbioside, steviolbioside D, rubusoside, steviolbioside A, steviolbioside B, rebaudioside B, stevioside, rebaudioside G, stevioside A, stevioside B, stevioside C, rebaudioside A, rebaudioside E, rebaudioside E2, rebaudioside E4, rebaudioside E6, rebaudioside E3, rebaudioside D, rebaudioside I, rebaudioside AM, rebaudioside D7, rebaudioside M, rebaudioside M4, rebaudioside la, rebaudioside lb, rebaudioside lc, rebaudioside Id, rebaudioside le, rebaudioside If, rebaudioside Ig, rebaudioside lh, rebaudioside li
- steviol glycoside(s) particularly steviolmonoside, steviolmonoside A, steviolbioside, steviolbioside D, rubusoside, steviolbioside A, steviolbioside B, rebaudioside B, stevioside, rebaudioside G, stevioside A, stevioside B, stevioside C, rebaudioside A, rebaudioside E, rebaudioside E2, rebaudioside E4, rebaudioside E6, rebaudioside E3, rebaudioside D, rebaudioside 1, rebaudioside AM, rebaudioside D7, rebaudioside M, rebaudioside M4, rebaudioside la, rebaudioside lb, rebaudioside lc, rebaudioside Id, rebaudioside le, rebaudioside If, rebaudioside Ig, rebaudioside lh, reb
- steviol glycoside(s) particularly, steviolmonoside, steviolmonoside A, steviolbioside, steviolbioside D, rubusoside, steviolbioside A, steviolbioside B, rebaudioside B, stevioside, rebaudioside G, stevioside A, stevioside B, stevioside C, rebaudioside A, rebaudioside E, rebaudioside E2, rebaudioside E4, rebaudioside E6, rebaudioside E3, rebaudioside D, rebaudioside 7, rebaudioside AM, rebaudioside 7)7, rebaudioside M, rebaudioside M4, rebaudioside la, rebaudioside lb, rebaudioside lc, rebaudioside Id, rebaudioside le, rebaudioside If, rebaudioside Ig, rebaudioside lh, rebaudio
- steviol glycoside(s) particularly, steviolmonoside, steviolmonoside A, steviolbioside, steviolbioside D, rubusoside, steviolbioside A, steviolbioside B, rebaudioside B, stevioside, rebaudioside G, stevioside A, stevioside B, stevioside C, rebaudioside A, rebaudioside E, rebaudioside E2, rebaudioside E4, rebaudioside E6, rebaudioside E3, rebaudioside D, rebaudioside /, rebaudioside AM, rebaudioside D7, rebaudioside M, rebaudioside M4, rebaudioside la, rebaudioside lb, rebaudioside lc, rebaudioside Id, rebaudioside le, rebaudioside If, rebaudioside lg, rebaudioside Ih, reb
- polyol refers to a molecule that contains more than one hydroxyl group.
- a polyol may be a diol, triol, or a tetraol which contain 2, 3, and 4 hydroxyl groups, respectively.
- a polyol also may contain more than four hydroxyl groups, such as a pentaol, hexaol, heptaol, or the like, which contain 5, 6, or 7 hydroxyl groups, respectively.
- a polyol also may be a sugar alcohol, polyhydric alcohol, or polyalcohol which is a reduced form of carbohydrate, wherein the carbonyl group (aldehyde or ketone, reducing sugar) has been reduced to a primary or secondary hydroxyl group.
- polyols include, but are not limited to, erythritol, maltitol, mannitol, sorbitol, lactitol, xylitol, inositol, isomalt, propylene glycol, glycerol, threitol, galactitol, hydrogenated isomaltulose, reduced isomalto-oligosaccharides, reduced xylo- oligosaccharides, reduced gentio-oligosaccharides, reduced maltose syrup, reduced glucose syrup, hydrogenated starch hydrolyzates, polyglycitols and sugar alcohols or any other carbohydrates capable of being reduced which do not adversely affect the taste of the sweetener composition.
- steviol glycoside(s) particularly steviolmonoside, steviolmonoside A, steviolbioside, steviolbioside D, rubusoside, steviolbioside A, steviolbioside B, rebaudioside B, stevioside, rebaudioside G, stevioside A, stevioside B, stevioside C, rebaudioside A, rebaudioside E, rebaudioside E2, rebaudioside E4, rebaudioside E6, rebaudioside E3, rebaudioside D, rebaudioside I, rebaudioside AM, rebaudioside D7, rebaudioside M, rebaudioside M4, rebaudioside la, rebaudioside lb, rebaudioside lc, rebaudioside Id, rebaudioside le, rebaudioside If rebaudioside lg, rebaudioside lh, rebaudioside
- steviol glycoside(s) particularly steviolmonoside, steviolmonoside A, steviolbioside, steviolbioside D, rubusoside, steviolbioside A, steviolbioside B, rebaudioside B, stevioside, rebaudioside G, stevioside A, stevioside B, stevioside C, rebaudioside A, rebaudioside E, rebaudioside E2, rebaudioside E4, rebaudioside E6, rebaudioside E3, rebaudioside D, rebaudioside I, rebaudioside AM, rebaudioside D7, rebaudioside M, rebaudioside M4, rebaudioside la, rebaudioside lb, rebaudioside lc, rebaudioside Id, rebaudioside le, rebaudioside If, rebaudioside Ig, rebaudioside lh, rebaudioside
- carbohydrate generally refers to aldehyde or ketone compounds substituted with multiple hydroxyl groups, of the general formula (CH 2 0) n , wherein n is 3- 30, as well as their oligomers and polymers.
- the carbohydrates of the present invention can, in addition, be substituted or deoxygenated at one or more positions.
- Carbohydrates, as used herein, encompass unmodified carbohydrates, carbohydrate derivatives, substituted carbohydrates, and modified carbohydrates.
- the phrases “carbohydrate derivatives”,“substituted carbohydrate”, and“modified carbohydrates” are synonymous.
- Modified carbohydrate means any carbohydrate wherein at least one atom has been added, removed, or substituted, or combinations thereof.
- carbohydrate derivatives or substituted carbohydrates include substituted and unsubstituted monosaccharides, disaccharides, oligosaccharides, and polysaccharides.
- the carbohydrate derivatives or substituted carbohydrates optionally can be deoxygenated at any corresponding C-position, and/or substituted with one or more moieties such as hydrogen, halogen, haloalkyl, carboxyl, acyl, acyloxy, amino, amido, carboxyl derivatives, alkylamino, dialkylamino, arylamino, alkoxy, aryloxy, nitro, cyano, sulfo, mercapto, imino, sulfonyl, sulfenyl, sulfmyl, sulfamoyl, carboalkoxy, carboxamido, phosphonyl, phosphinyl, phosphoryl, phosphino, thioester, thioether, oximin
- steviol glycoside(s) particularly steviolmonoside, steviolmonoside A, steviolbioside, steviolbioside D, rubusoside, steviolbioside A, steviolbioside B, rebaudioside B, stevioside, rebaudioside G, stevioside A, stevioside B, stevioside C, rebaudioside A, rebaudioside E, rebaudioside E2, rebaudioside E4, rebaudioside E6, rebaudioside E3, rebaudioside D, rebaudioside 7, rebaudioside AM, rebaudioside 7)7, rebaudioside M, rebaudioside M4, rebaudioside la, rebaudioside 1 b, rebaudioside 7c, rebaudioside Id, rebaudioside le, rebaudioside If, rebaudioside lg, rebaudioside lh, rebaudioside
- Functional ingredients generally are classified into categories such as carotenoids, dietary fiber, fatty acids, saponins, antioxidants, nutraceuticals, flavonoids, isothiocyanates, phenols, plant sterols and stanols (phytosterols and phytostanols); polyols; prebiotics, probiotics; phytoestrogens; soy protein; sulfides/thiols; amino acids; proteins; vitamins; and minerals.
- Functional ingredients also may be classified based on their health benefits, such as cardiovascular, cholesterol-reducing, and anti-inflammatory. Exemplary functional ingredients are provided in WO2013/096420, the contents of which is hereby incorporated by reference.
- steviol glycoside(s) particularly steviolmonoside, steviolmonoside A, steviolbioside, steviolbioside D, rubusoside, steviolbioside A, steviolbioside B, rebaudioside B, stevioside, rebaudioside G, stevioside A, stevioside B, stevioside C, rebaudioside A, rebaudioside E, rebaudioside E2, rebaudioside E4, rebaudioside E6, rebaudioside E3, rebaudioside D, rebaudioside I, rebaudioside AM, rebaudioside D7, rebaudioside M, rebaudioside M4, rebaudioside la, rebaudioside lb, rebaudioside lc, rebaudioside Id, rebaudioside le, rebaudioside If, rebaudioside lg, rebaudioside lh, rebaudio
- steviol glycoside(s) particularly steviolmonoside, steviolmonoside A, steviolbioside, steviolbioside D, rubusoside, steviolbioside A, steviolbioside B, rebaudioside B, stevioside, rebaudioside G, stevioside A, stevioside B, stevioside C, rebaudioside A, rebaudioside E, rebaudioside E2, rebaudioside E4, rebaudioside E6, rebaudioside E3, rebaudioside D, rebaudioside I, rebaudioside AM, rebaudioside D7, rebaudioside M, rebaudioside M4, rebaudioside la, rebaudioside lb, rebaudioside lc, rebaudioside Id, rebaudioside le,
- steviol glycoside(s) particularly steviolmonoside, steviolmonoside A, steviolbioside, steviolbioside D, rubusoside, steviolbioside A, steviolbioside B, rebaudioside B, stevioside, rebaudioside G, stevioside A, stevioside B, stevioside C, rebaudioside A, rebaudioside E, rebaudioside E2, rebaudioside E4, rebaudioside E6, rebaudioside E3, rebaudioside D, rebaudioside I, rebaudioside AM, rebaudioside D7, rebaudioside M, rebaudioside M4, rebaudioside la, rebaudioside lb, rebaudioside lc, rebaudioside Id, rebaudioside le, rebaudioside If rebaudioside lg, rebaudioside lh, rebaudioside
- the conventional methods such as mixing, kneading, dissolution, pickling, permeation, percolation, sprinkling, atomizing, infusing and other methods may be used.
- the highly purified target steviol glycoside can be added before or after heat treatment of food products.
- the present invention is also directed to sweetness enhancement in beverages using steviolmonoside, steviolmonoside A, steviolbioside, steviolbioside D, rubusoside, steviolbioside A, steviolbioside B, rebaudioside B, stevioside, rebaudioside G, stevioside A, stevioside B, stevioside C, rebaudioside A, rebaudioside E, rebaudioside E2, rebaudioside E4, rebaudioside E6, rebaudioside E3, rebaudioside D, rebaudioside 1, rebaudioside AM, rebaudioside D7, rebaudioside M, rebaudioside M4, rebaudioside la, rebaudioside lb, rebaudioside lc, rebaudioside Id, rebaudioside le, rebaudioside If, rebaudioside Ig, rebaudioside lh, rebaudioside
- sweetness enhancer refers to a compound capable of enhancing or intensifying the perception of sweet taste in a composition, such as a beverage.
- sweetness enhancer is synonymous with the terms “sweet taste potentiator,” “sweetness potentiator,” “sweetness amplifier,” and “sweetness intensifier.”
- sweetness recognition threshold concentration is the lowest known concentration of a sweet compound that is perceivable by the human sense of taste, typically around 1.0% sucrose equivalence (1.0% SE).
- the sweetness enhancers may enhance or potentiate the sweet taste of sweeteners without providing any noticeable sweet taste by themselves when present at or below the sweetness recognition threshold concentration of a given sweetness enhancer; however, the sweetness enhancers may themselves provide sweet taste at concentrations above their sweetness recognition threshold concentration.
- the sweetness recognition threshold concentration is specific for a particular enhancer and can vary based on the beverage matrix. The sweetness recognition threshold concentration can be easily determined by taste testing increasing concentrations of a given enhancer until greater than 1.0% sucrose equivalence in a given beverage matrix is detected. The concentration that provides about 1.0% sucrose equivalence is considered the sweetness recognition threshold.
- sweetener is present in the beverage in an amount from about 0.0001% to about 12% by weight, such as, for example, about 0.0001 % by weight, about 0.0005% by weight, about 0.001 % by weight, about 0.005% by weight, about 0.01 % by weight, about 0.05% by weight, about 0.1 % by weight, about 0.5% by weight, about 1.0% by weight, about 1.5% by weight, about 2.0% by weight, about 2.5% by weight, about 3.0% by weight, about 3.5% by weight, about 4.0% by weight, about 4.5% by weight, about 5.0% by weight, about 5.5% by weight, about 6.0% by weight, about 6.5% by weight, about 7.0% by weight, about 7.5% by weight, about 8.0% by weight, about 8.5% by weight, about 9.0% by weight, about 9.5% by weight, about 10.0% by weight, about 10.5% by weight, about 11.0% by weight, about 11.5% by weight or about 12.0% by weight.
- the sweetener is present in the beverage in an amount from about 0.0001% by weight to about 10% by weight, such as for example, from about 0.0001% by weight to about 0.0005% by weight, from about 0.0005% by weight to about 0.001% by weight, from about 0.001% by weight to about 0.005% by weight, from about 0.005% by weight to about 0.01% by weight, from about 0.01% by weight to about 0.05% by weight, from about 0.05% by weight to about 0.1% by weight, from about 0.1% by weight to about 0.5% by weight, from about 0.5% by weight to about 1% by weight, from about 1% by weight to about 2% by weight, from about 2% by weight to about 3% by weight, from about 3% by weight to about 4% by weight, from about 4% by weight to about 5% by weight, from about 5% by weight to about 6% by weight, from about 6% by weight to about 7% by weight, from about 7% by weight to about 8% by weight, from about 8% by weight to about 9% by weight,
- the sweetener is a traditional caloric sweetener.
- Suitable sweeteners include, but are not limited to, sucrose, fructose, glucose, high fructose corn syrup and high fructose starch syrup.
- the sweetener is erythritol.
- the sweetener is a rare sugar.
- Suitable rare sugars include, but are not limited to, D-allose, D-psicose, D-ribose, D-tagatose, L-glucose, L- fucose, L-arabinose, D-turanose, D-leucrose and combinations thereof. It is contemplated that a sweetener can be used alone, or in combination with other sweeteners.
- the rare sugar is D-allose. In a more particular embodiment, D-allose is present in the beverage in an amount of about 0.5% to about 10% by weight, such as, for example, from about 2% to about 8%. In another embodiment, the rare sugar is D-psicose. In a more particular embodiment, D-psicose is present in the beverage in an amount of about 0.5% to about 10% by weight, such as, for example, from about 2% to about 8%.
- the rare sugar is D-ribose.
- D-ribose is present in the beverage in an amount of about 0.5% to about 10% by weight, such as, for example, from about 2% to about 8%.
- the rare sugar is D-tagatose.
- D-tagatose is present in the beverage in an amount of about 0.5% to about 10% by weight, such as, for example, from about 2% to about 8%.
- the rare sugar is L-glucose.
- L-glucose is present in the beverage in an amount of about 0.5% to about 10% by weight, such as, for example, from about 2% to about 8%.
- the rare sugar is L-fucose.
- L-fucose is present in the beverage in an amount of about 0.5% to about 10% by weight, such as, for example, from about 2% to about 8%.
- the rare sugar is L-arabinose.
- L-arabinose is present in the beverage in an amount of about 0.5% to about 10% by weight, such as, for example, from about 2% to about 8%.
- the rare sugar is D-turanose. In a more particular embodiment, D-turanose is present in the beverage in an amount of about 0.5% to about 10% by weight, such as, for example, from about 2% to about 8%. In yet another embodiment, the rare sugar is D-leucrose. In a more particular embodiment, D-leucrose is present in the beverage in an amount of about 0.5% to about 10% by weight, such as, for example, from about 2% to about 8%.
- sweetness enhancer at a concentration at or below its sweetness recognition threshold increases the detected sucrose equivalence of the beverage comprising the sweetener and the sweetness enhancer compared to a corresponding beverage in the absence of the sweetness enhancer.
- sweetness can be increased by an amount more than the detectable sweetness of a solution containing the same concentration of the at least one sweetness enhancer in the absence of any sweetener.
- the present invention also provides a method for enhancing the sweetness of a beverage comprising a sweetener comprising providing a beverage comprising a sweetener and adding a sweetness enhancer selected from steviolmonoside, steviolmonoside A, steviolbioside, steviolbioside D, rubusoside, steviolbioside A, steviolbioside B, rebaudioside B, stevioside, rebaudioside G, stevioside A, stevioside B, stevioside C, rebaudioside A, rebaudioside E, rebaudioside E2, rebaudioside E4, rebaudioside E6, rebaudioside E3, rebaudioside D, rebaudioside 7, rebaudioside AM, rebaudioside D7, rebaudioside M, rebaudioside M4, rebaudioside la, rebaudioside lb, rebaudioside lc, rebaudioside Id,
- steviol glycoside(s) particularly steviolmonoside, steviolmonoside A, steviolbioside, steviolbioside D, rubusoside, steviolbioside A, steviolbioside B, rebaudioside B, stevioside, rebaudioside G, stevioside A, stevioside B, stevioside C, rebaudioside A, rebaudioside E, rebaudioside E2, rebaudioside E4, rebaudioside E6 , rebaudioside E3, rebaudioside D, rebaudioside 7, rebaudioside AM, rebaudioside 7)7, rebaudioside M, rebaudioside M4, rebaudioside la, rebaudioside lb, rebaudioside lc, rebaudioside 7 ⁇ 7, rebaudioside le, rebaudioside If, rebaudioside
- the gene coding for the SuSy_At variant of SEQ ID 1 was cloned into the expression vector pLElAl7 (derivative of pRSF-lb, Novagen). The resulting plasmid was used for transformation of E.coli BL2l(DE3) cells.
- Cells were harvested by centrifugation (3220 x g, 20 rain, 4°C) and re-suspended to an optical density of 200 (measured at 600nm (ODeoo)) with cell lysis buffer (100 mM Tris-HCl pH 7.0; 2 mM MgCb, DNA nuclease 20 U/mL, lysozyme 0.5 mg/mL). Cells were then disrupted by sonication and crude extracts were separated from cell debris by centrifugation (18000 x g 40 min, 4°C). The supernatant was sterilized by filtration through a 0.2 pm filter and diluted 50:50 with distilled water, resulting in an enzymatic active preparation.
- cell lysis buffer 100 mM Tris-HCl pH 7.0; 2 mM MgCb, DNA nuclease 20 U/mL, lysozyme 0.5 mg/mL.
- activity in Units is defined as follows: 1 mU of SuSy_At turns over 1 nmol of sucrose into fructose in 1 minute. Reaction conditions for the assay are 30°C, 50 mM potassium phosphate buffer pH 7.0, 400 mM sucrose at to, 3 mM MgCb, and 15 mM uridine diphosphate (UDP).
- Reaction conditions for the assay are 30°C, 50 mM potassium phosphate buffer pH 7.0, 400 mM sucrose at to, 3 mM MgCb, and 15 mM uridine diphosphate (UDP).
- EXAMPLE 1 The gene coding for the UGTS12 variant of SEQ ID 2 (EXAMPLE 1) was cloned into the expression vector pLElAl7 (derivative of pRSF-lb, Novagen). The resulting plasmid was used for transformation of E.coli BL2l(DE3) cells.
- Cells were harvested by centrifugation (3220 x g, 20 min, 4°C) and re-suspended to an optical density of 200 (measured at 600nm (ODeoo)) with cell lysis buffer (100 mM Tris-HCl pH 7.0; 2 mM MgCF, DNA nuclease 20 U/mL, lysozyme 0.5 mg/mL). Cells were then disrupted by sonication and crude extracts were separated from cell debris by centrifugation (18000 x g 40 min, 4°C). The supernatant was sterilized by filtration through a 0.2 pm filter and diluted 50:50 with 1 M sucrose solution, resulting in an enzymatic active preparation.
- cell lysis buffer 100 mM Tris-HCl pH 7.0; 2 mM MgCF, DNA nuclease 20 U/mL, lysozyme 0.5 mg/mL.
- activity in Units is defined as follows: 1 mU of UGTS12 turns over 1 nmol of rebaudioside A (Reb A) into rebaudioside D (Reb D) in 1 minute. Reaction conditions for the assay are 30°C, 50 mM potassium phosphate buffer pH 7.0, 10 mM Reb A at to, 500 mM sucrose, 3 mM MgCh, 0.25 mM uridine diphosphate (UDP) and 3 U/mL of SuSy At. EXAMPLE 4
- the gene coding for the UGT76G1 variant of SEQ ID 3 was cloned into the expression vector pLElAl7 (derivative of pRSF-lb, Novagen). The resulting plasmid was used for transformation of E.coli BL2l(DE3) cells.
- Cells were harvested by centrifugation (3220 x g, 20 min, 4°C) and re-suspended to an optical density of 200 (measured at 600nm (ODeoo)) with cell lysis buffer (100 mM Tris-HCl pFI 7.0; 2 mM MgCh, DNA nuclease 20 U/mL, lysozyme 0.5 mg/mL). Cells were then disrupted by sonication and crude extracts were separated from cell debris by centrifugation (18000 x g 40 min, 4°C). The supernatant was sterilized by filtration through a 0.2 pm filter and diluted 50:50 with 1 M sucrose solution, resulting in an enzymatic active preparation.
- activity in Units is defined as follows: 1 mU of UGT76G1 turns over 1 nmol of rebaudioside D (Reb D ) into rebaudioside M (Reb M) in 1 minute. Reaction conditions for the assay are 30°C, 50 mM potassium phosphate buffer pH 7.0, 10 mM Reb D at to, 500 mM sucrose, 3 mM MgCh, 0.25 mM uridine diphosphate (UDP) and 3 U/mL of SuSy_At.
- SvG7 molecules were synthesized directly from stevioside (see Fig. 1 la) in a one-pot reaction, utilizing the three enzymes (see EXAMPLES 1, 2, 3 and 4): UGTS12 (variant of SEQ ID 2), SuSy_At (variant of SEQ ID 1) and UGT76G1 (variant of SEQ ID 3).
- the final reaction solution contained 348 U/L UGTS12, 1341 U/L SuSy_At, 10 U/L UGT76G1, 47 mM stevioside, 0.32 mM uridine diphosphate (UDP), 0.99 M sucrose, 3.9 mM MgCl 2 and potassium phosphate buffer (pH 6.6).
- 206 mL of distilled water were mixed with 0.24 g MgCh.OFbO, 102 g sucrose, 9.8 mL of 1.5 M potassium phosphate buffer (pH 6.6) and 15 g stevioside.
- the final volume of the reaction mixture was adjusted to 300 mL.
- HPLC assay was carried out on Agilent HP 1200 HPLC system, comprised of a pump, a column thermostat, an auto sampler, a UV detector capable of background correction and a data acquisition system. Analytes were separated using Agilent Poroshell 120 SB- Cl 8, 4.6 mm x 150 mm, 2.7 pm at 40°C. The mobile phase consisted of two premixes:
- premix 2 containing 68% 10 mM phosphate buffer (pH2.6) and 32% acetonitrile.
- Elution gradient started with premix 1, changed to premix 2 to 50% at 12.5 minute, changed to premix 2 to 100% at 13 minutes. Total run time was 45 minutes.
- the column temperature was maintained at 40 °C.
- the injection volume was 5 pL.
- Rebaudioside species were detected by UV at 210 nm.
- Table 3 shows for each time point the conversion of stevioside into identified rebaudioside species (area percentage).
- the chromatograms of the starting material stevioside and the reaction mixture at 48 hours are shown in Fig. 11a and Fig. l ib respectively.
- retention times can occasionally vary with changes in solvent and/or equipment.
- the steviol glycosides were eluted from the YWD03 resin column by elution with
- HPLC fractions that corresponded to individual compounds from multiple runs were combined according to retention time. The fractions were freeze-dried.
- the purity of obtained fractions was evaluated by analytical HPLC method described in EXAMPLE 6.
- the chromatogram of purified rebaudioside 2a is shown in Fig. 1 lc.
- the chromatogram of purified rebaudioside 2m is shown in Fig. 1 ld.
- Correlation of HSQC and HMBC shows the presence seven anomeric signals, marked with li, lii, liii, liv, lv, lvi and lvii.
- the coupling constant of the anomeric protons of about 8 Hz, the broad signals of their sugar linkage and the NOE-correlations of the anomeric protons allow the identification of these seven sugars as b-D- glucopyranosides.
- Correlation of HSQC and HMBC shows the presence seven anomeric signals, marked with li, lii, liii, liv, lv, lvi and lvii.
- the coupling constant of the anomeric protons of about 8 Hz, the broad signals of their sugar linkage and the NOE-correlations of the anomeric protons allow the identification of these seven sugars as b-D- glucopyranosides.
- compositions, processes, methods, and steps, presently existing or later to be developed that perform substantially the same function or achieve substantially the same result as the corresponding embodiments described herein may be utilized according to the invention.
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Seasonings (AREA)
Abstract
Description
Claims
Priority Applications (9)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA3094203A CA3094203A1 (en) | 2018-03-16 | 2019-03-15 | High-purity steviol glycosides |
AU2019236227A AU2019236227B2 (en) | 2018-03-16 | 2019-03-15 | High-purity steviol glycosides |
BR112020018931-6A BR112020018931A2 (en) | 2018-03-16 | 2019-03-15 | HIGH PURITY STEVIOL GLYCOSIDES |
US16/981,684 US20210002318A1 (en) | 2018-03-16 | 2019-03-15 | High-purity steviol glycosides |
KR1020207029495A KR20200133251A (en) | 2018-03-16 | 2019-03-15 | High-purity steviol glycoside |
EP19767008.6A EP3764815A4 (en) | 2018-03-16 | 2019-03-15 | High-purity steviol glycosides |
JP2020549747A JP2021518369A (en) | 2018-03-16 | 2019-03-15 | High-purity steviol glycoside |
CN201980032858.7A CN112512337A (en) | 2018-03-16 | 2019-03-15 | High purity steviol glycosides |
MX2020009626A MX2020009626A (en) | 2018-03-16 | 2019-03-15 | High-purity steviol glycosides. |
Applications Claiming Priority (12)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201862644065P | 2018-03-16 | 2018-03-16 | |
US62/644,065 | 2018-03-16 | ||
US201862644407P | 2018-03-17 | 2018-03-17 | |
US62/644,407 | 2018-03-17 | ||
USPCT/US2018/026920 | 2018-04-10 | ||
PCT/US2018/026920 WO2019177634A1 (en) | 2018-03-16 | 2018-04-10 | High-purity steviol glycosides |
US201862682461P | 2018-06-08 | 2018-06-08 | |
US62/682,461 | 2018-06-08 | ||
US201862771937P | 2018-11-27 | 2018-11-27 | |
US62/771,937 | 2018-11-27 | ||
US201962806646P | 2019-02-15 | 2019-02-15 | |
US62/806,646 | 2019-02-15 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2019178471A1 true WO2019178471A1 (en) | 2019-09-19 |
Family
ID=67906901
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2019/022456 WO2019178471A1 (en) | 2018-03-16 | 2019-03-15 | High-purity steviol glycosides |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2019178471A1 (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2020112957A1 (en) * | 2018-11-27 | 2020-06-04 | Purecircle Usa Inc. | High-purity steviol glycosides |
WO2020168312A1 (en) * | 2019-02-15 | 2020-08-20 | Purecircle Usa Inc. | High-purity steviol glycosides |
CN111879865A (en) * | 2020-06-13 | 2020-11-03 | 武汉迈特维尔生物科技有限公司 | Method for separating and identifying stevioside |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9907326B2 (en) * | 2014-09-30 | 2018-03-06 | Suntory Beverage & Food Limited | Carbonated beverage, syrup used for preparing carbonated beverage, method for manufacturing carbonated beverage, and method for suppressing foaming in carbonated beverage |
US20190040434A1 (en) * | 2013-05-28 | 2019-02-07 | The Coca-Cola Company | High-Purity Steviol Glycosides |
-
2019
- 2019-03-15 WO PCT/US2019/022456 patent/WO2019178471A1/en active Application Filing
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20190040434A1 (en) * | 2013-05-28 | 2019-02-07 | The Coca-Cola Company | High-Purity Steviol Glycosides |
US9907326B2 (en) * | 2014-09-30 | 2018-03-06 | Suntory Beverage & Food Limited | Carbonated beverage, syrup used for preparing carbonated beverage, method for manufacturing carbonated beverage, and method for suppressing foaming in carbonated beverage |
Non-Patent Citations (2)
Title |
---|
OHTA, M ET AL.: "Characterization of Novel Steviol Glycosides from Leaves of Stevia rebaudiana Morita", JOURNAL OF APPLIED GLYCOSCIENCE, vol. 57, no. 3, 17 August 2010 (2010-08-17), pages 199 - 210, XP055121080 * |
PRAKASH, I ET AL.: "A Novel Diterpene Glycoside with Nine Glucose Units from Stevia rebaudiana Bertoni", BIOMOLECULES, vol. 7, no. 4, 31 January 2017 (2017-01-31), pages 1 - 10, XP055481452 * |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2020112957A1 (en) * | 2018-11-27 | 2020-06-04 | Purecircle Usa Inc. | High-purity steviol glycosides |
WO2020168312A1 (en) * | 2019-02-15 | 2020-08-20 | Purecircle Usa Inc. | High-purity steviol glycosides |
CN111879865A (en) * | 2020-06-13 | 2020-11-03 | 武汉迈特维尔生物科技有限公司 | Method for separating and identifying stevioside |
CN111879865B (en) * | 2020-06-13 | 2021-11-05 | 武汉迈特维尔生物科技有限公司 | Method for separating and identifying stevioside |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20210107933A1 (en) | High-purity steviol glycosides | |
AU2019236279B2 (en) | High-purity steviol glycosides | |
US20210246156A1 (en) | High-purity steviol glycosides | |
EP3887383A1 (en) | High-purity steviol glycosides | |
AU2020221412A1 (en) | High-purity steviol glycosides | |
AU2019236227B2 (en) | High-purity steviol glycosides | |
WO2019178471A1 (en) | High-purity steviol glycosides | |
WO2018213290A1 (en) | High-purity steviol glycosides | |
US20210002318A1 (en) | High-purity steviol glycosides | |
AU2018413277B2 (en) | High-purity steviol glycosides | |
AU2022300626A1 (en) | High-purity steviol glycosides | |
WO2024010442A1 (en) | High-purity steviol glycosides |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 19767008 Country of ref document: EP Kind code of ref document: A1 |
|
ENP | Entry into the national phase |
Ref document number: 3094203 Country of ref document: CA Ref document number: 2020549747 Country of ref document: JP Kind code of ref document: A |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 122022004581 Country of ref document: BR |
|
ENP | Entry into the national phase |
Ref document number: 2019236227 Country of ref document: AU Date of ref document: 20190315 Kind code of ref document: A |
|
ENP | Entry into the national phase |
Ref document number: 20207029495 Country of ref document: KR Kind code of ref document: A |
|
REG | Reference to national code |
Ref country code: BR Ref legal event code: B01A Ref document number: 112020018931 Country of ref document: BR |
|
ENP | Entry into the national phase |
Ref document number: 2019767008 Country of ref document: EP Effective date: 20201016 |
|
ENP | Entry into the national phase |
Ref document number: 112020018931 Country of ref document: BR Kind code of ref document: A2 Effective date: 20200923 |